parsed_lemmas	candidate_id	curated_cbg	split
effect|nacl|,|-lrb-|nh4|-rrb-|2so4|,|COMPOUND_ENTITY|dodecylsulphate|temperature|conformational|property|light-chain|dimer|GENE_ENTITY|fab-fragments|immunoglobulin|g|investigate|use|spin-label|method|.	50527	0.0	7
spasmogenic|,|tachyphylactic|,|vascular|activity|c4a|abrogate|removal|cooh-terminal|COMPOUND_ENTITY|,|property|characteristic|c3a|GENE_ENTITY|c5a|anaphylatoxin|.	50759	0.0	8
attempt|imitate|condition|infant|gut|,|reinvestigate|,|vitro|presence|add|COMPOUND_ENTITY|GENE_ENTITY|transferrin|,|bacteriostatic|activity|e.|coli|fresh|breast-milk|,|commercial|bottle-milk|,|mixture|feed|infant|study|.	51021	0.0	8
injection|COMPOUND_ENTITY|0.75|mg|elicited|increase|GENE_ENTITY|gh|10|control|subject|,|11|atopic|patient|.	51223	0.0	8
glycemic|response|iv|glucose|similar|study|period|;|,|post-prandial|glucose-stimulated|insulin|response|increase|cortisone|COMPOUND_ENTITY|plus|GENE_ENTITY|gh|therapy|.	51441	0.0	7
GENE_ENTITY|diminish|absorbance|change|epinephrine|,|stop|conversion|COMPOUND_ENTITY|prostaglandin|.	51474	0.0	8
intravenously|administer|COMPOUND_ENTITY|,|0.5|mg/kg|,|cause|consistent|rise|human|serum|GENE_ENTITY|growth|hormone|level|,|peak|value|usually|occur|30|minute|infusion|.	51485	0.0	8
amino|terminus|fibrinogen|moiety|cryofibrinogen|find|consist|COMPOUND_ENTITY|,|tyrosine|,|small|quantity|aspartic|acid|,|consistent|nh2|terminal|moiety|composition|normal|GENE_ENTITY|fibrinogen|soluble|fibrin|monomer|complex|.	51762	0.0	8
mean|plasma|GENE_ENTITY|correlate|significantly|mean|plasma|COMPOUND_ENTITY|dose|drug|.	51796	0.0	8
conclude|study|decrease|sodium|efflux|erythrocyte|patient|hyperthyroidism|associate|decrease|activity|COMPOUND_ENTITY|component|GENE_ENTITY|atpase|erythrocyte|membrane|.	52167	0.0	7
average|dimension|filament|grow|predialysed|GENE_ENTITY|absence|COMPOUND_ENTITY|+|328|nm|long|,|13|nm|wide|bare|central|zone|111|nm|long|.	52188	0.0	7
Sera|canine|patient|contain|isoenzyme|GENE_ENTITY|phosphatase|-lrb-|alp|-rrb-|resemble|intestinal|alp|respect|heat|inactivation|,|COMPOUND_ENTITY|inhibition|,|sensitivity|anti-canine|intestinal|alp|antibody|,|differ|regard|electrophoretic|migration|.	52221	0.0	7
prostaglandin|e1|potent|stimulator|COMPOUND_ENTITY|cyclase|group|,|GENE_ENTITY|naf|.	52231	0.0	8
plasma|level|chlorpromazine|-lrb-|cpz|-rrb-|GENE_ENTITY|measure|repeatedly|14|psychiatric|patient|COMPOUND_ENTITY|treatment|.	52380	0.0	8
-lrb-|4|-rrb-|Free|radical|scavenger|prevent|reverse|COMPOUND_ENTITY|+|inhibiton|GENE_ENTITY|cytochrome|c3|+|reduction|xanthine|oxidase|.	52708	0.0	7
norepinephrine|-lrb-|ne|-rrb-|,|dopamine|-lrb-|da|-rrb-|,|COMPOUND_ENTITY|hydroxylase|-lrb-|th|-rrb-|,|catechol-o-methyltransferase|-lrb-|GENE_ENTITY|comt|-rrb-|monoamine|oxidase|-lrb-|mao|-rrb-|level|measure|human|brain|tissue|obtain|autopsy|series|39|patient|die|medical|accidental|cause|.	52739	0.0	7
plasma|renin|concentration|find|strong|predict|power|hypotensive|effect|atenolol|bendrofluazide|low|GENE_ENTITY|patient|pronounced|blood|pressure|decrease|bendrofluazide|high|renin|patient|,|especially|essential|hypertensive|,|COMPOUND_ENTITY|.	53257	0.0	8
binding|COMPOUND_ENTITY|spin|label|microsomal|GENE_ENTITY|cytochrome|p-450|.	53379	1.0	7
fviii/vwf|isolate|preparative|counter|immunoelectrophoresis|directly|plasma|use|antibody|factor|viii-related|antigen|,|reduce|sodium|dodecyl|sulfate|presence|COMPOUND_ENTITY|,|electrophorese|5|%|polyacrylamide|gel|separate|GENE_ENTITY|fviii/vwf|subunit|protein|.	53510	0.0	8
COMPOUND_ENTITY|GENE_ENTITY|rbp|molecule|enhance|affinity|pa|,|resumably|change|tertiary|structure|,|presence|retinol|essential|protein-protein|interaction|.	54641	0.0	8
relative|GENE_ENTITY|potency|human|chlorpromazine|,|thioridazine|,|trifluoperazine|,|butaperazine|,|COMPOUND_ENTITY|correlate|relative|clinical|potency|.	54740	0.0	7
parathyroid|hormone|-lrb-|GENE_ENTITY|-rrb-|prostaglandin|e1|-lrb-|COMPOUND_ENTITY|-rrb-|produce|dose-related|increase|camp|level|calcium|efflux|isolate|tubule|.	54771	0.0	7
lower|nocturnal|release|prolactin|testosterone|occur|man|feed|vegetarian|diet|,|woman|,|COMPOUND_ENTITY|administration|decrease|nocturnal|release|GENE_ENTITY|prolactin|cause|greater|decrease|plasma|dehydroepiandrosterone|-lrb-|dhea|-rrb-|.	54790	0.0	7
malondialdehyde|-lrb-|COMPOUND_ENTITY|-rrb-|formation|induce|collagen|GENE_ENTITY|thrombin|study|subgroup|8|patient|.	54891	0.0	8
result|evaluate|4|variant|:|1|-rrb-|positive|sucrose|test|presence|shf|erythrocyte|,|2|-rrb-|positive|sucrose|test|presence|GENE_ENTITY|foreign|erythrocyte|,|3|-rrb-|authohaemolysis|10|%|COMPOUND_ENTITY|0.9|%|nacl|solution|,|4|-rrb-|haemolysis|foreign|erythrocyte|10|%|sucrose|0.9|%|nacl|.	55398	0.0	8
methylate|insulin|dimethyl|proton|resonance|COMPOUND_ENTITY|,|phenylalanine-b1|lysine-b29|follow|function|pH.|native|GENE_ENTITY|insulin|pkapp|value|6.7|8.0|obtain|phenylalanine-b1|glycine-a1|-lrb-|assignment|tentative|-rrb-|11.2|lysine-b29|.	55410	0.0	7
evidence|present|indicate|bisulfite|ion|-lrb-|hso3|-|-rrb-|add|GENE_ENTITY|carbonyl|group|dinoprostone|-lrb-|COMPOUND_ENTITY|-rrb-|delta|10,11|-|bond|prostaglandin|a2|.	55702	0.0	8
blood|COMPOUND_ENTITY|level|determine|Lactate|Analyzer|640|Kontron|67|adult|GENE_ENTITY|insulin-independent|diabetic|hypoglycemic|treatment|usual|therapeutical|dose|phenformin|.	55885	0.0	8
prospective|study|renal|funcition|healthy|people|patient|ra|start|COMPOUND_ENTITY|therapeutic|dose|epithelial|cell|excretion|transiently|raise|group|excretion|GENE_ENTITY|nag|increase|case|day|increase|sustain|10|day|,|value|higher|patient|healthy|subject|.	56319	0.0	8
,|feel|GENE_ENTITY|urokinase|catalyze|cleavage|nh2-terminal|peptide|bond|Glu-Pga|glu-ha|heavy|chain|COMPOUND_ENTITY|.	56353	0.0	7
Group|iv|patient|normal|basal|level|lh|normal|lh|,|GENE_ENTITY|COMPOUND_ENTITY|response|.	56403	0.0	7
comparison|healthy|control|similar|age|sex|,|COMPOUND_ENTITY|user|significantly|higher|hdl|cholesterol|-lrb-|p|0.001|-rrb-|GENE_ENTITY|apolipoprotein|a-i|-lrb-|p|0.01|-rrb-|level|.	56414	0.0	7
stoichiometry|labeling|GENE_ENTITY|proteolytic|fragment|purine|disulfide|analog|COMPOUND_ENTITY|triphosphate|.	56417	0.0	7
ca2|+|-|,|mg2|+|-|,|COMPOUND_ENTITY|activity|control|dtnb|myosin|practically|,|superprecipitation|actomyosin|prepare|actin|dtnb|GENE_ENTITY|myosin|occur|slowly|control|myosin|.	56705	0.0	7
result|suggest|GENE_ENTITY|act|COMPOUND_ENTITY|esterse|serine|protease|,|,|putative|enzyme|present|activated|form|supernatant|mitogen-stimulated|mononuclear|cell|.	56868	0.0	8
measurement|plasma|glucose|,|GENE_ENTITY|glucagon|maturity|onset|diabetic|patient|follow|oral|glucose|tolerance|test|oral|galactose|tolerance|test|week|treatment|COMPOUND_ENTITY|.	57181	0.0	7
application|apf|GENE_ENTITY|solution|extract|human|tooth|reduce|extent|enamel|subsurface|demineralization|induce|colonization|S.|mutan|ineffective|demineralization|acid|COMPOUND_ENTITY|buffer|.	57264	0.0	7
effect|thyroid|hormone|,|COMPOUND_ENTITY|d|,|cycloheximide|puromycin|GENE_ENTITY|trh-induced|secretion|tsh|,|study|pituitary|concentration|cyclic|amp|intrathyroidal|colloid|droplet|formation|.	57617	0.0	8
selective|blockade|COMPOUND_ENTITY|change|indicate|beta1-adrenoreceptor|mediate|change|plasma|GENE_ENTITY|renin|activity|.	57853	0.0	8
preparative|route|describe|include|:|-lrb-|-rrb-|displacement|carbonate|fe3|+|-|transferrin-co32|-|low|ph|follow|removal|co2|technique|;|-lrb-|b|-rrb-|addition|fecl3|apotransferrin|GENE_ENTITY|condition|;|-lrb-|c|-rrb-|oxidation|fe2|+|presence|apotransferrin|co2-free|condition|;|-lrb-|d|-rrb-|reaction|apotransferrin|nonsubstituting|COMPOUND_ENTITY|+|complex|absence|co2|;|-lrb-|e|-rrb-|attempt|displace|anion|weak|fe3|+|-|transferrin-anion|complex|.	58605	0.0	7
increase|conformational|stability|mitochondrial|soluble|GENE_ENTITY|-lrb-|f1|-rrb-|substitution|h2o|COMPOUND_ENTITY|.	58871	1.0	7
major|question|mechanism|myosin|atpase|fluorescence|change|accompany|binding|COMPOUND_ENTITY|GENE_ENTITY|myosin|conformational|change|induce|atp|subsequent|hydrolysis|atp|initial|pi|burst|.	59101	0.0	7
effect|ihp|COMPOUND_ENTITY|kinetics|GENE_ENTITY|methemoglobin|examine|.	59206	0.0	7
GENE_ENTITY|act|esterase|protease|strengthen|ability|pralidoxime|methansulfonate|-lrb-|COMPOUND_ENTITY|-rrb-|reestablish|lif|activity|supernatant|previously|inactivate|pmsf|.	59233	0.0	8
GENE_ENTITY|supernatant|factor|responsible|cgmp-generating|effect|render|inactive|treatment|COMPOUND_ENTITY|esterase|protease|inhibitor|,|phenylmethylsulfonyl|fluoride|,|indicate|factor|closely|related|,|identical|.	59476	0.0	8
-lrb-|2|-rrb-|edta-washing|procedure|remove|COMPOUND_ENTITY|chain|,|cause|desensitization|Akazara|GENE_ENTITY|myosin|.	59529	0.0	7
sarcoidosis|therapy|COMPOUND_ENTITY|GENE_ENTITY|acth|--|role|acth|therapy|.	59634	0.0	7
presence|alpha-adrenoceptor|block|agent|,|phenoxybenzamine|-lrb-|2-9|GENE_ENTITY|-rrb-|COMPOUND_ENTITY|-lrb-|3-1|mum|-rrb-|,|increase|transmitter|overflow|obtain|stimulation|6-5|8-3-fold|respectively|.	59642	0.0	7
activity|hexokinase|,|glucokinase|,|phosphofructokinase|,|GENE_ENTITY|dehydrogenase|,|glucose-6-phosphatase|,|fructose-1|,6|-|diphosphatase|determine|loach|embryo|develop|solution|insulin|,|COMPOUND_ENTITY|,|estrone|thyroxin|different|stage|embryogenesis|.	59978	0.0	8
lack|COMPOUND_ENTITY|stimulation|GENE_ENTITY|gastrin|release|man|.	60010	0.0	8
effect|stimulant|drug|,|dextroamphetamine|COMPOUND_ENTITY|,|secretion|GENE_ENTITY|growth|hormone|hyperactive|child|.	60105	0.0	8
independent|method|,|atpase|activity|measurement|analysis|elution|pattern|COMPOUND_ENTITY|column|,|introduction|trinitrophenyl|group|GENE_ENTITY|myosin|heavy|meromyosin|subfragment|1|molecule|responsible|remarkable|change|atpase|activity|.	60402	0.0	7
superprecipitation|induce|atp|markedly|enhance|sa-blocking|high|concentration|COMPOUND_ENTITY|+|substrate|;|increase|affinity|GENE_ENTITY|myosin|actin|block|Sa|.	60629	0.0	7
mechanism|ristocetin|induce|platelet|agglutination|presence|GENE_ENTITY|factor|study|chemically|alter|ristocetin|similar|antibiotic|,|COMPOUND_ENTITY|,|reaction|water-soluble|carbodiimide|presence|glycine|methyl|ester|ph|4.75|.	60958	0.0	8
day|1|,|response|lh|GENE_ENTITY|significantly|-lrb-|p|0.05|-rrb-|reduce|COMPOUND_ENTITY|,|day|2|value|control|treated|group|similar|significantly|-lrb-|p|0.05|-rrb-|lower|value|day|1|.	61212	0.0	7
p-chlorophenylalanine|,|produce|depletion|GENE_ENTITY|5-ht|concentration|,|effect|qualitatively|similar|previously|find|chronic|chlordiazepoxide|acute|COMPOUND_ENTITY|social|interaction|test|anxiety|.	61237	0.0	7
compare|effect|exogenous|COMPOUND_ENTITY|meal-stimulated|GENE_ENTITY|gastrin|plasma|immunoreactive|calcitonin|-lrb-|ict|-rrb-|study|13|normal|adult|man|.	61460	0.0	7
use|radioactive|steroid|substrate|GENE_ENTITY|c19|configuration|,|kinetic|study|tissue|major|pathway|COMPOUND_ENTITY|production|delta5|pathway|,|i.e.|pregnenolone|lead|17|alpha-hydroxypregnenolone|lead|dehydroepiandrosterone|lead|androstenedione|androstenediol|lead|testosterone|,|accumulation|dehydroepiandrosterone|androstenediol|.	61709	0.0	8
COMPOUND_ENTITY|inhibition|action|potential|GENE_ENTITY|prolactin|secreting|cell|line|modulate|oestrogen|.	61786	0.0	7
COMPOUND_ENTITY|deiodination|associate|GENE_ENTITY|nadph-dependent|lipid|peroxidation|submicrosomal|system|.	62139	0.0	7
luteinize|hormone|response|luteinize|hormone|release|hormone|,|GENE_ENTITY|hormone|COMPOUND_ENTITY|response|insulin|induce|hypoglycaemia|functional|secondary|amenorrhoea|.	62202	0.0	7
COMPOUND_ENTITY|chain|isolate|akazara|myofibril|able|resensitize|edta-washed|akazara|GENE_ENTITY|myosin|.	62780	1.0	7
s-protein|stable|acid|GENE_ENTITY|,|,|evidence|reversible|denaturation|ph|3|26|degree|c.|his-48|s-protein|titrate|normally|lower|pk|rn-ase-a|probably|absence|COMPOUND_ENTITY|,|rn-ase-a|form|hydrogen|bond|his-48|cause|inaccessible|solvent|,|ph|value|9|.	62781	0.0	7
comparative|study|use|human|serum|indicate|t4|binding|serum|t4-binding|prealbumin|-lrb-|tbpa|-rrb-|inhibit|dnp|COMPOUND_ENTITY|,|binding|t4|t3|serum|GENE_ENTITY|t4-binding|globulin|-lrb-|tbg|-rrb-|decrease|dph|.	62831	0.0	8
response|significantly|higher|patient|duodenal|ulcer|healthy|subject|,|appear|involve|GENE_ENTITY|release|,|affect|COMPOUND_ENTITY|,|strongly|suppress|histamine|h2-blocker|.	63137	0.0	7
early|effect|25-hydroxycholecalciferol|-lrb-|COMPOUND_ENTITY|-rrb-|1,25-dihydroxycholecalciferol|-lrb-|1,25|-|-lrb-|oh|-rrb-|2-d3|-rrb-|ability|GENE_ENTITY|parathyroid|hormone|-lrb-|pth|-rrb-|elevate|cyclic|amp|intact|bone|cell|.	63304	0.0	7
attempt|study|functional|relation|pituitary|cyclic|amp|tsh|secretion|response|thyrotropin|release|hormone|-lrb-|GENE_ENTITY|-rrb-|thyroid|hormone|administration|,|pituitary|concentration|cyclic|amp|measure|protein|binding|assay|vivo|vitro|administration|test|material|-lrb-|trh|,|thyroxine|,|triiodothyronine|,|COMPOUND_ENTITY|d|,|puromycin|cycloheximide|singly|combination|-rrb-|.	63447	0.0	8
fibrinogen|,|fibrinogen|digest|GENE_ENTITY|,|purify|fragment|e|purify|fragment|d|interfere|reaction|plasmin|alpha2-antiplasmin|compete|alpha2-antiplasmin|COMPOUND_ENTITY|site|-lrb-|s|-rrb-|plasmin|a-chain|.	63560	0.0	8
COMPOUND_ENTITY|+|,|0.25|4|mm|,|increase|GENE_ENTITY|fmlp-induced|superoxide|generation|lower|extent|ca2|+|.	63617	0.0	8
owe|broad|spectrum|action|-lrb-|cover|gram-positive|gram-negative|microorganism|anaerobe|-rrb-|consistently|strong|molar|action|,|COMPOUND_ENTITY|suit|GENE_ENTITY|beta-lactam|combination|component|intensive|care|patient|.	63789	0.0	7
free|alveolar|macrophage|active|LDH|,|mdh|,|sdh|,|nadh-tr|nadph-tr|,|g1-6-ph-dh|,|acid|alkaline|phosphatase|,|cytochrome-oxidase|peroxidase|,|GENE_ENTITY|,|amp-ase|mg2|+|-|activate|COMPOUND_ENTITY|,|tween-esterase|,|naphthol-asd-acetate|esterase|,|beta-galactosidase|.	64118	0.0	8
MST|patient|receive|MTX|significantly|longer|patient|receive|GENE_ENTITY|Survival|influence|COMPOUND_ENTITY|administration|.	64270	0.0	8
COMPOUND_ENTITY|8|microgram|kg-1|min-1|produce|marked|increase|cardiac|index|2.47|3.47|litre|GENE_ENTITY|min-1|m-2|small|change|heart|rate|-lrb-|65|68|beat|min-1|-rrb-|.	64426	0.0	7
effect|oral|contraceptive|contain|new|progestin|-lrb-|COMPOUND_ENTITY|-rrb-|plasma|renin|activity|,|GENE_ENTITY|growth|hormone|immunoreactive|insulin|.	64488	0.0	7
basis|hypothesis|opiate-like|neuropeptide|,|GENE_ENTITY|,|involve|etiology|schizophrenic|symptom|,|COMPOUND_ENTITY|1,2|mg|placebo|administer|intravenously|8|schizophrenic|patient|,|use|double-blind|,|crossover|design|.	64510	0.0	7
adipose|cell|larger|100|mum|responsive|-lrb-|express|absolute|effect|-rrb-|lipolytic|action|COMPOUND_ENTITY|antilipolytic|effect|GENE_ENTITY|insulin|.	64814	0.0	7
plasmodium|GENE_ENTITY|b|incubate|55|degree|c|15|min|presence|COMPOUND_ENTITY|treat|90|%|acetone|.	65413	0.0	7
GENE_ENTITY|inactivation|course|catalysis|chlorination|COMPOUND_ENTITY|.	65452	0.0	8
apomorphine|,|direct-acting|COMPOUND_ENTITY|agonist|,|stimulate|release|growth|hormone|-lrb-|hgh|-rrb-|suppress|release|GENE_ENTITY|prolactin|-lrb-|prl|-rrb-|anterior|pituitary|.	102724	0.0	7
inhibition|thyrotropin|GENE_ENTITY|secretion|COMPOUND_ENTITY|man|.	102857	0.0	7
similarly|,|mean|value|GENE_ENTITY|induce|COMPOUND_ENTITY|0.98|+|/|-|0.18|nmole|decrease|-lrb-|p|0.02|-rrb-|compare|value|1.26|+|/|-|0.2|control|.	102928	0.0	8
order|equalize|experimental|circumstance|,|standard|dilution|serum|free|vitamin|b-12|boil|serum|20|min|4-fold|dilution|COMPOUND_ENTITY|acid|buffer|ph|3.3|subsequent|passage|ch-sepharose|4-b|column|complex|hog|GENE_ENTITY|intrinsic|factor|-lrb-|-rrb-|.	103042	0.0	8
stimulation|GENE_ENTITY|biosynthesis|insulin|release|pyruvate|COMPOUND_ENTITY|.	103167	0.0	8
drug|ingestion|associate|enhancement|drug-metabolizing|enzyme|patient|severe|liver|disease|;|COMPOUND_ENTITY|demethylase|activity|enhance|proportionately|aryl|hydrocarbon|hydroxylase|activity|GENE_ENTITY|cytochrome|p-450|concentration|.	103370	0.0	7
suggest|COMPOUND_ENTITY|influence|depend|inhibition|GENE_ENTITY|catecol-o-metiltransferase|-lrb-|comt|-rrb-|.	103460	0.0	8
prove|highly|specific|,|potent|competitive|inhibitor|-lrb-|-rrb-|arginine|analog|l-canavanine|l-ornithine|,|-lrb-|ii|-rrb-|COMPOUND_ENTITY|analog|l-5|aminoethylcysteine|GENE_ENTITY|l-4|,5|-|transdehydrolysine|.	103560	0.0	7
identification|base|quantitative|cross-reactivity|muscle|activator|protein|brain|modulator|protein|activate|GENE_ENTITY|kinase|brain|phosphodiesterase|identical|property|protein|regard|sensitivity|ca2|+|,|uv|absorption|spectrum|,|uv|absorption|difference|spectrum|COMPOUND_ENTITY|+|,|mobility|sodium|dodecyl|sulfate-polyacrylamide|gel|electrophoresis|.	103690	0.0	8
effect|plp|COMPOUND_ENTITY|relaxation|coronary|artery|study|vitro|,|known|inhibitor|GENE_ENTITY|COMT|,|Pyrogallol|.	103923	0.0	8
consequently|,|GENE_ENTITY|COMPOUND_ENTITY|use|combination|,|appropriate|dose|schedule|change|avoid|potentially|effect|.	104759	0.0	8
COMPOUND_ENTITY|,|dopamine|receptor|antagonist|,|prevent|GENE_ENTITY|beta-endorphin-induced|catalepsy|increase|striatal|dopac|hva|.	105064	0.0	7
10|mm|COMPOUND_ENTITY|gel|difference|GENE_ENTITY|properdin|value|obtain|different|method|find|.	105595	0.0	8
result|chemotherapy|regimen|utilize|adriamycin|combination|vincristine|,|prednisone|plus|minus|COMPOUND_ENTITY|-lrb-|chop-hop|-rrb-|treatment|non-hodgkin|lymphoma|compare|non-adriamycin|contain|combination|-lrb-|GENE_ENTITY|cop|-rrb-|.	105990	0.0	8
GENE_ENTITY|,|COMPOUND_ENTITY|isoprenaline|cause|large|increment|pancreatic|blood|flow|;|drug|evoke|secretion|change|venous|osmolality|.	106511	0.0	7
COMPOUND_ENTITY|catabolism|co2|fixation|fatty|acid|Tetrahymena|:|evidence|pool|GENE_ENTITY|co2|.	106588	0.0	8
COMPOUND_ENTITY|-lrb-|sq|14,225|-rrb-|,|angiotensin-converting|enzyme|inhibitor|,|use|combination|propranolol|,|GENE_ENTITY|beta-adrenergic|block|agent|,|treatment|mild|moderate|hypertension|.	106980	0.0	8
uptake|mechanism|non-competitively|inhibit|potential|antiparkinson|drug|COMPOUND_ENTITY|-lrb-|amantadine|,|d|1|:|ki1|=|57|microm|,|ki2|=|96|microm|-rrb-|1-amino-3|,5|-|dimethyladamantane|-lrb-|memantine|,|d|145|:|GENE_ENTITY|ki1|=|97|microm|,|ki2|=|150|microm|-rrb-|.	107253	0.0	8
renal|clearance|dextran|range|molecular|size|glomerular|filtration|rate|-lrb-|gfr|,|COMPOUND_ENTITY|-rrb-|measure|seven|short-term|GENE_ENTITY|insulin-dependent|diabetic|-lrb-|mean|age|25|year|-rrb-|.	107510	0.0	7
GENE_ENTITY|erythrocyte|incubate|glucose|medium|accentuation|membrane|protein|aggregate|formation|;|,|completely|reverse|addition|COMPOUND_ENTITY|inosine|incubation|medium|use|fructose|,|intermediate|distal|``|block|''|glycolysis|,|sole|substrate|.	107544	0.0	8
24|h|treatment|COMPOUND_ENTITY|heparin|,|fresh|frozen|plasma|,|GENE_ENTITY|fibrinogen|cohn|i-fraction|select|case|,|increase|normalisation|parameter|,|plasma|protein|active|coagulation|.	107578	0.0	7
blood|glucose|plasma|GENE_ENTITY|response|hypoglycaemic|agent|,|chlorpropamide|-lrb-|diabenese|-rrb-|glibenclamide|-lrb-|COMPOUND_ENTITY|-rrb-|determine|normal|subject|strict|metabolic|control|double|blind|study|.	108109	0.0	7
suggest|degree|GENE_ENTITY|resistance|produce|secondary|early|profound|lowering|blood|glucose|follow|COMPOUND_ENTITY|.	108158	0.0	7
side-effect|palpitation|,|headache|,|syncope|drowsiness|occur|COMPOUND_ENTITY|obviate|combine|prazosin|GENE_ENTITY|beta-blocker|.	108488	0.0	8
measurement|radioactivity|nuclear|component|vivo|treatment|-lsb-|3h|-rsb-|dbd|1|h|indicate|preferential|drug|binding|high|molecular|weight|component|nuclear|residual|acidic|protein|-lrb-|non-histone|-rrb-|GENE_ENTITY|1|-lrb-|h1|-rrb-|-lrb-|COMPOUND_ENTITY|rich|,|f1|-rrb-|.	108619	0.0	7
efficiency|compound|induce|allosteric|inhibition|enzyme|compare|correlate|chemical|structure|:|aromatic|ring|,|free|phenolic|group|region|carbon|3|steroid|nucleus|lipophilic|substitution|region|c-12|,|GENE_ENTITY|c-17|find|main|structural|feature|require|maximal|efficiency|COMPOUND_ENTITY|dehydrogenase|.	109223	0.0	7
match|morphine|beta-endorphin|dose|approximately|equal|submaximal|submaximal|effect|occur|,|observe|antinociception|produce|GENE_ENTITY|approximately|time|longer|produce|COMPOUND_ENTITY|.	109322	0.0	7
combined|action|GENE_ENTITY|clostridal|aminopeptidase|lead|complete|hydrolysis|COMPOUND_ENTITY|nonapeptide|bradykinin|.	109459	0.0	8
plasma|progesterone|,|plasma|unconjugated|estradiol-17beta|-lrb-|COMPOUND_ENTITY|-rrb-|,|plasma|human|chorionic|somato-mammotropin|-lrb-|GENE_ENTITY|hcs|-rrb-|measure|serially|27|patient|threaten|abortion|.	109625	0.0	8
effect|beta-adrenergic|receptor|block|drug|,|non-selective|propranolol|cardioselective|COMPOUND_ENTITY|,|concentration|blood|glucose|,|serum|insulin|-lrb-|iri|-rrb-|GENE_ENTITY|growth|hormone|-lrb-|gh|-rrb-|study|8|healthy|male|volunteer|rest|exercise|.	110094	0.0	8
augmentation|secretion|GENE_ENTITY|factor|-lrb-|lif|-rrb-|leucocyte|dialysate|component|COMPOUND_ENTITY|glycine|.	110335	0.0	8
isolate|alpha|subunit|contain|bury|COMPOUND_ENTITY|,|GENE_ENTITY|c-2|proton|exchange|solvent|,|unusually|low|pk|3.3|.	110504	0.0	8
effect|iv|load|individual|amino|acid|-lrb-|alanine|,|arginine|,|histidine|,|leucine|,|phenylalanine|,|COMPOUND_ENTITY|-rrb-|serum|prolactin|-lrb-|prl|-rrb-|GENE_ENTITY|growth|hormone|-lrb-|gh|-rrb-|concentration|study|healthy|adult|male|-lrb-|n|=|5|-rrb-|.	110585	0.0	8
increase|ph|7.8|achieve|raise|COMPOUND_ENTITY|concentration|-lrb-|simultaneous|reduction|GENE_ENTITY|co2|concentration|-rrb-|,|positive|inotropic|response|accompany|augmented|current|.	110783	0.0	8
-lsb-|diagnostic|value|serial|determination|COMPOUND_ENTITY|GENE_ENTITY|hpl|plasma|total|estrogen|24-h-urine|compare|single|value|diagnosis|fetal|danger|-rsb-|.	110845	0.0	7
seven|normal|subject|classify|slow|-lrb-|SA|-rrb-|fast|acetylator|-lrb-|fa|-rrb-|accord|metabolic|rate|constant|COMPOUND_ENTITY|-lrb-|km|-rrb-|,|plasma|SMZ|half-life|,|percentage|n-acetyl|smz|6-hr|blood|sample|-lrb-|GENE_ENTITY|pi6|-rrb-|,|5|-|6-hr|urine|collection|-lrb-|ui5|--|6|-rrb-|,|6-hr|total|urine|collection|-lrb-|ui6|-rrb-|.	111153	0.0	8
-lsb-|influence|COMPOUND_ENTITY|response|noradrenaline|segment|isolate|coronary|artery|presence|GENE_ENTITY|beta-adrenergic|block|agent|-rsb-|.	111384	0.0	7
visual|pigment|extract|prepare|rhabdomeric|membrane|COMPOUND_ENTITY|deficient|blowfly|contain|5-10|time|lower|concentration|GENE_ENTITY|rhodopsin|extract|fly|raise|vitamin|rich|diet|.	111981	0.0	8
comparative|study|COMPOUND_ENTITY|-rrb-|GENE_ENTITY|Co|-lrb-|II|-rrb-|bind|glycyl-l-tyrosine|,|pseudosubstrate|carboxypeptidase|.	112063	0.0	7
blood|plasma|GENE_ENTITY|activity|study|radioimmune|method|clino|-|orthostatism|36|male|hypertensive|disease|15|healthy|male|3-day|medication|COMPOUND_ENTITY|daily|dose|120|mg|in-patient|condition|.	112079	0.0	8
media|commonly|employ|early|embryo|culture|contain|COMPOUND_ENTITY|buffer|,|maintenance|ph|probably|crucial|role|GENE_ENTITY|co2-bicarbonate|content|media|.	112080	0.0	8
COMPOUND_ENTITY|stimulate|GENE_ENTITY|renin|angiotensin|aldosterone|system|man|.	112231	0.0	8
examine|effect|addition|COMPOUND_ENTITY|growth|medium|activity|adenosylcobalamin-requiring|enzyme|GENE_ENTITY|methylmalonyl|coa|mutase|normal|human|fibroblast|mutant|human|fibroblast|derive|patient|inherit|methylmalonicacidemia|.	112311	0.0	8
GENE_ENTITY|agranulocytosis|rheumatoid|arthritis|patient|treat|COMPOUND_ENTITY|.	112726	0.0	8
compare|naoh-purified|elastin|,|GENE_ENTITY|sample|characterize|increase|phosphatidyl|--|COMPOUND_ENTITY|content|,|contain|equal|phosphatidylethanolamine|.	112839	0.0	8
narcotic|antagonist|inhibit|GENE_ENTITY|hormone|secretory|response|COMPOUND_ENTITY|hcl|-lrb-|0.75|mg|subcutaneously|-rrb-|.	113132	0.0	8
comparison|clofibrate|COMPOUND_ENTITY|GENE_ENTITY|vasopressin-responsive|diabetes|insipidus|.	151276	0.0	7
preparation|vascular|reactivity|abolish|indomethacin|partly|restore|1|5|ng/ml|pg2|,|adenosine|inhibit|response|noradrenaline|:|curve|5|ng/ml|GENE_ENTITY|concentration|right|parallel|1|ng/ml|curve|consistent|competitive|interaction|COMPOUND_ENTITY|pg2|.	152064	0.0	7
plasma|GENE_ENTITY|hormone|-lrb-|gh|-rrb-|COMPOUND_ENTITY|determine|serially|,|,|test|.	152202	0.0	7
effect|total|energy|withdrawal|-lrb-|fasting|-rrb-|thelevel|GENE_ENTITY|hormone|,|thyrotropin|,|cortisol|,|adrenaline|,|COMPOUND_ENTITY|,|t4|,|t3|,|rt3|healthy|male|.	152693	0.0	7
investigate|possibility|prostaglandin|-lrb-|pg|-rrb-|control|growth|hormone|-lrb-|GENE_ENTITY|-rrb-|secretion|human|,|study|effect|protracted|acute|administration|COMPOUND_ENTITY|acid|-lrb-|asa|-rrb-|indomethacin|-lrb-|id|-rrb-|,|pg|synthesis|inhibitor|,|basal|insulin-stimulated|gh|secretion|normal|volunteer|.	153278	0.0	7
factor|1|correlation|alpha-amino-n-butyric|acid|,|valine|,|methionine|,|isoleucine|,|leucine|,|tyrosine|phenylalanine|,|GENE_ENTITY|2|lysine|,|histidine|,|arginine|glutamine|-lrb-|contain|serine|-rrb-|,|factor|3|taurine|proline|,|factor|4|glycine|COMPOUND_ENTITY|,|factor|5|urea|factor|6|glutamic|acid|.	153672	0.0	7
observe|biphasic|increase|-lsb-|theta|-rsb-|222|COMPOUND_ENTITY|fluorescence|troponin|c|-lrb-|GENE_ENTITY|tnc|-rrb-|increase|-lsb-|ca2|+|-rsb-|.	153780	0.0	7
COMPOUND_ENTITY|GENE_ENTITY|growth|hormone|-lrb-|gh|-rrb-|secretion|-lrb-|spontaneous|variation|night|release|induce|insulin|hypoglycaemia|-rrb-|investigate|69|child|adolescent|.	154165	0.0	7
nature|platelet|antithrombin|elucidate|comparison|thrombin|binding|GENE_ENTITY|activity|intact|platelet|purification|antithrombin|platelet|lysate|use|glycerol|osmotic|lysis|,|COMPOUND_ENTITY|precipitation|sephadex|gel|filtration|technique|.	154284	0.0	8
intact|antibody|GENE_ENTITY|fragment|inhibit|enzyme|activity|trna|aminoacylation|COMPOUND_ENTITY|dependent|atp-32p|pyrophosphate|exchange|reaction|.	154423	0.0	8
correlation|lowering|arterial|pressure|degree|depletion|GENE_ENTITY|,|conclude|anti-hypertensive|mechanism|COMPOUND_ENTITY|come|decrease|secretion|renin|.	154442	0.0	7
COMPOUND_ENTITY|-lrb-|vitamin|d3|-rrb-|25-hydroxy|metabolite|transport|plasma|bind|specific|protein|,|binding|protein|cholecalciferol|metabolite|-lrb-|GENE_ENTITY|dbp|-rrb-|.	154617	1.0	7
result|study|indicate|l-adohcy|dialdehyde|,|d-adohcy|dialdehyde|,|COMPOUND_ENTITY|dialdehyde|affinity|labeling|reagent|GENE_ENTITY|HMT|.	154661	1.0	7
furthermore|,|administration|GENE_ENTITY|intravenous|infusion|re-establish|uterine|motility|normal|value|administration|COMPOUND_ENTITY|.	154957	0.0	8
GENE_ENTITY|release|antagonist|gaba|COMPOUND_ENTITY|-lsb-|proceedings|-rsb-|.	155087	0.0	8
study|,|examine|effect|COMPOUND_ENTITY|production|GENE_ENTITY|oaf|biological|activity|order|clarify|mechanism|action|glucocorticoid|lower|serum|calcium|disorder|.	155262	0.0	7
datum|12|patient|:|mean|p50|discontinuation|COMPOUND_ENTITY|28.2|mm|hg|+|/|-0.9|-lrb-|standard|error|mean|-rrb-|propranolol|therapy|31.7|+|/|-0.7|;|p|0.001|;|red|blood|cell|2,3-dpg|change|explain|increase|GENE_ENTITY|p50|.	155376	0.0	7
luminescene|COMPOUND_ENTITY|-lrb-|1270|nm|-rrb-|observe|illumination|air|saturated|solution|different|porphyrin|complex|zn|GENE_ENTITY|ccl4|.	155735	0.0	8
twenty-seven|case|treat|bb-k8|,|new|derivative|COMPOUND_ENTITY|acylate|l|-|-lrb-|-|-rrb-|-|gamma-amino-alpha-hydroxybutyric|acid|GENE_ENTITY|c-1|amino|group|2-deoxystreptamine|moiety|.	156715	0.0	7
patient|COMPOUND_ENTITY|,|probable|increase|GENE_ENTITY|rbp|achieve|.	156938	0.0	8
glucagon|infuse|insulin|,|plasma|glucose|level|rise|94|+|/|-|8|126|+|/|-|12|mg/100|ml|1|h|-lrb-|p|0.01|-rrb-|;|GENE_ENTITY|hormone|,|beta-hydroxy-butyrate|,|alanine|,|COMPOUND_ENTITY|,|glycerol|level|change|.	157011	0.0	7
intermediate|exchange|pi|oxygen|hydrolysis|18o-labeled|COMPOUND_ENTITY|GENE_ENTITY|myosin|investigate|.	157335	1.0	7
growth|hormone|-lrb-|gh|-rrb-|response|l-dopa|,|2-br-alpha-ergocryptine|-lrb-|COMPOUND_ENTITY|-rrb-|,|thyrotropine-releasing|hormone|-lrb-|GENE_ENTITY|trh|-rrb-|,|luteinize|hormone-releasing|hormone|-lrb-|lh-rh|-rrb-|,|glucagon|glucose|investigate|patient|active|acromegaly|.	157351	0.0	7
GENE_ENTITY|markedly|increase|tissue|level|camp|activate|situ|COMPOUND_ENTITY|protein|kinase|,|change|extent|MT|polymerization|.	157491	0.0	7
COMPOUND_ENTITY|GENE_ENTITY|monoamine|oxidase|b|substrate|man|.	158278	1.0	7
COMPOUND_ENTITY|,|formalin-fixed|,|washed|normal|platelet|undergo|GENE_ENTITY|vwf-mediated|agglutination|.	158362	0.0	7
estrogen|treatment|consist|diethylstilbestrol|,|stilbelstrol|diphosphate|GENE_ENTITY|-lrb-|chlorotraianisene|-rrb-|,|COMPOUND_ENTITY|.	158712	0.0	8
preparation|plasma|measurement|vivo|level|GENE_ENTITY|require|use|anticoagulant|contain|edta|,|theophylline|COMPOUND_ENTITY|e1|,|immediate|cooling|blood|high|speed|prolonged|centrifugation|reduce|platelet|contamination|.	158846	0.0	7
-lsb-|psychological|study|therapeutic|effect|COMPOUND_ENTITY|GENE_ENTITY|insulin|coma|combined|atropine-electroshock|treatment|-rsb-|.	159268	0.0	7
conclude|GENE_ENTITY|IRI|stimulatory|property|COMPOUND_ENTITY|intravenously|large|dose|completely|unrelated|.	159670	0.0	7
liver|weight|,|blood|COMPOUND_ENTITY|concentration|,|plasma|lactate|dehydrogenase|-lrb-|l-lactate|:|NAD|oxidoreductase|;|EC|1.1.1.27|-rrb-|activitvity|value|c16|:1|:|c18|:0|fatty|acid|liver|,|adipose|tissue|plasma|triglyceride|highest|bird|feed|high-flks|diet|measurement|negatively|correlate|GENE_ENTITY|pyruvate|carboxylase|activity|.	160145	0.0	7
methozamine|phenylephrine|lower|high|level|cyclic|amp|produce|high|concentration|COMPOUND_ENTITY|-lrb-|10|GENE_ENTITY|mum|-rrb-|acth|-lrb-|100|mu/ml|-rrb-|,|partially|inhibit|lipolysis|.	160220	0.0	7
effect|eaca|-lrb-|epsilon|aminocaproic|acid|-rrb-|survival|factor|viii|-lrb-|GENE_ENTITY|VIII|,|antihemophilic|factor|,|ahf|-rrb-|concentrate|infusion|hemophilic|subject|study|use|F.|VIII|preparation|:|intermediate|purity|``|cryoglobulin|''|high|purity|COMPOUND_ENTITY|concentrate|.	160832	0.0	7
desialylate|enzyme|protein|band|COMPOUND_ENTITY|sulphate/polyacrylamide-gel|electrophoresis|subunit|molecular|weight|indistinguishable|GENE_ENTITY|non-neuraminidase-treated|protein|.	201318	0.0	7
COMPOUND_ENTITY|acid|methyltetrahydrofolate|enhance|synthesis|GENE_ENTITY|me-cbl|normal|pa|cell|,|methotrexate|5-fluorouracil|depress|.	201529	0.0	8
influence|COMPOUND_ENTITY|enzymatic|activity|:|GENE_ENTITY|glucose-6-phosphate|dehydrogenase|.	201956	0.0	8
lymphocyte|production|macrophage|chemotactic|factor|-lrb-|ctx|-rrb-|macrophage|inhibition|factor|-lrb-|GENE_ENTITY|-rrb-|decrease|presence|COMPOUND_ENTITY|.	203401	0.0	8
pancreatic|exocrine|secretory|response|different|combination|pancreozymin-like|peptide|COMPOUND_ENTITY|GENE_ENTITY|secretin|study|110|healthy|control|subject|32|patient|pancreatic|disease|.	203729	0.0	8
serum|COMPOUND_ENTITY|assay|suggest|reliable|test|early|diagnosis|GENE_ENTITY|cs2|poisoning|.	204300	0.0	8
rise|cbf|GENE_ENTITY|inhalation|influence|intravenous|infusion|small|dose|COMPOUND_ENTITY|block|concomitant|rise|blood|pressure|.	205125	0.0	8
23|patient|group|1|receive|GENE_ENTITY|,|6|patient|group|2|receive|COMPOUND_ENTITY|vinblastine|15|patient|group|3|receive|methyl|ccnu|vinblastine|.	205849	0.0	7
blood|preserve|acid|COMPOUND_ENTITY|dextrose|use|effect|route|transfusion|plasma|glucose|,|free|fatty|acid|,|insulin|GENE_ENTITY|growth|hormone|-lrb-|gh|-rrb-|concentration|measure|transfusion|3|h|.	207179	0.0	7
COMPOUND_ENTITY|level|higher|maternal|blood|fetal|blood|find|follow|incidence|:|51|%|sample|ot|maternal|venous|blood|umbilical|arterial|blood|,|84|%|sample|GENE_ENTITY|ot|maternal|blood|umbilical|vein|blood|.	207730	0.0	7
amination|carboxyl-terminal|COMPOUND_ENTITY|peptide|GENE_ENTITY|aid|peptide|separation|.	207748	0.0	8
GENE_ENTITY|hormone|inhibition|induction|alkaline|phosphatase|activity|hydrocortisone|COMPOUND_ENTITY|deoxyuridine|hela|cell|.	207764	0.0	7
oral|calcium|supplement|significant|effect|serum|concentration|phosphate|,|magnesium|,|COMPOUND_ENTITY|d3|,|GENE_ENTITY|parathyroid|hormone|,|incidence|hypocalcemia|12|hour|age|0|supplement|infant|control|infant|.	207797	0.0	7
hapten|inhibition|assay|simple|sugar|,|so-called|m|kel|group|2|sugar|,|bear|configuration|hydroxy|group|c-3|GENE_ENTITY|COMPOUND_ENTITY|,|inhibitor|hemagglutinin|.	207870	0.0	7
normal|uremic|subject|,|serum|folate|unsaturated|fbp|level|tend|correlate|,|patient|large|dose|COMPOUND_ENTITY|acid|level|unsaturated|GENE_ENTITY|fbp|fall|level|serum|folate|rise|.	207968	0.0	7
effect|alprenolol|COMPOUND_ENTITY|plasma|GENE_ENTITY|renin|concentration|patient|arterial|hypertension|.	208235	0.0	7
liver|xanthine|dehydrogenase|-lrb-|GENE_ENTITY|-rrb-|kidney|arginase|increase|stage|COMPOUND_ENTITY|deficiency|.	208481	0.0	8
incubation|perform|COMPOUND_ENTITY|-lrb-|KRB|-rrb-|buffer|95|%|o2|5|%|GENE_ENTITY|co2|.	208736	0.0	8
effect|intralesional|injection|COMPOUND_ENTITY|GENE_ENTITY|glucose-6-phosphate|dehydrogenase|alanine|aminotransferase|activity|keloid|.	208828	0.0	7
study|effect|molybdate|GENE_ENTITY|reorganization|COMPOUND_ENTITY|accumulation|.	208890	0.0	8
concentration|phosphoribosylpyrophospate|-lrb-|COMPOUND_ENTITY|-rrb-|erythrocyte|normal|limit|subject|deficient|,|normal|,|GENE_ENTITY|aprt|activity|.	209166	0.0	8
stimulation|GENE_ENTITY|activity|achieve|orthostasis|COMPOUND_ENTITY|.	209334	0.0	8
result|obtain|demonstrate|following|:|1|-rrb-|sulfate|conjugate|group|excrete|considerably|slower|glucuronide|conjugate|;|2|-rrb-|COMPOUND_ENTITY|conjugate|steroid|non-reduced|ring-a|-lrb-|GENE_ENTITY|c-21|sulfate|-rrb-|excrete|-lrb-|presumably|form|-rrb-|faster|steroid-3-sulfate|,|require|reduction|ring-a|prior|conjugation|;|3|-rrb-|excretion|c-3|sulfate|ring-a|reduce|steroid|glycerol|side-chain|-lrb-|cortol|cortolone|-rrb-|significantly|faster|corresponding|steroid|dihydroxyacetone|side-chain|-lrb-|thf|,|5alpha-isomer|-rrb-|;|4|-rrb-|relative|concentration|c-21|sulfate|steroid|ring-a|intact|-lrb-|fk|,|EK|,|er|,|epier|6beta-hydroxycortisol|-rrb-|higher|concentration|c-21|glucuronide|steroid|.	209363	0.0	7
COMPOUND_ENTITY|stimulate|gastrin|secretion|completely|suppress|propranolol|,|beta-adrenergic|receptor|block|agent|,|effect|meal|stimulate|GENE_ENTITY|gastrin|secretion|.	209371	0.0	8
present|study|undertake|investigate|male|surgical|patient|effect|COMPOUND_ENTITY|anaesthesia|carbohydrate|metabolism|determine|plasma|growth|hormone|-lrb-|gh|-rrb-|,|GENE_ENTITY|insulin|,|blood|glucose|,|cortisol|,|compare|effect|anaesthesia|associate|surgical|operation|.	210187	0.0	7
COMPOUND_ENTITY|stimulate|GENE_ENTITY|p450|reduction|.	210867	0.0	8
protein|synthesis|continue|40|degree|c|appear|mitochondrial|,|:|-lrb-|-rrb-|whole-cell|protein|synthesis|permissive|temperature|34|degree|c|inhiby|tevenel|,|sulfamoyl|analogue|COMPOUND_ENTITY|specific|inhibitor|mitochondrial|protein|synthesis|;|,|whole-cell|protein|synthesis|40|degree|c|inhibit|tevenel|,|-lrb-|b|-rrb-|protein|synthesis|isolate|mitochondria|tsh1|cell|significantly|inhibit|40|degree|c.|-lrb-|c|-rrb-|40|degree|c|-lsb-|14c|-rsb-|leucine|incorporate|predominantly|mitochondrial|fraction|GENE_ENTITY|tsh1|cell|.	210903	0.0	7
major|product|glucose|fermentation|acetate|,|COMPOUND_ENTITY|,|GENE_ENTITY|co2|h2|.	211060	0.0	8
human|maternal|fetal|serum|GENE_ENTITY|growth|hormone|-lrb-|hgh|-rrb-|response|glucose|COMPOUND_ENTITY|.	211163	0.0	7
maternal|fetal|serum|GENE_ENTITY|hgh|response|glucose|,|COMPOUND_ENTITY|,|glucose|plus|leucine|examine|infusion|pregnant|woman|term|immediately|cesarean|section|.	211706	0.0	7
hypotensive|action|increase|plasma|GENE_ENTITY|activity|ca2|+|antagonist|-lrb-|COMPOUND_ENTITY|-rrb-|hypertensive|patient|.	212054	0.0	8
synthase|catalyze|formation|citrulline|COMPOUND_ENTITY|coincident|production|flavoprotein|,|contain|1|mol|fad|GENE_ENTITY|fmn|,|tetrahydrobiopterin|,|iron|.	212086	0.0	7
GENE_ENTITY|antibody|inhibit|thymidine|incorporation|32|%|cell|expose|0.05|mm|COMPOUND_ENTITY|+|shortly|add|-lsb-|3h|-rsb-|thymidine|,|incorporation|significantly|affect|antibody|0.7|mm|ca2|+|.	212097	0.0	7
result|indicate|effect|follow|corticotropin|releasing-hormone|cholecystokinin|,|specific|effect|result|vasopressin|,|COMPOUND_ENTITY|,|GENE_ENTITY|acth-related|hormone|,|cortisol|.	421861	0.0	7
study|difi|cell|displacement|specific|125i-cyp|binding|nonselective|-lrb-|propranolol|-rrb-|,|beta|1-selective|-lrb-|COMPOUND_ENTITY|atenolol|-rrb-|,|beta|2-selective|-lrb-|ici|118-551|-rrb-|antagonist|reveal|single|class|GENE_ENTITY|beta|2-adrenergic|receptor|.	422409	0.0	7
effect|COMPOUND_ENTITY|4-asa|,|drug|use|treatment|inflammatory|bowel|disease|,|modulation|experimental|colitis|colonic|generation|GENE_ENTITY|interleukin-1|evaluate|.	422482	0.0	8
chromosomal|translocation|t|-lrb-|15|;|17|-rrb-|-lrb-|q22|:21|-rrb-|acute|promyelocytic|leukemia|-lrb-|apl|-rrb-|fuse|pml|,|novel|gene|,|GENE_ENTITY|alpha|,|COMPOUND_ENTITY|acid|receptor|gene|.	422913	1.0	8
furthermore|,|identify|single|COMPOUND_ENTITY|residue|GENE_ENTITY|alpha|1|variant|,|replace|arginine|alpha|6|,|major|determinant|high|affinity|binding|bz|agonist|.	422992	0.0	8
selective|association|herpesvirus|trans-activator|COMPOUND_ENTITY|human|GENE_ENTITY|oct-1|homeo|domain|model|differential|positive|transcriptional|control|homeo|domain|.	423754	0.0	8
number|survive|blast|and/or|dna|synthesis|blast|treat|csf|plus|COMPOUND_ENTITY|dnr|greater|treat|GENE_ENTITY|csf|aml-193|cell|line|,|aml|patient|.	423771	0.0	7
test|hypothesis|monocyte|-lrb-|m|phi|-rrb-|mediator|major|contributor|COMPOUND_ENTITY|immunodepression|,|modulate|capacity|acute|ethanol|treatment|assess|production|transform|growth|factor-beta|-lrb-|GENE_ENTITY|tgf|beta|-rrb-|prostaglandin|e2|-lrb-|pge2|-rrb-|human|peripheral|blood|m|phi|.	424029	0.0	7
role|pituitary-specific|transcription|factor|-lrb-|GENE_ENTITY|-rrb-|closely|related|protein|COMPOUND_ENTITY|regulation|human|thyrotropin-beta|subunit|gene|expression|.	424049	0.0	7
contractile|response|substance|p|,|neurokinin|,|selective|agonist|nk1|,|nk2|GENE_ENTITY|tachykinin|receptor|activity|receptor-selective|antagonist|investigate|circular|muscle|strip|guinea-pig|isolate|renal|pelvis|presence|COMPOUND_ENTITY|-lrb-|3|microm|-rrb-|.	424058	0.0	7
furthermore|administer|GENE_ENTITY|1|vivo|use|experimental|model|regression|liver|initiate|short|precede|treatment|hepatomitogen|COMPOUND_ENTITY|acetate|-lrb-|cpa|-rrb-|.	424175	0.0	7
20|patient|,|investigate|effect|interleukin-2|-lrb-|GENE_ENTITY|-rrb-|treatment|adoptive|immunotherapy|cancer|circulate|level|:|thiamin|;|biotin|;|COMPOUND_ENTITY|;|pantothenate|;|riboflavin|;|nicotinate|;|vitamin|,|b6|,|b12|e|;|carotene|;|free|total|choline|;|inositol|;|free|total|carnitine|.	424279	0.0	7
meta-analysis|perform|9|controlled|trial|maternal|beta|-|/|COMPOUND_ENTITY|treatment|incidence|GENE_ENTITY|rds|infant|bear|30|week|gestation|report|.	424540	0.0	7
addition|COMPOUND_ENTITY|effector|cell|population|affect|nk|cell|activity|activation|nk|cell|ifn|GENE_ENTITY|interleukin|-lrb-|il|-rrb-|-2|.	424698	0.0	8
Verapamil|appear|similar|effect|quality|life|COMPOUND_ENTITY|GENE_ENTITY|angiotensin|convert|enzyme|-lrb-|ace|-rrb-|inhibitor|,|captopril|.	424983	0.0	7
3|-rrb-|change|GENE_ENTITY|activity|induce|fsh|lh|closely|associate|COMPOUND_ENTITY|production|.	425036	0.0	7
conclude|COMPOUND_ENTITY|,|GENE_ENTITY|ace|inhibitor|,|alter|alpha|1-adrenoceptor|Ang|II|receptor|sensitivity|selective|agonist|,|affect|baroreflex|sensitivity|.	425580	0.0	8
htz-19|cell|respond|dose-dependent|manner|midozolam|,|GENE_ENTITY|interfere|growth|regulation|mediate|COMPOUND_ENTITY|receptor|site|.	425802	1.0	7
present|study|,|reaction|apoetf|atp|,|adp|,|amp|,|COMPOUND_ENTITY|,|GENE_ENTITY|fmn|investigate|.	426165	0.0	8
intramembrane|interaction|GENE_ENTITY|receptor|COMPOUND_ENTITY|d2|receptor|major|mechanism|neuroleptic-like|action|neurotensin|.	426271	0.0	7
inhibitory|effect|tgf-beta|1|COMPOUND_ENTITY|hgf|synthesis|mrc-5|cell|additive|,|suggest|GENE_ENTITY|tgf-beta|1|dexamethasone|exert|effect|distinct|mechanism|.	426976	0.0	7
GENE_ENTITY|binding|induce|new|cleavage|5|'|-|ga-3|'|site|gc|box|COMPOUND_ENTITY|complex|.	427018	0.0	8
0.15|m|nacl|,|binding|GENE_ENTITY|ttr|absolute|requirement|native|ligand|,|COMPOUND_ENTITY|.	427143	0.0	8
preincubation|vasostatin|-lrb-|0.8|micrograms/ml|-rrb-|,|contain|n-terminal|domain|GENE_ENTITY|,|-lrb-|CGA1-76|,|cga1-113|cga1-143ff|-rrb-|,|inhibit|contractile|response|evoke|80|mm|k|+|,|2.6|microm|noradrenaline|-lrb-|na|-rrb-|,|65|nm|endothelin-1|-lrb-|et-1|-rrb-|COMPOUND_ENTITY|-rrb-|-|free|solution|sv|ITA|.	427244	0.0	7
direct|amino|acid|sequencing|peptide|mapping|cf-2|reveal|serine|660|,|700|,|737|,|813|COMPOUND_ENTITY|768|,|serine|795|,|phosphorylate|pka|GENE_ENTITY|pkg|,|serine|686|790|phosphorylate|pkc|.	427871	1.0	7
toxic|effect|moderate-dose|GENE_ENTITY|control|antihistamine|ibuprofen|,|oral|glucocorticoid|-lrb-|e.g.|,|COMPOUND_ENTITY|,|10|mg|twice|daily|second|week|GMCSF|administration|-rrb-|require|patient|serositis|,|pulmonary|infiltrate|,|severe|skin|eruption|.	428314	0.0	7
probe-less|genomic|typing|COMPOUND_ENTITY|-lrb-|type|1|diabetes-associated|-rrb-|non-arg52|-lrb-|non-type|1|diabetes-associated|-rrb-|GENE_ENTITY|hla-dqa1|allele|.	428462	0.0	7
second|,|use|system|provide|evidence|physical|association|GENE_ENTITY|tcr|require|effective|COMPOUND_ENTITY|phosphorylation|tcr|zeta-chain|subunit|,|presumably|reflect|delivery|p56lck|-lrb-|lck|-rrb-|tcr|.	428489	1.0	7
effect|COMPOUND_ENTITY|binding|human|GENE_ENTITY|tumor|necrosis|factor|alpha|-lrb-|hutnf|alpha|-rrb-|specific|cell-surface|receptor|cytotoxic|activity|vitro|investigate|.	429134	1.0	8
agent|,|thalidomide|,|COMPOUND_ENTITY|,|dexamethasone|polyclonal|anti-tnf-alpha|antibody|,|specific|Elisa|block|endogenous|GENE_ENTITY|tnf-alpha|production|bacillus|calmette|Guerin|-lrb-|bcg|-rrb-|-|infected|human|monocyte-derived|macrophage|vitro|culture|.	429328	0.0	7
examine|effect|ketamine|COMPOUND_ENTITY|,|anesthetic|elevate|serum|GENE_ENTITY|prolactin|level|primate|,|prolactin|secretion|squirrel|monkey|.	429424	0.0	7
COMPOUND_ENTITY|induce|strong|sustained|inhibition|plasma|convert|enzyme|activity|-lrb-|-96|%|4|h|,|-63|%|24|h|-rrb-|increase|plasma|GENE_ENTITY|renin|activity|-lrb-|+993|%|8|h|-rrb-|.	429425	0.0	7
Aim|study|investigate|acute|effect|intravenous|infusion|COMPOUND_ENTITY|circulate|growth|hormone|-lrb-|GENE_ENTITY|gh|-rrb-|level|acromegaly|.	429870	0.0	7
different|transport|affinity|observe|membrane|outward-facing|transport|site|translocator|able|bind|inhibitor|i.e.|COMPOUND_ENTITY|phosphate|-lrb-|GENE_ENTITY|plp|-rrb-|4,4|'|-|diisothiocyanostilbene-2|,2|'|-|disulfonate|-lrb-|dids|-rrb-|.	430015	0.0	7
vivo|,|GENE_ENTITY|undergo|phosphorylation|distinct|site|,|appear|identical|site|phosphorylate|COMPOUND_ENTITY|kinase|vitro|.	430300	0.0	7
patient|renal|failure|exist|inhibition|gastrin|acid|secretion|cause|weakening|mechanism|feedback|connection|COMPOUND_ENTITY|GENE_ENTITY|gastrin|,|permanent|stimulation|g-cell|,|hyperplasia|cell|develop|,|increase|secretory|activity|,|hypergastrinemia|.	430427	1.0	7
study|,|measure|superoxide|dismutase|-lrb-|GENE_ENTITY|-rrb-|,|catalase|-lrb-|cat|-rrb-|COMPOUND_ENTITY|peroxidase|gpx|-rrb-|activity|peripheral|blood|radiation|worker|-lrb-|111|case|-rrb-|control|-lrb-|108|case|-rrb-|,|analyze|chromosome|aberration|blood|lymphocyte|means|g-banding|technique|.	431394	0.0	7
antipsychotic|block|COMPOUND_ENTITY|receptor|pituitary|prolactin-secreting|cell|prevent|dopamine-induced|reduction|GENE_ENTITY|prolactin|release|.	431439	0.0	7
chlorambucil|-lrb-|clb|-rrb-|contribute|decrease|COMPOUND_ENTITY|b-cll|lymphocyte|;|incubation|drug|,|lower|level|gsh|find|normal|b|t|lymphocyte|,|b-cll|t|cell|,|t-cll|-lrb-|cd4|GENE_ENTITY|cd8|-rrb-|cell|.	431557	0.0	7
cell|line|produce|monoclonal|antibody|,|az-1|-lrb-|igg1|-rrb-|,|az-2|-lrb-|igg1|-rrb-|GENE_ENTITY|-lrb-|igm|-rrb-|COMPOUND_ENTITY|establish|.	432598	1.0	7
contrast|,|agent|increase|intracellular|COMPOUND_ENTITY|level|inhibit|GENE_ENTITY|il-2|production|leave|il-4|production|unaffected|.	432947	0.0	7
GENE_ENTITY|dismutase|-lrb-|sod|-rrb-|blood|concentration|,|free|radical|generation|-lrb-|sod-inhibitable|reaction|ferricytochrome|c|-rrb-|,|malondialdehyde|-lrb-|COMPOUND_ENTITY|-rrb-|plasma|concentration|,|unfractionated|leucocyte|filterability|rate|filterability|rate|granulocyte|mononuclear|sub-fraction|-lrb-|use|positive|pressure|filtration|system|5|mu|diameter|nuclepore|filter|-rrb-|,|monitor|exercise|patient|18|match|control|.	432964	0.0	7
epidermal|growth|factor|-lrb-|egf|-rrb-|platelet-derived|growth|factor|binding|receptor|fibroblast|induce|tyrosine|phosphorylation|plc|gamma|1|stable|association|GENE_ENTITY|1|receptor|protein|COMPOUND_ENTITY|kinase|.	433110	0.0	7
metabolic|assessment|GENE_ENTITY|1|selectivity|COMPOUND_ENTITY|.	433221	0.0	7
view|recent|finding|describe|direct|positive|modulation|COMPOUND_ENTITY|current|pkc|,|suggest|GENE_ENTITY|pkc|activity|,|fact|,|determine|threshold|ltp|induction|.	433906	0.0	7
GENE_ENTITY|+|t-epitope|repertoire|human|COMPOUND_ENTITY|receptor|alpha|subunit|severe|myasthenia|gravi|:|study|synthetic|peptide|.	433981	0.0	7
COMPOUND_ENTITY|therapy|,|normalization|EPO|decrease|GENE_ENTITY|pth|concentration|observe|kidney|transplant|patient|.	434207	0.0	7
mechanism|clinical|effectiveness|low-dose|long-term|COMPOUND_ENTITY|-lrb-|em|-rrb-|treatment|diffuse|panbronchiolitis|,|sinobronchial|syndrome|,|associate|otitis|media|effusion|investigate|study|effect|em|tumor|necrosis|factor|alpha|-lrb-|GENE_ENTITY|tnf-alpha|-rrb-|production|culture|human|monocyte|stimulate|lipopolysaccharide|.	434238	0.0	7
recently|clone|d4|dopamine|receptor|gene|-lrb-|drd4|-rrb-|considerable|homology|d2|d3|dopamine|receptor|-lrb-|drd2|GENE_ENTITY|-rrb-|;|pharmacologically|,|affinity|atypical|antipsychotic|clozapine|higher|COMPOUND_ENTITY|receptor|.	434703	1.0	8
find|GENE_ENTITY|potentiate|nmda|response|increase|probability|channel|opening|reduce|voltage-dependent|mg2|+|block|COMPOUND_ENTITY|channel|.	434977	0.0	7
objective|:|study|effect|long-term|in-vitro|exposure|human|GENE_ENTITY|secrete|pituitary|adenoma|cell|COMPOUND_ENTITY|gh|release|,|intracellular|gh|concentration|gh|messenger|ribonucleic|acid|-lrb-|mrna|-rrb-|level|.	435275	0.0	7
describe|`|complementary|'|mutation|end|keratin|express|cell|-lrb-|k5|,|coexpress|GENE_ENTITY|-rrb-|,|change|COMPOUND_ENTITY|gly|helix|termination|peptide|,|detect|altered|antibody|binding|confirm|sequencing|use|polymerase|chain|reaction|.	435510	0.0	7
use|GENE_ENTITY|rii|antibody|flow|cytometric|analysis|assess|capacity|COMPOUND_ENTITY|modulate|cytokine-induced|fc|epsilon|rii|expression|normal|asthmatic|.	436121	0.0	7
co-aggregation|GENE_ENTITY|-|cd8-p56lck|kinase|tcr|cd45|-|cell|restore|tcr-induced|protein|COMPOUND_ENTITY|phosphorylation|,|phospholipase|c|gamma|1|regulation|calcium|signal|.	436692	0.0	7
ctll-2|ht-2|cell|stably|transfect|expression|plasmid|encode|normal|human|GENE_ENTITY|constitutively|active|version|mouse|p56-lck|kinase|-lrb-|lck|-lsb-|y505|-rsb-|-rrb-|contain|striking|elevation|level|tyrosine|phosphorylation|protein|-lrb-|34-36|,|50-60|,|62-68|,|77-78|,|104-110|kda|-rrb-|,|determine|immunoblot|analysis|use|COMPOUND_ENTITY|antibody|.	437030	0.0	7
ligand|binding|property|recombinant|GENE_ENTITY|protein|study|measurement|COMPOUND_ENTITY|equilibrium|cyanide|binding|.	437396	0.0	8
base|comparison|analysis|restrained|molecular|dynamics|trajectory|,|find|,|turn|stabilize|formation|hydrogen|bond|,|COMPOUND_ENTITY|molecule|possess|slight|twist|dmso|solution|relative|orientation|GENE_ENTITY|deamino-oxytocin|crystalline|state|.	437835	0.0	7
recombinant|human|GENE_ENTITY|add|isolate|adult|rat|leydig|cell|exert|stimulatory|effect|COMPOUND_ENTITY|production|reach|maximal|effect|dose|10|-lrb-|-10|-rrb-|mol/l|-lrb-|testosterone|production|14.9|+|/|-|1.7|45.1|+|/|-|6.2|pmol/10|-lrb-|6|-rrb-|cells/3|h|-rrb-|.	437931	0.0	7
like|natural|ligand|COMPOUND_ENTITY|gtp|,|analog|capable|inhibit|h|+|/|oh|-|conductance|UCP|measure|proteoliposome|reconstitute|GENE_ENTITY|UCP|.	438106	0.0	7
COMPOUND_ENTITY|immunoperoxidase|method|apply|material|use|monoclonal|antibody|:|antiglial|fibrillary|acidic|protein|-lrb-|GENE_ENTITY|gfap|-rrb-|,|anti-vimentin|-lrb-|vimentin|-rrb-|,|ln-1|ln-3|.	438917	1.0	7
COMPOUND_ENTITY|--|>|aspartate|substitution|alpha-subunit|GENE_ENTITY|hexosaminidase|cause|juvenile-onset|tay-sachs|disease|lebanese-canadian|family|.	439198	0.0	7
GENE_ENTITY|binding|modify|addition|COMPOUND_ENTITY|.	439564	0.0	7
COMPOUND_ENTITY|alter|circulate|level|neurotransmitter|,|dopamine|,|norepinephrine|,|epinephrine|,|hypothalamic-pituitary-adrenal|axis|hormone|corticotropin-releasing|factor|-lrb-|crf|-rrb-|,|GENE_ENTITY|adrenocorticotropic|hormone|-lrb-|acth|-rrb-|,|cortisol|.	439798	0.0	7
measure|norepinephrine|-lrb-|ne|-rrb-|,|COMPOUND_ENTITY|-lrb-|e|-rrb-|-lrb-|nmol.l-1|:|radioenzymatic|assay|-rrb-|GENE_ENTITY|npy|-lrb-|pmol.l-1|:|immunoradiometric|assay|-rrb-|plasma|concentration|,|blood|sample|draw|femoral|artery|coronary|sinus|,|baseline|dobutamine|infusion|.	440234	0.0	7
characterize|cytosolic|pla2|enzyme|respect|substrate|specificity|,|sensitivity|detergent|,|ca2|+|ion|dependency|optimum|ph.|find|phosphatidylethanolamine|,|phosphatidylcholine|,|preferred|substrate|,|COMPOUND_ENTITY|+|ion|essential|expression|GENE_ENTITY|pla2|activity|,|enzyme|active|broad|ph|range|,|optimum|ph|9.0|,|sodium-deoxycholate|inhibit|enzyme|activity|strongly|concentration-dependent|manner|.	440240	0.0	7
GENE_ENTITY|ai|level|significantly|increase|follow|COMPOUND_ENTITY|apo|b|reduce|20|%|.	440956	0.0	7
examine|role|CNTF|,|culture|rat|embryonic|hippocampal|neuron|maintain|recombinant|human|GENE_ENTITY|different|time|,|prior|exposure|toxic|dose|COMPOUND_ENTITY|5|day|vitro|24|hr|.	441212	0.0	7
Enalapril|,|like|COMPOUND_ENTITY|,|angiotensin-converting|enzyme|-lrb-|GENE_ENTITY|ace|-rrb-|inhibitor|largely|use|antihypertensive|drug|;|recently|report|induce|pemphigus|,|thiol|drug|.	441580	0.0	7
study|suggest|specificity|GENE_ENTITY|transport|modulate|phosphorylation|vinblastine|,|COMPOUND_ENTITY|,|actinomycin|d|transport|,|colchicine|,|diminish|dephosphorylation|sodium|butyrate|.	442603	0.0	7
GENE_ENTITY|kalyan|g6pd|kerala|;|deficient|variant|India|cause|317|COMPOUND_ENTITY|--|>|ly|mutation|.	442630	0.0	7
known|way|start|activation|GENE_ENTITY|a-2|-lrb-|pl-a2|-rrb-|,|arachidonic|acid|produce|,|,|turn|,|undergo|metabolic|pathway|lead|thromboxane|a-2|;|pathway|block|intraplatelet|asa|irreversible|inactivation|Cyclooxygenase|,|insensitive|extra-platelet|COMPOUND_ENTITY|.	442684	0.0	7
human|GENE_ENTITY|a-iv|-lrb-|apo|a-iv|-rrb-|exhibit|common|protein|polymorphism|detectable|isoelectric|focus|-lrb-|ief|-rrb-|single|base|substitution|codon|360|replace|frequently|occur|glutamine|residue|-lrb-|allele|1|-rrb-|COMPOUND_ENTITY|-lrb-|allele|2|-rrb-|.	442793	1.0	7
result|suggest|inhibition|ptdins|4,5-p2|hydrolysis|pma|COMPOUND_ENTITY|attributable|reduce|tyrosine|phosphorylation|GENE_ENTITY|plc-gamma|1|.	442852	0.0	7
p110|recognize|directly|antiserum|c-terminal|region|COMPOUND_ENTITY|kinase|raf-1|related|p110|polypeptide|detect|GENE_ENTITY|anti-raf-1|immunoprecipitate|.	442943	0.0	7
COMPOUND_ENTITY|elute|GENE_ENTITY|hlbp14|human|laminin|affinity|column|,|imply|human|laminin|contain|poly-n-acetyllactosamine|residue|.	443197	1.0	7
sk-n-mc|human|neuroblastoma|cell|,|COMPOUND_ENTITY|response|10|nm|isoproterenol|-lrb-|iso|-rrb-|mediate|primarily|GENE_ENTITY|beta|1-adrenergic|receptor|.	443422	1.0	7
c-myc|,|protein|product|GENE_ENTITY|protooncogene|,|member|basic|helix-loop-helix|COMPOUND_ENTITY|class|transcription|factor|.	443557	0.0	7
,|extent|gap|COMPOUND_ENTITY|phosphorylation|induce|GENE_ENTITY|csf-1|approximately|10|%|induce|pdgf-bb|nih3t3|fibroblast|.	444075	1.0	7
csf|GENE_ENTITY|protein|,|igg|igm|level|101|ms|patient|treatment|high-dose|intravenous|COMPOUND_ENTITY|.	444190	0.0	7
study|carry|child|acquire|immune|deficiency|syndrome|assess|effect|combined|GENE_ENTITY|2a|therapy|COMPOUND_ENTITY|immunological|profile|plasma|zidovudine|concentration|.	444274	0.0	7
Buprenorphine|-lrb-|BUP|-rrb-|partial|opioid|agonist|effect|GENE_ENTITY|level|examine|COMPOUND_ENTITY|addict|14|methadone-maintained|patient|switch|sublingual|bup|2|mg|daily|1|month|.	445013	0.0	7
rapid|nongenomic|vitro|effect|COMPOUND_ENTITY|intracellular|electrolyte|,|cell|volume|,|na|-lrb-|+|-rrb-|-|h|+|antiport|find|human|mononuclear|leukocyte|-lrb-|GENE_ENTITY|hml|-rrb-|.	445125	0.0	7
number|well-characterized|cytokine|implicate|negative|regulation|hematopoiesis|:|ferritin|h-subunit|-lrb-|hf|-rrb-|,|lactoferrin|-lrb-|lf|-rrb-|,|prostaglandin|e|-lrb-|pge|-rrb-|,|tumor|necrosis|factor|-lrb-|tnf|-rrb-|,|interferon|-lrb-|ifn|-rrb-|,|transform|growth|factor-beta|-lrb-|tgf|beta|-rrb-|,|acetyl-n-ser-asp-lys-pro|-lrb-|acsdkp|-rrb-|thymosin-beta|4|,|pyroglu-glu-asp-cys-lys|-lrb-|peedck|-rrb-|,|macrophage|inflammatory|protein-1|alpha|-lrb-|mip-1|alpha|-rrb-|,|inhibin|,|superoxide|dismutase|-lrb-|GENE_ENTITY|-rrb-|,|glutathione|-lrb-|COMPOUND_ENTITY|-rrb-|well-known|.	445502	0.0	7
COMPOUND_ENTITY|-rrb-|,|ni|-lrb-|ii|-rrb-|,|Fe|-lrb-|II|-rrb-|completely|ineffective|,|mn|-lrb-|ii|-rrb-|GENE_ENTITY|Co|-lrb-|II|-rrb-|free|radical|scavenging|capacity|,|exhibit|relative|rate|constant|ratio|respectively|0.513|0.287|.	445686	0.0	7
author|examine|56|COMPOUND_ENTITY|,|paraffin-embedded|specimen|include|37|oral|cavity|,|use|antibody|specific|ck19|-lrb-|ks19|.1|4.62|-rrb-|,|antibody|nuclear|proliferation|marker|,|GENE_ENTITY|proliferate|cell|nuclear|antigen|-lrb-|pcna|-rrb-|-lrb-|19a2|-rrb-|,|antibody|putative|tumor|suppressor|gene|,|p53|-lrb-|pab1801|-rrb-|.	446067	0.0	7
pure|COMPOUND_ENTITY|camp|phosphodiesterase|-lrb-|GENE_ENTITY|cgi-pde|-rrb-|microgram|quantity|isolate|bovine|aortic|smooth|muscle|5000-fold|purification|use|deae|ion-exchange|affinity|chromatography|derivative|specific|cgi-pde|inhibitor|cilostamide|conjugate|ligand|aminoethyl|agarose|-lrb-|cit-agarose|-rrb-|.	446196	0.0	7
COMPOUND_ENTITY|inhibit|production|il-2|GENE_ENTITY|il-2r|alpha-chain|expression|.	447207	0.0	7
receptor|cleavage|catalytically|active|alpha-thrombin|tightly|couple|GENE_ENTITY|,|resultant|generation|ip3|dag|,|increase|-lsb-|COMPOUND_ENTITY|-rsb-|,|translocation|pkc|-lrb-|fig.|3|-rrb-|.	447270	0.0	7
GENE_ENTITY|synthase|-lrb-|nos|-rrb-|catalyze|oxidation|COMPOUND_ENTITY|l-citrulline|nitric|oxide|-lrb-|-rrb-|no-releasing|compound|.	447484	0.0	8
conclude|GENE_ENTITY|mrna|express|lymphocyte|,|consistent|camp|regulation|COMPOUND_ENTITY|transport|present|normal|lymphocyte|defective|cf-derived|lymphocyte|.	447535	0.0	7
COMPOUND_ENTITY|decrease|norepinephrine|concentration|,|epinephrine|,|GENE_ENTITY|beta-endorphin|,|cortisol|,|ADH|,|glucose|concentration|significantly|increase|compare|preincision|value|.	447627	0.0	7
,|COMPOUND_ENTITY|elevation|m|phi|GENE_ENTITY|tgf|beta|pge2|production|contribute|decrease|t|cell|proliferation|abnormal|m|phi|function|alcohol|exposure|,|result|depressed|immune|response|.	447708	0.0	7
examine|effect|phorbol|ester|pma|-lrb-|phorbol|12-myristate|13-acetate|-rrb-|stimulate|pkc|combination|adenosine|receptor|agonist|neca|-lrb-|5|'|-|-lrb-|n-ethyl|-rrb-|-|carboxamido|adenosine|-rrb-|forskolin|raise|COMPOUND_ENTITY|,|level|GENE_ENTITY|c-fos|jun|binding|transcriptional|activity|transcription|factor|,|activator|protein-1|-lrb-|ap-1|-rrb-|.	447770	0.0	7
view|importance|carbonic|anhydrase|-lrb-|CA|-rrb-|bone|resorption|,|examine|ca-inhibitory|property|flurbiprofen|use|bovine|human|GENE_ENTITY|II|compare|acetazolamide|nsaid|,|COMPOUND_ENTITY|indomethacin|.	448230	0.0	7
improve|safety|autotransplantation|myeloma|,|peripheral|blood|stem|cell|-lrb-|pbsc|-rrb-|collection|attempt|75|previously|treat|patient|administration|high-dose|COMPOUND_ENTITY|-lrb-|hd-ctx|;|6|g/m2|-rrb-|granulocyte-macrophage|colony-stimulating|factor|-lrb-|GENE_ENTITY|gm-csf|-rrb-|.	448330	0.0	7
carboxy-terminal|COMPOUND_ENTITY|alpha|b-crystallin|amine-donor|substrate|GENE_ENTITY|tissue|transglutaminase|.	448497	1.0	7
effect|COMPOUND_ENTITY|t-lymphocyte|proliferative|response|serum|GENE_ENTITY|prolactin|concentration|critically|ill|patient|.	449318	0.0	7
observation|suggest|GENE_ENTITY|play|role|acidification|lysosome|,|possibly|limited|permeability|lysosomal|membrane|COMPOUND_ENTITY|.	449459	0.0	7
examine|effect|chronic|administration|angiotensin|i-converting|enzyme|-lrb-|ace|-rrb-|inhibitor|circulate|GENE_ENTITY|ii|-lrb-|aii|-rrb-|concentration|,|20|mg|COMPOUND_ENTITY|administer|daily|7|consecutive|day|healthy|volunteer|.	450071	0.0	7
near|c-terminal|end|basonuclin|surface|putative|alpha-helix|,|stripe|COMPOUND_ENTITY|residue|similar|transcription|factor|GENE_ENTITY|prdii-bf1|.	450555	0.0	7
decrease|oxygen|tension|,|basal|ach-stimulated|COMPOUND_ENTITY|production|attenuate|,|cgmp|production|snp|,|indicate|oxygen|modulation|GENE_ENTITY|edrf|production|.	451259	0.0	7
chimeric|COMPOUND_ENTITY|-rrb-|-|atpase|contain|nucleotide|binding/hinge|domain|GENE_ENTITY|serca|2|serca|2|type|ca2|+|dependence|,|nucleotide|binding/hinge|cooh-terminal|transmembrane|domain|serca|3|require|serca|3|type|ca2|+|dependence|.	451944	0.0	7
,|idrapril|potentiate|capsaicin-induced|bronchoconstriction|-lrb-|model|relate|liability|GENE_ENTITY|inhibitor|produce|cough|patient|-rrb-|effectively|COMPOUND_ENTITY|.	452187	0.0	7
patient|previously|treat|,|interferon-alpha|-lrb-|GENE_ENTITY|-rrb-|ifn-alpha|chemotherapy|COMPOUND_ENTITY|.	452199	0.0	7
basic|variant|glutamine|residue|replace|COMPOUND_ENTITY|position|89|-lrb-|GENE_ENTITY|ttr|gln-89|-rrb-|.	452328	0.0	7
ligation|atp|receptor|b|cell|previously|elicit|increase|cytosolic|free|COMPOUND_ENTITY|+|inositol|phosphate|production|induction|c-fos|mrna|expression|increase|expression|GENE_ENTITY|il-2|transferrin|receptor|.	452361	0.0	7
GENE_ENTITY|mrna|level|mrc-5|cell|hl-60|cell|dose-dependently|suppress|tgf-beta|1|COMPOUND_ENTITY|;|10|ng/ml|tgf-beta|1|suppress|hgf|mrna|level|32|%|35|%|control|culture|,|respectively|,|mrc-5|cell|hl-60|cell|,|10|-lrb-|-6|-rrb-|m|dexamethasone|suppress|43|%|38|%|,|respectively|.	452547	0.0	7
beta|1ar|blockade|-lrb-|-|-rrb-|-|adrenaline|cause|maximum|effect|GENE_ENTITY|2ar|COMPOUND_ENTITY|noradrenaline|beta|1ar|.	623227	0.0	7
pretreatment|th|clone|leu3a|result|dose-dependent|suppression|antigen-induced|proliferative|response|,|inositol|phosphate|accumulation|,|increase|free|cytoplasmic|calcium|ion|-lrb-|-lsb-|COMPOUND_ENTITY|-rsb-|-rrb-|,|il-2|mrna|accumulation|,|GENE_ENTITY|il-2|secretion|,|membrane|il-2r|expression|.	623827	0.0	7
ability|enhance|target|tissue|GENE_ENTITY|action|,|COMPOUND_ENTITY|improve|glycemic|control|niddm|patient|previously|fail|therapy|sulfonylurea|agent|.	623938	0.0	7
effect|GENE_ENTITY|pupil|size|abolish|COMPOUND_ENTITY|pretreatment|,|indicate|effect|mediate|arachidonic|acid|metabolite|.	624681	0.0	7
anti-platelet|aggregatory|effect|indomethacin-pretreated|coronary|artery|enhance|COMPOUND_ENTITY|histamine|,|stimulator|edrf|production|,|superoxide|dismutase|,|prolong|half-life|edrf|,|inhibit|GENE_ENTITY|edrf|inhibitor|hemoglobin|.	624774	0.0	7
randomize|,|partial-crossover|study|conduct|uraemic|patient|dialysis-associated|anaemia|transfusional|iron|overload|evaluate|effect|COMPOUND_ENTITY|chelation|therapy|recombinant|human|erythropoietin|treatment|hepatic|iron|storage|determine|computed|tomography|,|serum|ferritin|concentration|GENE_ENTITY|transferrin|saturation|.	624781	0.0	7
l/v|versus|1|/|-lsb-|s|-rsb-|plot|GENE_ENTITY|change|presence|COMPOUND_ENTITY|acid|linear|non-linear|curve|,|suggest|positive|co-operativity|.	624926	0.0	7
report|c/t|dimorphism|GENE_ENTITY|-lrb-|tm|-rrb-|gene|predict|ala455|--|COMPOUND_ENTITY|replacement|sixth|egf-like|domain|tm|.	624930	0.0	7
determine|conformational|property|c-terminal|region|insulin|b-chain|relative|helical|core|molecule|,|investigate|fluorescence|property|insulin|analog|amino|acid|b28|b29|substitute|COMPOUND_ENTITY|proline|residue|respectively|,|-lrb-|-lsb-|wb28|,|pb29|-rsb-|GENE_ENTITY|insulin|-rrb-|.	624937	0.0	7
September|1983|April|1985|,|15|patient|previously|untreated|intermediate|high|grade|lymphoma|treat|GENE_ENTITY|-lrb-|cyclophosphamide|,|vincristine|,|cytarabine|,|COMPOUND_ENTITY|,|leucovorin|,|adriamycin|,|bleomycin|,|prednisone|-rrb-|.	625028	0.0	7
follow|compound|synthesize|:|-lsb-|tip1|,|lys17|,18|,|glu21|-rsb-|glucagon|-lrb-|2|-rrb-|;|-lsb-|GENE_ENTITY|,|tyr5|,|arg12|,|lys17|,18|,|glu21|-rsb-|glucagon|-lrb-|3|-rrb-|;|-lsb-|dhis1,d-phe4|,|tyr5|,|COMPOUND_ENTITY|,|lys17|,18|,|glu21|-rsb-|glucagon|-lrb-|4|-rrb-|;|-lsb-|dhis1,asp3,d-phe4|,|tyr5|,|arg12|,|lys17|,18|,|glu21|+|+|+|-rsb-|glucagon|-lrb-|5|-rrb-|;|des-phe6|-|-lsb-|tip1,d-phe4|,|tyr5|,|arg12|,|glu21|-rsb-|glucagon|-lrb-|6|-rrb-|;|des-phe6|-|-lsb-|asp3,d-phe4|,|tyr5|,|arg12|,|glu21|-rsb-|glucagon|-lrb-|7|-rrb-|.	625302	0.0	7
human|GENE_ENTITY|contain|single|tryptophan|residue|position|72|internal|COMPOUND_ENTITY|residue|position|89|125|,|use|reagent|specifically|cleave|residue|,|conjunction|antipeptide|antisera|,|localize|site|attachment|photoaffinity|ligand|.	625999	0.0	7
association|gm-csf|signaling|g-protein|,|pld|,|GENE_ENTITY|,|COMPOUND_ENTITY|kinase|,|na|+|/|h|+|antiport|remain|poorly|understand|.	626124	0.0	7
,|COMPOUND_ENTITY|find|directly|stimulate|GENE_ENTITY|et1|+|2|release|culture|human|umbilical|vein|endothelial|cell|.	626169	0.0	8
biological|effect|COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|mediate|binding|closely|related|nuclear|receptor|-lrb-|GENE_ENTITY|rar|alpha|,|rar|beta|,|rar|gamma|-rrb-|belong|steroid-thyroid|nuclear|receptor|family|.	626447	1.0	8
serum|factor|,|anaphylatoxin|c3a|GENE_ENTITY|and/or|COMPOUND_ENTITY|derivative|enhance|lps-induced|il|1|tnf|production|.	626792	0.0	8
COMPOUND_ENTITY|inhibit|production|interferon-beta|-lrb-|GENE_ENTITY|ifn-beta|-rrb-|human|fibroblast|cell|response|sendai|virus|poly|-lrb-|ri|-rrb-|.	626934	0.0	8
measure|free|COMPOUND_ENTITY|-lrb-|ft3|-rrb-|,|thyrotropin|-lrb-|tsh|-rrb-|,|GENE_ENTITY|c-reactive|protein|-lrb-|crp|-rrb-|serum|39|acutely|ill|medical|patient|die|month|admission|39|age|-|sex-matched|control|patient|select|random|total|294|acute|medical|admission|.	627016	0.0	7
stimulation|corticotropin|analogue|physical|-lrb-|cold-pressor|test|-rrb-|mental|-lrb-|color-word|mathematic|-rrb-|stress|test|elevated|response|serum|COMPOUND_ENTITY|,|prolactin|GENE_ENTITY|growth|hormone|concentration|.	627240	0.0	7
COMPOUND_ENTITY|assay|cell|micromanipulate|contact|GENE_ENTITY|b19|somata|assess|secretory|state|.	627347	0.0	7
result|work|reveal|combine|determination|urine|cea|fer|,|cea|GENE_ENTITY|COMPOUND_ENTITY|tpa|higher|sensitivity|determination|individual|marker|.	627622	0.0	8
treatment|GENE_ENTITY|modify|plasma|clearance|endogenous|e2|,|accelerate|disappearance|rate|5|alpha-dihydrotestosterone|-lrb-|COMPOUND_ENTITY|-rrb-|.	628298	0.0	8
behaviorally|active|dose|,|COMPOUND_ENTITY|administer|i.c.v.|increase|plasma|level|immunoreactive|beta-e|-lrb-|GENE_ENTITY|beta-e|-rrb-|affect|concentration|immunoreactive|alpha-melanocyte-stimulating|hormone|,|suggest|pcp|increase|release|beta-e|anterior|lobe|pituitary|.	629664	0.0	7
Aim|work|investigate|effect|androgen|-lrb-|testosterone|COMPOUND_ENTITY|-rrb-|GENE_ENTITY|insulin|receptor|mrna|level|insulin|binding|activity|metabolic|growth-promoting|action|insulin|human|larynx|carcinoma|cell|line|-lrb-|hep-2|-rrb-|.	629821	0.0	8
section|149|breast|carcinoma|examine|over-expression|GENE_ENTITY|oncoprotein|use|COMPOUND_ENTITY|immunoperoxidase|technique|different|specific|antibody|.	629941	0.0	8
thirty-three|patient|receive|COMPOUND_ENTITY|,|doxorubicin|,|vincristine|,|prednisone|,|bleomycin|-lrb-|GENE_ENTITY|chop-bleo|-rrb-|.	630260	0.0	8
stimulation|cd3-ti|GENE_ENTITY|induce|rapid|COMPOUND_ENTITY|phosphorylation|68-kda|protein|human|jurkat|t|cell|line|.	630700	0.0	7
synthesis|GENE_ENTITY|1|endothelial|cell|stimulate|adrenaline|,|noradrenaline|,|angiotensin|ii|,|COMPOUND_ENTITY|,|thrombine|,|interleukin|1|hypoxia|.	631521	0.0	7
future|study|prove|COMPOUND_ENTITY|helpful|treat|diabetic|retino|-|nephropathy|possibility|suppress|growth|hormone|GENE_ENTITY|igf-i|.	631525	0.0	8
method|:|recombinant|dna|technology|use|analyze|marker|chromosome|11p15|location|:|gene|COMPOUND_ENTITY|hydroxylase|-lrb-|th|-rrb-|insulin|-lrb-|INS|-rrb-|c-harvey-ras|oncogene|-lrb-|GENE_ENTITY|hras|-rrb-|.	632035	0.0	7
evidence|hypothalamo-growth|hormone|dysfunction|panic|disorder|:|profile|growth|hormone|-lrb-|GENE_ENTITY|-rrb-|response|clonidine|,|COMPOUND_ENTITY|,|caffeine|,|glucose|,|grf|trh|panic|disorder|patient|versus|healthy|volunteer|.	632050	0.0	8
blockade|COMPOUND_ENTITY|receptor|and/or|stimulation|gabaergic|system|reduce|BDNF|GENE_ENTITY|ngf|mrna|hippocampus|ngf|protein|hippocampus|septum|.	632107	0.0	7
study|renal|effect|reinfuse|low|dose|angiotensin|ii|-lrb-|1|ng|kg-1|min-1|-rrb-|seven|salt-replete|healthy|volunteer|pretreatment|angiotensin|convert|enzyme|-lrb-|ace|-rrb-|inhibitor|COMPOUND_ENTITY|-lrb-|25|mg|-rrb-|establish|natriuretic|renal|haemodynamic|response|GENE_ENTITY|ace|inhibition|normal|man|result|suppression|circulate|angiotensin|ii|.	632108	0.0	7
web|2086|inhibit|paf-induced|COMPOUND_ENTITY|release|,|effect|release|induce|histamine|GENE_ENTITY|thrombin|.	632278	0.0	7
expression|GENE_ENTITY|gene|inducible|activator|protein|kinase|-lrb-|COMPOUND_ENTITY|-rrb-|c|-lrb-|pma|-rrb-|signal|transduction|pathway|differentially|regulate|steroid|dexamethasone|retinoic|acid|.	632476	0.0	8
accord|result|obtain|polymerase|chain|reaction-assisted|mrna|detection|,|transcribe|gene|cellular|retinol|-|cellular|retinoic|acid-binding|protein|,|nuclear|COMPOUND_ENTITY|acid|receptor|,|rar-alpha|,|-|gamma|,|GENE_ENTITY|rxr-alpha|,|rar-beta|.	632770	0.0	7
average|daily|GENE_ENTITY|dose|rise|significantly|COMPOUND_ENTITY|placebo|group|compare|baseline|.	632952	0.0	7
GENE_ENTITY|stimulate|release|6-keto-pgf1|alpha|secretion|p|luteal|cell|species|,|inhibit|indomethacin|ibuprofen|,|acth|alter|COMPOUND_ENTITY|content|luteal|cell|.	633144	0.0	7
result|suggest|caution|use|GENE_ENTITY|sensitize|myeloid|leukemia|cell|COMPOUND_ENTITY|+|ara-c|chemotherapy|.	633541	0.0	8
specifically|,|opioid|,|include|2-n-pentyloxy-2-phenyl-4-methyl-morpholine|,|COMPOUND_ENTITY|,|GENE_ENTITY|beta-endorphin|,|interact|il-2|receptor|-lrb-|134|-rrb-|regulate|production|il-1|il-2|-lrb-|48-50|,|135|-rrb-|.	633755	0.0	7
multivariate|adjusted|rr|individual|heat|source|,|control|maternal|age|,|COMPOUND_ENTITY|acid|supplement|,|family|history|GENE_ENTITY|NTD|,|exposure|heat|source|,|hot|tub|use|,|2.8|-lrb-|95|%|ci|,|1.2|6.5|-rrb-|;|sauna|,|1.8|-lrb-|95|%|ci|,|0.4|7.9|-rrb-|;|fever|,|1.8|-lrb-|95|%|ci|,|0.8|4.1|-rrb-|;|electric|blanket|,|1.2|-lrb-|95|%|ci|,|0.5|2.6|-rrb-|.	633823	0.0	7
increase|COMPOUND_ENTITY|phosphorylation|135-kda|100-kda|substrate|specific|anti-hla|class|,|anti-cd6|,|GENE_ENTITY|anti-cd7|,|anti-cd28|antibody|cause|increase|tyrosine|phosphorylation|.	633947	0.0	8
use|saturation|transfer|electron|paramagnetic|resonance|-lrb-|st-epr|-rrb-|laser-induced|photolysis|caged|COMPOUND_ENTITY|monitor|change|microsecond|rotational|dynamics|spin-labeled|f-actin|presence|GENE_ENTITY|myosin|subfragment-1|-lrb-|s1|-rrb-|.	634034	0.0	7
COMPOUND_ENTITY|-lrb-|dex|-rrb-|-lrb-|100|nm|-rrb-|potentiate|GENE_ENTITY|pth-induced|-lrb-|40|nm|-rrb-|camp|synthesis|subconfluent|mg-63|cell|-lrb-|1.5-fold|increase|,|p|0.05|-rrb-|.	634079	0.0	7
suggest|reduce|level|COMPOUND_ENTITY|aspartate|elevated|GENE_ENTITY|gdh|activity|spinal|cord|als|patient|reflect|overactivity|neuron|release|potentially|excitotoxic|amino|acid|causally|related|spinal|neuro-degenerative|change|characteristic|ALS|.	634638	0.0	7
new|COMPOUND_ENTITY|response|element|transcribe|region|human|GENE_ENTITY|c-fos|gene|.	635221	0.0	7
plasma|GENE_ENTITY|-1|-|like|immunoactivity|27|patient|aneurysmal|subarachnoid|hemorrhage|-lrb-|COMPOUND_ENTITY|-rrb-|measure|serially|radioimmunoassay|2|week|SAH|onset|.	635433	0.0	7
addition|5|mm|COMPOUND_ENTITY|allow|GENE_ENTITY|crp|abolish|binding|.	635689	0.0	7
COMPOUND_ENTITY|,|GENE_ENTITY|angiotensin|convert|enzyme|-lrb-|ace|-rrb-|inhibitor|,|free|radical|scavenging|ability|,|attributable|thiol|group|.	636329	1.0	7
COMPOUND_ENTITY|,|potent|inhibitor|prostaglandin|synthesis|,|know|increase|maternal|blood|pressure|response|GENE_ENTITY|angiotensin|ii|infusion|.	637087	0.0	7
arachidonic|acid|important|mediator|insulin|secretion|-lrb-|1|-rrb-|glucose|activate|GENE_ENTITY|a2|increase|endogenous|unesterified|level|arachidonic|acid|,|-lrb-|2|-rrb-|arachidonic|acid|mobilize|ca2|+|islet|endoplasmic|reticulum|-lrb-|3|-rrb-|arachidonic|acid|propose|regulate|voltage-dependent|COMPOUND_ENTITY|+|channel|beta-cell|.	637169	0.0	7
moderate|low|concentration|immunoreactive|process|detect|calcitonin|gene-related|peptide|,|alpha-melanocyte|stimulating|hormone|,|dynorphin|b|,|thyrotropin|release|hormone|,|leucine-enkephalin|,|dynorphin|,|GENE_ENTITY|ii|,|beta-endorphin|,|vasopressin|COMPOUND_ENTITY|antisera|,|respectively|.	637311	0.0	7
structural|functional|approach|classification|complex|GENE_ENTITY|c|system|find|COMPOUND_ENTITY|bacterium|.	637411	0.0	7
treatment|interleukin-1|-lrb-|il-1|-rrb-|COMPOUND_ENTITY|result|diminish|synthesis|enhance|catabolism|matrix|proteoglycan|,|chondrocyte|sensitive|human|recombinant|GENE_ENTITY|il-1|alpha|il-1|beta|.	637546	0.0	7
COMPOUND_ENTITY|alter|GENE_ENTITY|lipoprotein|lipase|activity|cardiac|myocyte|.	637651	0.0	7
possible|involvement|arachidonic|acid|derivative|mediate|GENE_ENTITY|induction|investigate|treatment|cyclo-oxygenase|inhibitor|COMPOUND_ENTITY|lipoxygenase|inhibitor|nordihydroguaiaretic|acid|-lrb-|ndga|-rrb-|.	637751	0.0	7
dna|encode|GENE_ENTITY|ribozyme|-lrb-|fosrb|-rrb-|clone|pmamneo|expression|plasmid|,|resultant|vector|transfect|a2780ddp|cell|resistant|chemotherapeutic|agent|COMPOUND_ENTITY|.	637940	0.0	7
vitamin|derivative|COMPOUND_ENTITY|acid|exert|effect|transcription|distinct|class|nuclear|receptor|,|retinoic|acid|receptor|-lrb-|rar|-rrb-|GENE_ENTITY|retinoid|x|receptor|-lrb-|rxr|-rrb-|.	638114	1.0	7
vitamin|derivative|retinoic|acid|exert|effect|transcription|distinct|class|nuclear|receptor|,|COMPOUND_ENTITY|acid|receptor|-lrb-|rar|-rrb-|GENE_ENTITY|retinoid|x|receptor|-lrb-|rxr|-rrb-|.	638123	0.0	7
effect|inhibitor|nitric|oxide|synthesis|examine|endothelium-dependent|relaxation|induce|COMPOUND_ENTITY|human|alpha-calcitonin|gene-related|peptide|-lrb-|GENE_ENTITY|cgrp|-rrb-|rat|isolate|aortic|ring|preconstrict|noradrenaline|.	638227	0.0	7
gastric|acid|play|important|role|absorption|process|COMPOUND_ENTITY|vitamin|b12|,|determine|level|iron|,|ferritin|,|vitamin|GENE_ENTITY|b12|,|folic|acid|75|serum|sample|obtain|continuous|omeprazole|therapy|-lrb-|6-48|month|start|therapy|-rrb-|34|patient|peptic|disease|-lrb-|primarily|reflux|esophagitis|-rrb-|.	638457	0.0	7
principal|aim|test|hypothesis|reduction|serum|cholesterol|treatment|COMPOUND_ENTITY|-lsb-|competitive|inhibitor|GENE_ENTITY|3-hydroxy-3-methylglutaryl|coenzyme|-lrb-|hmg|coa|-rrb-|reductase|--|regulatory|enzyme|cholesterol|synthesis|-rsb-|average|period|5|yr|lead|reduction|fatal|non-fatal|myocardial|infarction|.	639933	1.0	7
GENE_ENTITY|agonist|stimulate|dna|synthesis|jurkat|cell|pathway|independent|COMPOUND_ENTITY|intracellular|free|calcium|.	640076	0.0	7
patient|-lsb-|GENE_ENTITY|receptor|-lrb-|er|-rrb-|-|positive|,|tumor|size|3|cm|-rsb-|register|observation|arm|clinical|trial|385|-lrb-|er-negative|and/or|tumor|size|greater|equal|3|cm|-rrb-|randomly|assign|adjuvant|chemotherapy|-lrb-|cyclophosphamide|,|COMPOUND_ENTITY|,|fluorouracil|,|prednisone|cycle|-rrb-|observation|.	640252	0.0	7
COMPOUND_ENTITY|enhancer-binding|protein|GENE_ENTITY|atf-1|activate|transcription|response|camp-dependent|protein|kinase|.	640683	1.0	8
gap|protein|59|68|kda|phosphorylate|tyrosine|thrombin|stimulation|src-related|protein|COMPOUND_ENTITY|kinase|,|fyn|,|GENE_ENTITY|lyn|yes|,|associate|gap|complex|,|detectable|agonist|stimulation|.	640712	0.0	7
low-dose|COMPOUND_ENTITY|vascular|response|pregnant|patient|sensitive|GENE_ENTITY|angiotensin|ii|.	640840	0.0	8
patient|method|:|adult|patient|poor-risk|lbl|remission|treatment|cyclophosphamide|,|doxorubicin|,|vincristine|,|COMPOUND_ENTITY|-lrb-|GENE_ENTITY|chop|;|patient|-rrb-|all-like|regimen|-lrb-|patient|-rrb-|,|treat|high-dose|cyclophosphamide|total|body|irradiation|-lrb-|tbi|-rrb-|follow|nonpurged|autologous|bone|marrow|transplantation|-lrb-|abmt|-rrb-|.	641076	0.0	7
effect|twice|time|daily|COMPOUND_ENTITY|GENE_ENTITY|p24|antigenaemia|CDC|stage|ii/iii|patient|.	641131	0.0	8
titration|diferric|GENE_ENTITY|produce|difference|uv|spectrum|,|propose|primary|binding|site|phosphonic|acid|include|protein|group|bind|synergistic|COMPOUND_ENTITY|anion|require|formation|stable|ferric|transferrin|complex|.	641237	0.0	8
,|cd4|regulate|cd3/ti|signal|transduction|t-all|cell|COMPOUND_ENTITY|phosphorylation|substrate|GENE_ENTITY|cd2|regulate|-lsb-|ca2|+|-rsb-|signal|transduction|separate|mechanism|.	641392	0.0	7
epinephrine|,|COMPOUND_ENTITY|,|cortisol|,|GENE_ENTITY|growth|hormone|response|similar|,|epinephrine|response|slightly|delay|growth|hormone|response|appear|smaller|elderly|.	641776	0.0	7
38|GENE_ENTITY|isolate|,|35|-lrb-|92|%|-rrb-|methicillin|-|multiply-resistant|;|,|PRSA|isolate|sensitive|COMPOUND_ENTITY|coumermycin|.	642428	0.0	7
inhibition|GENE_ENTITY|,|selegiline|inhibit|uptake|dopamine|COMPOUND_ENTITY|presynaptic|nerve|increase|turnover|dopamine|.	642647	0.0	8
animal|inject|tracer|dose|radioactive|steroid|,|pretreatment|GENE_ENTITY|increase|uterine|oviductal|accumulation|e2|-|COMPOUND_ENTITY|radioactivity|.	642792	0.0	8
,|hl60|cell|,|procarbazine|metabolize|myeloperoxidase|COMPOUND_ENTITY|metabolize|GENE_ENTITY|cytochrome|p-450|system|.	642825	1.0	7
8-thiocyanatoflavin|COMPOUND_ENTITY|,|GENE_ENTITY|fmn|,|fad|level|prepare|diazonium|salt|corresponding|8-aminoflavin|physical|chemical|property|study|.	643043	0.0	8
holo-crabp|substrate|retinoic|acid|catabolism|rat|testis|microsome|criterion|:|1|-rrb-|rate|retinoic|acid|metabolism|crabp|excess|retinoic|acid|exceed|rate|support|free|retinoic|acid|;|2|-rrb-|increase|GENE_ENTITY|decrease|rate|predict|free|retinoic|acid|substrate|;|3|-rrb-|holo-crabp|lower|Michaelis|constant|-lrb-|1.8|nm|-rrb-|COMPOUND_ENTITY|acid|elimination|free|retinoic|acid|-lrb-|49|nm|-rrb-|.	643705	0.0	7
COMPOUND_ENTITY|cause|strong|inhibition|concentration|correspond|therapeutic|serum|level|,|inhibition|influence|presence|high|level|GENE_ENTITY|interleukin|2|.	643743	0.0	8
ph|threshold|human|duodenal|COMPOUND_ENTITY|secretion|diffusion|GENE_ENTITY|co2|.	643881	0.0	8
development|COMPOUND_ENTITY|premature|infant|intravenous|application|GENE_ENTITY|all-rac-alpha-tocopheryl|acetate|.	644011	0.0	8
provide|evidence|protein|-lrb-|s|-rrb-|-|tar|complex|molecular|mass|approximately|75|kda|COMPOUND_ENTITY|gel|,|ns1|,|complex|precipitate|GENE_ENTITY|ns1|antibody|,|suggest|ns1|mediate|trans-activation|induce|alteration|binding|activity|cellular|protein|-lrb-|s|-rrb-|indirect|manner|.	644152	0.0	7
change|associate|maturation|target|cell|vitro|appear|prerequisite|COMPOUND_ENTITY|production|response|increase|camp|level|presence|GENE_ENTITY|insulin|igf-i|.	644368	0.0	7
GENE_ENTITY|e-4philadelphia|-lrb-|glu13|--|Lys|,|arg145|--|COMPOUND_ENTITY|-rrb-|.	644884	0.0	7
predict|increase|jcycle|shorten|agreement|available|datum|,|model|prediction|work|output|COMPOUND_ENTITY|insensitive|change|GENE_ENTITY|myosin|phosphorylation|unexpected|remain|test|future|experiment|.	644886	0.0	7
deficient|GENE_ENTITY|hormone|-lrb-|gh|-rrb-|response|hypoglycaemia|,|,|common|patient|normal|COMPOUND_ENTITY|response|.	645537	0.0	7
reversal|endothelin-1-induced|contraction|COMPOUND_ENTITY|GENE_ENTITY|myosin|dephosphorylation|tracheal|smooth|muscle|.	645959	0.0	7
variable|level|GENE_ENTITY|chromosome|negativity|achieve|use|interferon-alfa|,|COMPOUND_ENTITY|,|combination|chemotherapy|,|allogeneic|bone|marrow|transplantation|.	646820	0.0	7
GENE_ENTITY|II|induce|rise|mean|arterial|pressure|-lrb-|map|-rrb-|renal|vasoconstriction|partly|antagonize|fall|glomerular|filtration|rate|-lrb-|gfr|-rrb-|cna|completely|abolish|COMPOUND_ENTITY|.	647330	0.0	7
datum|suggest|activation|tyrosine|kinase|system|early|response|binding|GENE_ENTITY|,|gm-csf|,|tnf|,|ifn|respective|cell|surface|receptor|,|addition|COMPOUND_ENTITY|sulfoxide|,|result|phosphorylation|event|-lrb-|s|-rrb-|play|role|secure|common|element|biologic|response|agent|.	647518	0.0	7
shape|24|h|GENE_ENTITY|profile|curve|change|significantly|octreotide|treatment|-lrb-|p|0.05|-rrb-|consist|nadir|peak|closely|link|time|COMPOUND_ENTITY|administration|.	647565	0.0	7
find|GENE_ENTITY|+|t|cell|susceptible|COMPOUND_ENTITY|inhibition|produce|cyclic|amp|cd4|+|t|cell|.	647745	0.0	8
induction|terminal|differentiation|promyelocytic|leukemia|cell|line|hl60|COMPOUND_ENTITY|-lrb-|dmso|-rrb-|accompany|block|rna|elongation|exon|GENE_ENTITY|c-myc|gene|.	648018	0.0	7
simple|computer|model|blood|plasma|-lrb-|citrate|100|mumol/l|,|GENE_ENTITY|37|mumol/l|-rrb-|use|compare|Fe|-lrb-|III|-rrb-|binding|efficacy|blood|l1|clinically|use|intravenously|administer|chelate|agent|COMPOUND_ENTITY|.	648118	0.0	7
addition|GENE_ENTITY|significantly|increase|-lsb-|COMPOUND_ENTITY|-rsb-|HT|compare|nt|-lrb-|13.8|+|/|-|5.3|nm|vs|0.9|+|/|-|1.9|nm|,|p|0.01|-rrb-|.	648146	0.0	8
hs368|contain|iron|-lrb-|0.15|0.43|mol|fe/mol|5-lo|2|preparation|-rrb-|detectable|oxygenase|,|GENE_ENTITY|synthase|anaerobic|COMPOUND_ENTITY|hydroperoxidase|activity|.	648263	0.0	7
experiment|,|administration|COMPOUND_ENTITY|-lrb-|1|mg|,|im|-rrb-|,|clonidine|-lrb-|0.300|mg|,|orally|-rrb-|,|atropine|plus|clonidine|,|pyridostigmine|-lrb-|120|mg|,|orally|-rrb-|,|yohimbine|-lrb-|30|mg|,|orally|-rrb-|,|pyridostigmine|plus|yohimbine|,|0|min|follow|GENE_ENTITY|ghrh|administration|60|min|later|.	648283	0.0	7
COMPOUND_ENTITY|clonidine|,|inhibitory|effect|overcome|mean|GENE_ENTITY|ghrh-elicited|gh|peak|response|significantly|-lrb-|p|0.05|-rrb-|higher|control|study|.	648466	0.0	7
molecular|characteristic|human|COMPOUND_ENTITY|cell|line|examine|specifically|GENE_ENTITY|mdr1|gene|amplification|southern|analysis|overexpression|messenger|rna|.	648795	0.0	7
study|putative|difference|central|neurotransmitter|function|depressive|subtype|,|GENE_ENTITY|hormone|,|adrenocorticotropic|hormone|-lrb-|acth|-rrb-|,|COMPOUND_ENTITY|,|prolactin|response|alpha|2-noradrenergic|receptor|agonist|clonidine|-lrb-|1.3|micrograms/kg|i.v.|-rrb-|examine|26|subject|major|depression|,|13|melancholia|.	649154	0.0	7
observation|suggest|role|membrane|lipid|environment|mediate|human|erythrocyte|GENE_ENTITY|inhibition|,|observe|CPZ|retain|inhibitory|effect|fraction|enzyme|-lrb-|5-6|%|total|-rrb-|solubilize|erythrocyte|treatment|phosphatidylinositol-specific|phospholipase|c|-lrb-|pi-plc|-rrb-|bacillus|thuringiensis|;|furthermore|,|Triton|x-100|able|reverse|COMPOUND_ENTITY|effect|case|pi-plc-solubilized|enzyme|.	649387	0.0	7
trypsin|digestion|chum|salmon|GENE_ENTITY|hormone|,|follow|mass|spectrometry|establish|cys-49|link|cys-161|,|COMPOUND_ENTITY|link|cys-186|.	850093	0.0	7
topical|antiandrogenic|activity|COMPOUND_ENTITY|canrenoate|-lrb-|GENE_ENTITY|cak|-rrb-|,|compare|spironolactone|-lrb-|sp|-rrb-|,|assay|vivo|female|golden|syrian|hamster|flank|organ|stimulate|subcutaneous|administration|testosterone|propionate|.	850139	0.0	7
overall|,|datum|indicate|amino|acid|COMPOUND_ENTITY|function|binding|site|GENE_ENTITY|PAI|.	850479	0.0	8
COMPOUND_ENTITY|protease|domain|GENE_ENTITY|pk1|delta|fe1x|exhibit|amidolytic|activity|characteristic|wt|t-pa|.	851428	0.0	7
GENE_ENTITY|activity|alter|COMPOUND_ENTITY|.	851448	0.0	7
direct|measurement|ability|minoxidil|compete|bind|egf|receptor|indicate|COMPOUND_ENTITY|probably|bind|GENE_ENTITY|egf|receptor|.	851922	1.0	7
mature|splenic|b|cell|express|migm|migd|,|migm|crosslinking|stimulate|tyrosine|phosphorylation|32-kda|mb-1|protein|,|migd|crosslinking|stimulate|COMPOUND_ENTITY|phosphorylation|GENE_ENTITY|mb-1-related|protein|33|34|kda|.	852154	0.0	7
primary|structure|isolate|GENE_ENTITY|head|-lrb-|myosin|subfragment-1|-rrb-|heavy|chain|localization|site|group|responsible|binding|hydrolysis|COMPOUND_ENTITY|myosin|interaction|actin|,|consider|.	852191	1.0	7
order|establish|age-related|reduce|growth|hormone|-lrb-|gh|-rrb-|responsiveness|gh-releasing|hormone|-lrb-|GENE_ENTITY|-rrb-|improve|treatment|low|theophylline|,|drug|mainly|act|cyclic|adenosine|3|'|,|5|'|-|monophosphate|-lrb-|camp|-rrb-|,|calcium-mediated|mechanism|,|adult|subject|-lrb-|aged|20-37|-rrb-|elderly|man|-lrb-|aged|64-79|-rrb-|test|ghrh|-lrb-|50|microgram|iv|bolus|-rrb-|,|COMPOUND_ENTITY|-lrb-|1.67|mg/min|3|h|-rrb-|,|combination|drug|.	852684	0.0	7
addition|,|mab|adhesion|molecule|lfa-3|,|GENE_ENTITY|,|lfa-1|,|cd29|,|COMPOUND_ENTITY|phosphatase|cd45|inhibit|proliferation|,|indicate|involvement|t|t|cell|interaction|.	852759	0.0	7
human|group|ii|GENE_ENTITY|a2|porcine|group|phospholipase|a2|augment|COMPOUND_ENTITY|e2|production|similar|manner|.	853137	0.0	7
low|level|GENE_ENTITY|mrna|detect|transiently|induction|ionomycin|,|simultaneous|induction|agent|increase|-lrb-|COMPOUND_ENTITY|-rrb-|lead|enhance|level|ifn-gamma|mrna|detectable|12|h.|ifn-gamma|mrna|detect|ctl|activate|-lrb-|camp|-rrb-|i-increasing|agent|pkc-activating|agent|pma|,|suggest|transcriptional|activation|ifn-gamma|gene|strictly|dependent|ca2|-lrb-|+|-rrb-|-|mediate|cyclosporin|a-dependent|event|.	853242	0.0	7
low|level|ifn-gamma|mrna|detect|transiently|induction|ionomycin|,|simultaneous|induction|agent|increase|-lrb-|camp|-rrb-|lead|enhance|level|ifn-gamma|mrna|detectable|12|h.|GENE_ENTITY|mrna|detect|ctl|activate|-lrb-|COMPOUND_ENTITY|-rrb-|i-increasing|agent|pkc-activating|agent|pma|,|suggest|transcriptional|activation|ifn-gamma|gene|strictly|dependent|ca2|-lrb-|+|-rrb-|-|mediate|cyclosporin|a-dependent|event|.	853273	0.0	7
basic|region|neighbor|COMPOUND_ENTITY|c-terminus|protein|GENE_ENTITY|srp19|require|bind|signal|recognition|particle|rna|.	853265	0.0	7
COMPOUND_ENTITY|GENE_ENTITY|albumin|binding|curve|reveal|association|constant|remain|unchanged|-lrb-|ka|approximately|1.0|x|10|-lrb-|5|-rrb-|m-1|-rrb-|,|fraction|albumin|molecule|present|react|ligand|.	853607	1.0	7
bioassay|experiment|use|COMPOUND_ENTITY|large|epicardial|donor|artery|segment|basal|release|GENE_ENTITY|edrf|edrf|release|response|acetylcholine|.	853879	0.0	7
concentration|,|,|iapp|significantly|-lrb-|p|0.05|-rrb-|inhibit|COMPOUND_ENTITY|-lrb-|10|-lrb-|-7|-rrb-|m|-rrb-|release|insulin|30|%|,|cgrp|significantly|inhibit|carbachol-stimulated|release|GENE_ENTITY|insulin|33|%|compare|control|group|.	854212	0.0	7
important|vasoconstrictor|,|fluid|-|sodium-retaining|factor|COMPOUND_ENTITY|system|,|sympathetic|nerve|activity|,|vasopressin|;|vasodilator|,|volume|,|sodium-eliminating|factor|atrial|natriuretic|peptide|,|vasodilator|prostaglandin|like|prostacyclin|prostaglandin|e2|,|dopamine|,|GENE_ENTITY|bradykinin|,|possibly|,|endothelial|derive|relaxing|factor|-lrb-|edrf|-rrb-|.	854272	0.0	7
effect|calcium|channel|blocker|nifedipine|-lrb-|20|mg|sublingual|-rrb-|,|COMPOUND_ENTITY|-lrb-|10|mg|i.v.|-rrb-|growth|hormone|-lrb-|gh|-rrb-|,|thyrotropin|-lrb-|tsh|-rrb-|,|prolactin|-lrb-|prl|-rrb-|gonadotropin|-lrb-|lh|fsh|-rrb-|secretion|induce|growth|hormone|release|hormone|-lrb-|ghrh|-rrb-|,|GENE_ENTITY|hypoglycemia|,|thyrotropin|release|hormone|-lrb-|trh|-rrb-|,|metoclopramide|gonadotropin|release|hormone|-lrb-|gnrh|-rrb-|,|study|group|normal|volunteer|-lrb-|27|man|8|woman|-rrb-|.	854445	0.0	7
venodilatory|response|COMPOUND_ENTITY|-lrb-|0.8|mg|sublingually|-rrb-|measure|10|healthy|young|male|volunteer|cool|-lsb-|24.3|+|/|-|0.6|degree|c|skin|temperature|-lrb-|tsk|-rrb-|-rsb-|warm|environment|-lrb-|34.7|+|/|-|0.2|degree|c|GENE_ENTITY|tsk|-rrb-|.	854594	0.0	7
platelet|stimulate|thrombin|COMPOUND_ENTITY|triphosphate|-lrb-|gtp|-lsb-|s|-rsb-|-rrb-|,|activate|phospholipase|c|protein|kinase|c|-lrb-|GENE_ENTITY|pkc|-rrb-|,|enhancement|3-phosphorylated|phosphoinositide|accumulation|-lrb-|3-ppi|-rrb-|.	855174	1.0	7
cytosine|arabinoside|-lrb-|COMPOUND_ENTITY|-rrb-|,|target|cell|s-phase|mitotic|cell|cycle|,|include|chemotherapeutic|regimen|treatment|acute|myelogenous|leukemia|,|explore|hypothesis|recruitment|quiescent|immature|leukemic|blast|cell|cycle|early|acting|growth|factor|GENE_ENTITY|interleukin|3|-lrb-|il-3|-rrb-|increase|efficacy|ara-c|kill|leukemic|stem|cell|.	855451	0.0	7
series|study|,|recombinant|GENE_ENTITY|2a|-lrb-|rifn|alpha|2a|,|roferon-a|-rrb-|administer|-lrb-|273|man|-rrb-|combine|COMPOUND_ENTITY|-lrb-|91|man|-rrb-|patient|acquire|immunodeficiency|syndrome|-lrb-|aids|-rrb-|-|related|kaposi|sarcoma|-lrb-|ks|-rrb-|.	855508	0.0	7
immunohistochemical|study|demonstrate|dystrophic|axon|contain|COMPOUND_ENTITY|hydroxylase|neuropeptide|tyrosine|-lrb-|npy|-rrb-|-|like|immunoreactivity|neuropeptide|-lrb-|vip|,|substance|p|,|gastrin-releasing|peptide|-lsb-|grp|-rsb-|/|GENE_ENTITY|bombesin|,|met-enkephalin|-rrb-|.	855541	0.0	7
monoamine|oxidase|type-b|-lrb-|GENE_ENTITY|-rrb-|metabolism|COMPOUND_ENTITY|generate|hydrogen|peroxide|,|,|oxidative|stress|nigrostriatal|dopaminergic|neuron|.	855809	1.0	7
,|COMPOUND_ENTITY|responsive|tumor|,|GENE_ENTITY|mdr1|and/or|gst-pi|expression|detect|.	855977	0.0	7
effect|GENE_ENTITY|potentiate|COMPOUND_ENTITY|+|ionophore|a23187|free|arachidonic|acid|-lrb-|aa|-rrb-|.	856385	0.0	7
COMPOUND_ENTITY|release|,|plasma|level|GENE_ENTITY|beta-tg|pf4|significantly|increase|symptomatic|period|allergen|provocation|acetylcholine|inhalation|.	856577	0.0	7
order|reappraise|androgen|glucocorticoid|secretion|disease|,|measure|serum|androstenedione|,|dehydroepiandrosterone-sulphate|,|total|free|testosterone|,|GENE_ENTITY|globulin|,|lh|,|fsh|,|prl|,|cortisol|,|corticosteroid-binding|globulin|,|urinary|free|COMPOUND_ENTITY|45|woman|polycystic|ovary|syndrome|27|control|,|subdivide|obese|normal-weight|subject|.	856658	0.0	7
,|catalase|abnormality|good|tool|study|pre-neoplastic|neoplastic|evolution|lesion|adjacent|tissue|lower|female|genital|tract|;|furthermore|,|-rrb-|provide|earlier|,|powerful|means|detect|GENE_ENTITY|progression|squamous|cell|carcinoma|,|combine|clinical|histological|examination|;|ii|-rrb-|model|investigate|drug|situ|h2o2|scavenger|agent|increase|COMPOUND_ENTITY|peroxidase|activity|-lrb-|gsh|-rrb-|.	857119	0.0	7
contrast|,|regulatory|decrease|inhibit|strongly|addition|1|mm|quinine|,|10|microm|bapta-am|medium|ca2|+|,|0.5|mm|dids|,|partly|1|mm|egta|medium|ca2|+|,|10|microm|COMPOUND_ENTITY|,|substitution|medium|cl|-|GENE_ENTITY|no3|-|.	857250	0.0	7
removal|plasma|blood|wash|label|lymphocyte|COMPOUND_ENTITY|antibody|reduce|proportion|cd5|+|cd19|+|cell|increase|proportion|cd16|+|cd57|-|cd16|+|cd57|+|cell|,|compare|measure|wash|,|change|proportion|cd5|+|GENE_ENTITY|cd19|-|,|cd5|-|cd19|+|,|cd4|+|cd8|-|,|cd4|-|cd8|+|cd16|-|cd57|+|cell|.	857276	0.0	7
binding|125i-labeled|gmp-140|neutrophil|hl60|cell|rosetting|neutrophil|hl60|cell|thrombin-activated|platelet|inhibit|COMPOUND_ENTITY|,|excess|unlabeled|fluid-phase|GENE_ENTITY|gmp-140|,|Fab|fragment|affinity-purified|rabbit|anti-gmp-140|antibody|,|murine|anti-gmp-140|monoclonal|antibody|,|ak|4|.	857518	0.0	8
apparent|km|-lrb-|6.6|microm|-rrb-|vmax|-lrb-|99|nmol|x|GENE_ENTITY|x|mg-1|-rrb-|observe|n|omega-hydroxy-l-arginine|similar|observe|COMPOUND_ENTITY|-lrb-|km|=|2.3|microm|;|vmax|=|54|mumol|x|min-1|x|mg-1|-rrb-|.	858241	0.0	7
GENE_ENTITY|gamma|concentration|0.95|ng/ml|reference|group|0.2|ng/ml|tumour|patient|0.01|micrograms/ml|COMPOUND_ENTITY|add|-lrb-|p|0.05|-rrb-|.	858532	0.0	7
effect|antibiotic|na0344|,|smooth|muscle|relaxant|,|phosphorylation|myosin|light|chain|-lrb-|mlc|,|20|kda|-rrb-|compare|COMPOUND_ENTITY|interaction|use|native|actomyosin|preparation|contain|GENE_ENTITY|mlc|kinase|activity|.	858561	0.0	7
presence|human|single-stranded|dna|binding|protein|-lrb-|GENE_ENTITY|-rrb-|slightly|reduce|degree|untwist|presence|COMPOUND_ENTITY|.	858693	0.0	8
approach|study|proposal|,|compare|effect|immunosuppressive|agent|,|COMPOUND_ENTITY|-lrb-|csa|-rrb-|transform|growth|factor-beta|-lrb-|GENE_ENTITY|tgf|beta|-rrb-|,|alloantigen-presenting|capability|fresh|lc|,|culture|lc|,|peripheral|blood|mononuclear|cell|-lrb-|pbmc|-rrb-|.	858796	0.0	7
order|test|hypothesis|,|investigate|intracellular|level|manganous|superoxide|dismutase|-lrb-|mnsod|-rrb-|glutathione|-lrb-|COMPOUND_ENTITY|-rrb-|l-m|-lrb-|pntnf|-rrb-|cell|carry|GENE_ENTITY|tnf|gene|induce|dexamethasone|-lrb-|dm|-rrb-|.	859049	0.0	7
earlier|work|demonstrate|GENE_ENTITY|cd8|receptor|couple|COMPOUND_ENTITY|kinase|term|p56lck|normal|transform|t|lymphocyte|.	859323	1.0	7
inhibition|use|different|accessory|cell|-lrb-|pbm|bcl|-rrb-|,|COMPOUND_ENTITY|present|GENE_ENTITY|il2|-|il4-dependent|proliferation|activate|t-cell|.	859525	0.0	8
plasma|renin|activity|GENE_ENTITY|concentration|,|arterial|pressure|,|serum|osmolality|measure|17|patient|random|epidural|injection|6.7|ml|0.75|%|COMPOUND_ENTITY|-lrb-|n|=|7|-rrb-|volume|saline|-lrb-|n|=|10|-rrb-|.	859840	0.0	7
binding|bumetanide|independent|buffer|composition|use|,|quantity|GENE_ENTITY|-lrb-|0.32|%|-rrb-|,|heparin|-lrb-|40|units/ml|-rrb-|,|sodium|azide|-lrb-|0.5|%|-rrb-|anticoagulant|-lrb-|edta|,|heparin|COMPOUND_ENTITY|-rrb-|.	859873	0.0	8
high|lysability|GENE_ENTITY|cell|colon-carcinoma|cell|resistant|COMPOUND_ENTITY|associate|high|expression|icam-1|,|lfa-3|,|nca|less-differentiated|phenotype|.	859920	0.0	8
percent|COMPOUND_ENTITY|produce|maximum|increase|55|+|/|-|11|%|-lrb-|n|=|8|-rrb-|,|maximum|increase|34|+|/|-|13|%|aqueous|flow|-lrb-|n|=|5|-rrb-|,|maximum|increase|74|+|/|-|18|%|GENE_ENTITY|pin|-lrb-|n|=|8|-rrb-|.	860265	0.0	7
datum|suggest|COMPOUND_ENTITY|inhibit|transcription|c-myc|protooncogene|block|binding|important|regulatory|factor|,|prevent|formation|GENE_ENTITY|c-myc|transcription|initiation|complex|.	860291	0.0	8
effect|COMPOUND_ENTITY|parathyroid|hormone|-lrb-|GENE_ENTITY|pth|-rrb-|pth-related|protein|regulate|phosphate|uptake|opossum|kidney|cell|.	860885	0.0	7
estimation|maternal|serum|GENE_ENTITY|use|conjunction|alpha-fetoprotein|-lrb-|afp|-rrb-|COMPOUND_ENTITY|-lrb-|e3|-rrb-|estimate|risk|syndrome|-lrb-|ds|-rrb-|affect|fetus|.	860966	0.0	7
ak1|slower|electrophoretic|mobility|ph|8.3|anode|,|higher|lysine|content|,|lower|COMPOUND_ENTITY|content|,|lower|km|l-arginine|higher|km|mg|-lrb-|2|+|-rrb-|-|atp|GENE_ENTITY|ak2|.	861039	0.0	7
COMPOUND_ENTITY|2|mg.l-1|convert|minor|secretion|perfusion|standard|solution|-lrb-|water|-145|ml.min-1|,|na|-0.09|cl|-0.04|mmol.min-1|-rrb-|absorption|-lrb-|water|0.93|GENE_ENTITY|ml.min-1|,|na|0.23|,|cl|0.25|mmol.min-1|-rrb-|15|min|.	861051	0.0	7
GENE_ENTITY|treated|individual|know|develop|cholestatic|liver|dysfunction|,|hypothesize|hypoprothrombinemia|deficiency|liver-synthesized|clotting|factor|prevent|COMPOUND_ENTITY|k|replacement|.	861674	0.0	7
,|treatment|GENE_ENTITY|plc-gamma|1|COMPOUND_ENTITY|phosphatase|substantially|decrease|catalytic|activity|plc-gamma|1|.	861675	0.0	8
enhancement|result|combine|individual|perturbation|ethanol|propidium|COMPOUND_ENTITY|,|ethanol|increase|GENE_ENTITY|ache|activity|.	861722	0.0	7
p68|protein|-lrb-|refer|GENE_ENTITY|basis|molecular|weight|68,000|human|cell|-rrb-|COMPOUND_ENTITY|kinase|induce|interferon|treatment|activate|double-stranded|-lrb-|ds|-rrb-|rna|.	862191	1.0	7
cross-reaction|follow|peptide|:|glucagon|,|endorphin|,|angiotensin|,|ii|,|leucine-enkephalin|,|COMPOUND_ENTITY|,|GENE_ENTITY|bradykinin|,|oxytocin|dernorthin|,|indicate|high|specificity|substance|P.|means|immuno-enzyme|histochemical|method|,|stain|nerve|fiber|locate|gelaliternous|substance|Rolando|,|interpeduncular|nucleus|,|substantia|nigra|nerve|cell|body|vestibular|nucleus|,|lateral|tegmental|nucleus|mesencephalon|ventral|region|ventricle|.	862408	0.0	7
basophil|expose|il|3|release|significant|mediator|response|GENE_ENTITY|,|COMPOUND_ENTITY|buffer|addition|ca2|+|/|mg2|+|,|indicate|presence|il|3|ca2|-lrb-|+|-rrb-|-|dependent|mediator|release|induce|c5a|partially|ca2|+|independent|.	862938	0.0	7
,|treatment|camp|analog|,|COMPOUND_ENTITY|analog|,|markedly|altered|GENE_ENTITY|ly-6e|expression|trigger|ifn|,|mrna|cell|surface|protein|level|.	862944	0.0	7
determine|GENE_ENTITY|prostaglandin|release|influence|COMPOUND_ENTITY|uptake|,|indomethacin|-lrb-|14|microm|-rrb-|add|cyclo-oxygenase|inhibitor|.	863016	0.0	8
June|1985|October|1988|,|42|newly|diagnose|patient|superficial|bladder|carcinoma|-lrb-|pta|GENE_ENTITY|-rrb-|treat|transurethral|tumor|resection|subsequent|daily|instillation|COMPOUND_ENTITY|c|.	863236	0.0	7
ara-ctp|formation|increase|substantially|GENE_ENTITY|activator|include|phorbol|dibutyrate|mezerein|-lrb-|10-100|nm|-rrb-|;|process|inhibit|70|%|pk-c|inhibitor|h-7|-lrb-|50|microm|-rrb-|,|pk-c|inhibitor|staurosporine|,|COMPOUND_ENTITY|,|ha1004|.	863508	0.0	7
addition|csf-1|cell|stimulate|stabilize|non-covalent|GENE_ENTITY|dimerization|result|activation|csf-1r|kinase|COMPOUND_ENTITY|phosphorylation|receptor|certain|cytoplasmic|protein|.	864034	0.0	7
effect|GENE_ENTITY|ii|receptor|antagonist|mk|954|angiotensin|ii-induced|increase|free|cytosolic|COMPOUND_ENTITY|+|growth|vascular|smooth|muscle|cell|.	864313	0.0	8
electropermeabilized|neutrophil|,|,|activation|GENE_ENTITY|addition|fmlp|strongly|depend|COMPOUND_ENTITY|+|concentration|,|absent|100|nm|free|ca2|+|present|reach|maximum|activation|free|-lsb-|ca2|+|-rsb-|500|nm|.	864445	0.0	7
increase|beta|2-glycoprotein-1|excretion|find|49|-lrb-|82|%|-rrb-|subject|;|raise|excretion|alpha|1-microglobulin|,|COMPOUND_ENTITY|protein|,|beta|2-microglobulin|find|46|-lrb-|77|%|-rrb-|,|45|-lrb-|75|%|-rrb-|,|31|-lrb-|52|%|-rrb-|,|respectively|,|increase|urinary|GENE_ENTITY|n-acetyl-beta-d-glucosaminidase|activity|32|54|subject|-lrb-|59|%|-rrb-|.	864813	0.0	7
present|investigation|,|melanin|concentrate|hormone|-lrb-|mch|-rrb-|elicit|pigment|aggregation|-lrb-|ec50|approximately|1|x|10|-lrb-|-7|-rrb-|m|-rrb-|associate|significant|reduction|COMPOUND_ENTITY|content|;|1|x|10|-lrb-|-7|-rrb-|m|GENE_ENTITY|mch|reduce|camp|content|basal|level|50.4|+|/|-|2.8|pmol/mg|protein|36.9|+|/|-|3.8|pmol/mg|protein|.	865194	0.0	7
week|series|laboratory|test|carry|:|local|eosinophil|influx|determine|use|rhinobrush|technique|;|level|eosinophil|cationic|protein|-lrb-|GENE_ENTITY|-rrb-|analyse|nasal|lavage|fluid|;|secretory|response|intranasal|COMPOUND_ENTITY|measure|.	865885	0.0	7
increase|enzyme|activity|find|concomitant|constant|GENE_ENTITY|dismutase|mrna|immunoreactive|protein|level|accompany|rise|intracellular|copper|COMPOUND_ENTITY|.	865943	0.0	7
55|kda|u-pa|form|lower|mw|form|-lrb-|33|kda|-rrb-|derive|55|kda|GENE_ENTITY|tyr-phosphorylated|u-pa|secrete|culture|media|human|fibrosarcoma|cell|-lrb-|ht-1080|-rrb-|phosphorylate|COMPOUND_ENTITY|u-pa|present|tissue|extract|tumor|induce|nude|mouse|ht-1080|cell|.	866710	0.0	7
datum|comparative|study|administer|orally|,|atenolol|reduce|blood|pressure|similar|extent|,|similar|proportion|patient|,|usual|therapeutic|dose|beta-adrenoceptor|antagonist|-lrb-|acebutolol|,|celiprolol|,|betaxolol|,|indenolol|,|metoprolol|,|nadolol|,|pindolol|,|propranolol|,|tertatolol|-rrb-|,|GENE_ENTITY|enzyme|-lrb-|ace|-rrb-|inhibitor|-lrb-|e.g.|captopril|,|enalapril|lisinopril|-rrb-|,|calcium|antagonist|-lrb-|e.g.|COMPOUND_ENTITY|,|diltiazem|,|felodipine|,|isradipine|,|nitrendipine|,|nifedipine|,|verapamil|-rrb-|,|doxazosin|,|ketanserin|alpha-methyldopa|.	866977	0.0	7
cell|untreated|group|sensitive|vitro|vincristine|,|prednisolone|,|l-asparaginase|-lrb-|l-asp|-rrb-|,|vinblastine|,|5-fluorouracil|,|epirubicin|,|bleomycin|-lrb-|blm|-rrb-|,|COMPOUND_ENTITY|-lrb-|vp16|-rrb-|respect|%|ci|value|GENE_ENTITY|l-asp|,|vp16|,|BLM|,|mitoxantrone|respect|ld50|value|relapsed|group|.	867069	0.0	7
predominant|contemporary|marker|discuss|chemical|class|,|follow|:|glycoprotein|marker|,|include|GENE_ENTITY|antigen|-lrb-|cea|-rrb-|,|alpha-fetoprotein|-lrb-|afp|-rrb-|,|beta-human|chorionic|gonadotropin|-lrb-|beta-hcg|-rrb-|,|prostate|specific|antigen|-lrb-|psa|-rrb-|;|mucinous|glycoprotein|,|include|CA|15-3|,|CA|19-9|,|mucinous-like|cancer|antigen|associate|antigen|,|CA|125|;|enzyme|,|include|prostatic|acid|phosphatase|-lrb-|PAP|-rrb-|,|neuron|specific|enolase|-lrb-|nse|-rrb-|,|COMPOUND_ENTITY|acid|dehydrogenase|-lrb-|ldh|-rrb-|,|placental|alkaline|phosphatase|-lrb-|plap|-rrb-|;|hormone|related|endocrine|molecule|,|include|calcitonin|,|thyroglobulin|,|catecholamine|;|,|molecule|immune|system|,|include|immunoglobulin|beta-2-microglobulin|.	867130	0.0	7
hand|,|absence|COMPOUND_ENTITY|+|,|CD|enhancement|characteristic|GENE_ENTITY|melittin-pla2-lipid|complex|disappear|incubation|45|degree|c|.	867379	0.0	7
fk|506|,|rapamycin|,|COMPOUND_ENTITY|:|effect|il-4|GENE_ENTITY|il-10|mrna|level|t-helper|2|cell|line|.	867627	0.0	7
follow|administration|COMPOUND_ENTITY|,|insulin|response|glucose|load|increase|two-fold|five-fold|second|phase|,|respectively|,|GENE_ENTITY|insulin|sensitivity|increase|factor|2|.	867752	0.0	7
GENE_ENTITY|cgrp|,|10|-lrb-|-8|-rrb-|m|,|inhibit|COMPOUND_ENTITY|release|insulin|pp|.	867936	0.0	7
existence|GENE_ENTITY|receptor|-lrb-|high|affinity|membrane-binding|site|-rrb-|,|positive|effect|cbg|COMPOUND_ENTITY|cyclase|activity|,|report|.	867955	0.0	8
possibility|enhance|length|dependence|COMPOUND_ENTITY|+|sensitivity|cardiac|tnc|reconstitution|attributable|reduce|GENE_ENTITY|tnc|binding|exclude|length|dependence|partially|extract|fast|fibre|reduce|one-half|normal|value|50|%|deletion|native|tnc|.	868021	0.0	7
basis|amino|acid|sequence|alignment|papain|GENE_ENTITY|b|,|double|mutant|-lrb-|val133ala/ser205glu|-rrb-|produce|val133|ser205|replace|Ala|COMPOUND_ENTITY|,|respectively|,|triple|mutant|-lrb-|val133ala/val157gly/ser205glu|-rrb-|,|val157|replace|gly|.	869168	0.0	7
COMPOUND_ENTITY|myocardial|ischaemia|increase|GENE_ENTITY|anf|release|man|.	869367	0.0	8
plasma|profile|adrenocorticotropic|hormone|,|COMPOUND_ENTITY|,|GENE_ENTITY|growth|hormone|prolactin|patient|untreated|Parkinson|disease|.	870167	0.0	7
COMPOUND_ENTITY|-rrb-|-|atpase|GENE_ENTITY|calmodulin|-lrb-|cam|-rrb-|activity|determine|gerbil|brain|p2|fraction|cytosol|,|respectively|,|interval|0.5|,|2|,|6|,|12|,|24|h|ccl4|administration|.	870506	0.0	7
,|inhibitory|effect|dextran|COMPOUND_ENTITY|congener|interaction|hiv|gp120|cellular|GENE_ENTITY|cd4|receptor|ascribe|specific|binding|-lrb-|``|shield|''|-rrb-|gp120|.	870644	1.0	7
use|human|factor-dependent|cell|line|,|mo7|,|normal|human|neutrophil|,|find|internalization|exquisitely|temperature-dependent|,|ligand/receptor|internalization|detectably|occur|4|degree|c.|activation|gm-csf|receptor|previously|stimulate|number|postreceptor|signal|transduction|pathway|,|include|activation|tyrosine|kinase|activation|COMPOUND_ENTITY|kinase|,|GENE_ENTITY|raf-1|.	870926	0.0	7
direct|ca2|-lrb-|+|-rrb-|-|bind|measurement|ca2|+|affinity|low-affinity|site|enhance|absence|atp|conversely|reduce|GENE_ENTITY|selectively|extract|myofibril|,|compare|ca2|+|affinity|presence|COMPOUND_ENTITY|.	871020	0.0	7
include|molecule|naturally|present|body|-lsb-|GENE_ENTITY|dismutase|-lrb-|sod|-rrb-|,|alpha-tocopherol|,|glutathione|precursor|,|ascorbic|acid|,|adenosine|,|lactoferrin|carotenoid|-rsb-|synthetic|antioxidant|-lsb-|thiol|,|ebselen|-lrb-|pz51|-rrb-|,|xanthine|oxidase|inhibitor|,|inhibitor|phagocyte|function|,|iron|ion|chelator|COMPOUND_ENTITY|-rsb-|.	871105	0.0	7
3|day|culture|cell|respond|GENE_ENTITY|10|day|egf|-lrb-|10|ng/ml|-rrb-|induce|significant|increase|COMPOUND_ENTITY|e2|production|.	871321	0.0	7
evidence|GENE_ENTITY|protein-70|associate|COMPOUND_ENTITY|receptor|involve|receptor-dna|binding|.	871388	0.0	8
,|COMPOUND_ENTITY|aromatic|amino|acid|position|37|GENE_ENTITY|hegf|essential|biological|activity|.	871730	0.0	8
COMPOUND_ENTITY|change|basal|gh|level|subject|GENE_ENTITY|ghrh-induced|gh|rise|younger|group|,|restore|normal|gh|response|GHRH|older|subject|-lrb-|mean|peak|response|time|higher|baseline|group|-rrb-|.	872408	0.0	7
physiological|concentration|,|atp|,|adp|,|COMPOUND_ENTITY|inhibit|enzyme|atriplex|spongiosa|panicum|miliaceum|-lrb-|GENE_ENTITY|nad-me-type|plant|-rrb-|,|atp|inhibitory|species|.	872822	0.0	7
k1|:1|k1|:2|stability|constant|follow|:|diazepam|,|k1|:1|=|5.23|m-1|k1|:2|=|8.6|m-2|;|griseofulvin|,|k1|:1|=|5.54|m-1|GENE_ENTITY|:2|=|8.82|m-2|;|progesterone|,|k1|:1|=|5.48|m-1|k1|:2|=|42.47|m-2|;|17|COMPOUND_ENTITY|,|k1|:1|=|5.38|m-1|k1|:2|=|36.9|m-2|;|testosterone|,|k1|:1|=|5.07|m-1|k1|:2|=|27.47|m-2|.	873115	0.0	7
behaviour|human|serum|GENE_ENTITY|presence|chemically|distinct|ligand|:|COMPOUND_ENTITY|,|dansylsarcosine|hemin|,|compare|buffer|reverse|micelle|isooctane|,|water|,|sodium|bis|-lrb-|2-ethylhexyl|-rrb-|sulfosuccinate|hexadecyl|trimethylammonium|bromide|,|system|select|mimic|membrane-water|interface|.	873118	0.0	7
chlorpropamide|potentiate|GENE_ENTITY|water|flow|,|hypothesis|COMPOUND_ENTITY|sensitize|renal|tubule|adh-induced|water|flow|.	873330	0.0	7
GENE_ENTITY|-rrb-|activity|increase|-lrb-|p|0.02|-rrb-|,|t-pa|antigen|decrease|-lrb-|p|0.01|-rrb-|,|plasminogen|activator|inhibitor|-lrb-|pai-1|-rrb-|fibrinogen|unaffected|COMPOUND_ENTITY|treatment|.	873900	0.0	7
result|indicate|tn|antigen|express|GENE_ENTITY|epitopic|structure|complex|COMPOUND_ENTITY|alpha-ser|-lrb-|thr|-rrb-|.	874229	0.0	7
effect|COMPOUND_ENTITY|506|,|mycophenolic|acid|,|bredinin|okt-3|-|,|pma|-|,|alloantigen-induced|activation|molecule|expression|culture|cd4|+|GENE_ENTITY|cd8|+|human|lymphocyte|.	874488	0.0	7
yac|cell|variant|-lrb-|GENE_ENTITY|-rrb-|isolate|,|COMPOUND_ENTITY|analog|camp|inducer|modify|ly-6e|induction|.	874564	0.0	7
deletion|mutant|intracellular|region|il-2r|beta|,|lack|previously|describe|``|critical|domain|''|amino|acid|267|322|carboxyl-terminal|198|residue|-lrb-|GENE_ENTITY|beta|88|-rrb-|,|lack|ability|co-precipitate|COMPOUND_ENTITY|kinase|activity|,|measure|phosphorylation|il-2r|beta|vitro|.	875204	0.0	7
analog|,|equal|molar|concentration|COMPOUND_ENTITY|,|inhibit|atp-dependent|activation|GENE_ENTITY|cdp|reduction|and/or|accessory|activation|GDP|reduction|greater|45|%|.	875404	0.0	7
epidermal|growth|factor|-lrb-|GENE_ENTITY|-rrb-|-|stimulate|COMPOUND_ENTITY|phosphorylation|egf|receptor|degradation|cell|express|egf|receptor|truncate|residue|973|.	875441	0.0	8
mitogenic|combination|anti-cd2|antibody|-lrb-|9.6|+|9-1|-rrb-|fail|stimulate|activation|variant|measure|mobilization|intracellular|COMPOUND_ENTITY|+|GENE_ENTITY|il-2|production|.	875455	0.0	7
pas-iv|bind|GENE_ENTITY|similar|characteristic|maximum|binding|consistently|approximately|50|%|gpiiib|binding|inhibit|COMPOUND_ENTITY|.	875483	0.0	8
cyclic|adenosine|monophosphate|-lrb-|COMPOUND_ENTITY|-rrb-|elevate|agent|-lrb-|forskolin|,|isoproterenol|,|camp|analogue|,|dibutyryl|camp|-rrb-|inhibit|lectin-stimulated|GENE_ENTITY|il2|production|t|cell|,|inhibit|il2|production|jurkat|cell|.	875559	0.0	7
effect|12|week|COMPOUND_ENTITY|acid|-lrb-|EPA|-rrb-|administration|-lrb-|2.7|g/day|-rrb-|plasma|lipoprotein|subfraction|level|activity|GENE_ENTITY|lecithin|:|cholesterol|acyltransferase|-lrb-|lcat|-rrb-|lipid|transfer|protein|-lrb-|ltp|-rrb-|investigate|.	875754	0.0	7
beta|2-glycoprotein-1|stable|urine|physiological|ph|range|,|conclude|measurement|provide|means|detect|chronic|malfunction|renal|tubule|marginally|sensitive|assay|alpha|1-microglobulin|COMPOUND_ENTITY|protein|,|reliable|assay|beta|2-microglobulin|GENE_ENTITY|n-acetyl-beta-d-glucosaminidase|.	875781	0.0	7
,|cell|express|activate|cytoplasmic|COMPOUND_ENTITY|kinase|,|p60v-src|,|stimulate|epidermal|growth|factor|,|gap|phosphorylate|tyrosine|serine|form|distinct|complex|phosphoprotein|62|190|kda|-lrb-|p62|GENE_ENTITY|p190|-rrb-|.	1022782	0.0	7
COMPOUND_ENTITY|,|structurally|unrelated|compound|ra|,|suppress|GENE_ENTITY|il-6r|expression|,|correspondingly|,|inhibit|cell|growth|.	1022785	0.0	7
proliferation|study|reveal|72|hr|COMPOUND_ENTITY|treatment|,|basal|ec|growth|inhibit|33|%|cell|exhibit|lowered|responsiveness|GENE_ENTITY|basic|fibroblast|growth|factor|-lrb-|bfgf|-rrb-|.	1023508	0.0	7
GENE_ENTITY|sensitivity|improve|young|healthy|control|subject|COMPOUND_ENTITY|therapy|-lrb-|6.5|+|/|-|0.5|7.6|+|/|-|0.7|mg/kg|.	1023819	0.0	7
correlation|find|GENE_ENTITY|-lrb-|1|-rrb-|total|bilirubin|,|-lrb-|2|-rrb-|COMPOUND_ENTITY|-lrb-|3|-rrb-|alkaline|phosphatase|.	1023858	0.0	7
amphipathic|surface|228-238|region|COMPOUND_ENTITY|233-containing|gpib|alpha|protein|associate|strongly|complementary|surface|vwf|binding|gpib/ix|receptor|complex|help|explain|heighten|association|GENE_ENTITY|vwf|receptor|pt-vwd|.	1024351	0.0	7
fall|GENE_ENTITY|response|isoprenaline|COMPOUND_ENTITY|significantly|greater|elderly|.	1025060	0.0	7
dose-dependent|effect|COMPOUND_ENTITY|GENE_ENTITY|insulin|secretion|glucose|uptake|human|.	1025613	0.0	7
gonadotropin-releasing|hormone|induce|response|-lsb-|ca2|+|-rsb-|purify|cell|population|mixed|cell|population|,|GENE_ENTITY|affect|-lsb-|COMPOUND_ENTITY|-rsb-|purify|gonadotrope|.	1025840	0.0	7
combined|treatment|30|mg|COMPOUND_ENTITY|600|ie|GENE_ENTITY|kallikrein|day|produce|elevation|motility|significant|change|sperm|parameter|.	1026133	0.0	7
,|negatively|charge|chain|COMPOUND_ENTITY|important|divalent|cation|binding|GENE_ENTITY|beta-galactosidase|.	1026430	0.0	7
GENE_ENTITY|hfla|catalyze|16|alpha-hydroxylation|COMPOUND_ENTITY|3-sulfate|-lrb-|dhea-sulfate|-rrb-|reconstituted|system|.	1026649	1.0	7
kinetic|method|determination|iodide|base|inhibitory|effect|pd|-lrb-|GENE_ENTITY|-rrb-|catalysed|reaction|ethylenediaminetetraacetic|acid|-lrb-|COMPOUND_ENTITY|-rrb-|-|Co|-lrb-|III|-rrb-|hypophosphite|ion|describe|.	1026870	0.0	7
best|isoenzyme|neuron-specific|enolase|-lrb-|26|point|-rrb-|,|prostatic|acid|phosphatase|-lrb-|23|point|-rrb-|,|placental|alkaline|phosphatase|-lrb-|20|point|-rrb-|,|GENE_ENTITY|1|-lrb-|16|point|-rrb-|,|COMPOUND_ENTITY|dehydrogenase|1|-lrb-|16|point|-rrb-|.	1026979	0.0	7
ascertain|extent|prolactin|response|COMPOUND_ENTITY|severely|depressed|patient|,|measure|8|a.m.|pre|-|postdexamethasone|GENE_ENTITY|prolactin|level|104|depressed|42|normal|subject|.	1027048	0.0	7
sister|experience|common|cold|pemphigus|develop|display|positive|macrophage|migration|inhibition|-lrb-|GENE_ENTITY|-rrb-|test|combination|drug|compound|COMPOUND_ENTITY|,|caffeine|,|chlorpheniramine|maleate|phenylephrine|hcl|,|receive|2|week|prior|appearance|cutaneous|lesion|.	1027119	0.0	7
COMPOUND_ENTITY|+|influx|paf|stimulation|block|2|min|egta|,|increase|formation|GENE_ENTITY|5-lipoxygenase|metabolite|observe|.	1027688	0.0	7
change|cytosolic|COMPOUND_ENTITY|+|level|pivotal|receptor-initiated|signal|transduction|,|especially|signal|il2|gene|transcription|GENE_ENTITY|il2|synthesis/secretion|.	1027967	0.0	7
Protocol|treatment|involve|4|cycle|drug|-lsb-|cyclophosphamide|-lrb-|GENE_ENTITY|-rrb-|COMPOUND_ENTITY|-lrb-|VCR|-rrb-|-rsb-|drug|-lsb-|ctx|VCR|actinomycin-d|-lrb-|act-d|-rrb-|doxorubicin|-lrb-|adr|-rrb-|-rsb-|regimen|local|irradiation|-lrb-|50|gy|-rrb-|involve|bone|.	1028265	0.0	7
inhibition|COMPOUND_ENTITY|production|GENE_ENTITY|epidermal|growth|factor|human|granulosa|cell|normal|polycystic|ovary|.	1028338	0.0	7
,|incubation|similar|extract|catalytic|subunit|COMPOUND_ENTITY|protein|kinase|cause|phosphorylation|rap2b|,|observe|closely|homologous|protein|,|rap1a|GENE_ENTITY|rap1b|.	1028379	0.0	7
thermogenic|effect|thyroid|hormone|:|interaction|COMPOUND_ENTITY|GENE_ENTITY|insulin|.	1028429	1.0	7
result|indicate|COMPOUND_ENTITY|inhibit|platelet|secretion|interfere|activation|phosphoinositide-specific|phospholipase|c|protein|kinase|c|GENE_ENTITY|thrombin|.	1028474	0.0	7
plase|inhibitor|--|COMPOUND_ENTITY|,|hydrocortisone|,|dexamethasone|,|indomethacin|--|potent|inhibitor|lt|-|GENE_ENTITY|tnf-mediated|cell|destruction|,|suggest|selective|deacylation|specific|membrane|pl|plase|activation|important|step|event|lead|lt|-|tnf-mediated|cellular|destruction|vitro|.	1028595	0.0	7
mechanism|Fe|uptake|characterise|use|59fe|complex|citrate|,|nitrilotriacetate|,|COMPOUND_ENTITY|,|59fe|add|Eagle|minimum|essential|medium|-lrb-|mem|-rrb-|compare|human|transferrin|-lrb-|GENE_ENTITY|tf|-rrb-|label|59fe|iodine-125|.	1030204	0.0	7
bovine|serum|albumin|-lrb-|bsa|-rrb-|porcine|serum|GENE_ENTITY|-lrb-|fib|-rrb-|multiply|label|COMPOUND_ENTITY|+|use|different|ligand|:|dtpa|dianhydride|,|isothio-cyanato-benzyl-dtpa|-lrb-|itcb-dtpa|-rrb-|,|coordinate|carboxylate|employ|macromolecular|linkage|,|isothiocyanatobenzyl-trita|,|macrocyclic|ligand|.	1030359	1.0	7
indicate|increase|clearance|rate|plasma|COMPOUND_ENTITY|albumin|cause|significant|increase|GENE_ENTITY|insulin|,|aspartame|effect|.	1031416	0.0	7
GENE_ENTITY|immunoprecipitate|protein|separate|COMPOUND_ENTITY|,|transfer|nitrocellulose|,|incubate|-lsb-|alpha|32p|-rsb-|gtp|demonstrate|binding|radiolabele|gtp|Mr|21,000|protein|.	1031571	0.0	7
distinct|sequence|motif|absolutely|essential|function|enhancer|:|COMPOUND_ENTITY|response|element|-lrb-|cre|-rrb-|,|target|repression|GENE_ENTITY|tse-1|,|hepatocyte-specific|element|.	1031613	0.0	7
COMPOUND_ENTITY|reduce|cholesterol|low-density|lipoprotein|increase|GENE_ENTITY|antithrombin|iii|activity|80-year-old|man|low|plasma|pyridoxal|5-phosphate|.	1031736	0.0	7
patient|low|grade|COMPOUND_ENTITY|g-cbf|normal|limit|pre-operatively|post-operatively|,|statistically|significant|increase|GENE_ENTITY|cbf|week|post-operatively|.	1031815	0.0	7
effect|tgf|alpha|tgf|beta|thecal|cell|differentiation|evaluate|quantitate|change|androstenedione|COMPOUND_ENTITY|accumulation|culture|treat|tgf|absence|-lrb-|basal|-rrb-|presence|GENE_ENTITY|hcg|,|estradiol|-lrb-|e2|-rrb-|,|combination|hcg|e2|.	1032061	0.0	7
result|suggest|GENE_ENTITY|,|tgf-beta|,|igf-i|,|COMPOUND_ENTITY|androstendione|pge2|para|-|and/or|autocrine|modulatory|effect|basal|fsh-stimulated|inhibin|secretion|mature|porcine|g-cell|vitro|demonstrate|secretion|proteohormone|inhibin|steroid|progesterone|closely|related|.	1032126	0.0	7
pain|injection|COMPOUND_ENTITY|occur|67|,|36|7|%|patient|Sal|+|p2|.5|,|a20|+|GENE_ENTITY|p2|.5|a30|+|p2|group|,|respectively|,|a30|+|p2|.5|group|.	1032879	0.0	7
result|GENE_ENTITY|highly|specific|il-1|beta|convertase|absolute|requirement|COMPOUND_ENTITY|p1|small|hydrophobic|amino|acid|p1|'|.	1033163	0.0	7
investigate|difference|prl|secretion|,|characterize|molecular|form|circulate|GENE_ENTITY|postpartum|woman|breastfeeding|-lrb-|n|=|5|-rrb-|sleep|-lrb-|n|=|5|-rrb-|eumenorrheic|woman|galactorrhea|-lrb-|n|=|5|-rrb-|trh|stimulation|-lrb-|n|=|4|-rrb-|,|metaclopramide|infusion|-lrb-|n|=|5|-rrb-|,|COMPOUND_ENTITY|administration|-lrb-|n|=|2|-rrb-|.	1033458	0.0	7
study|,|use|purify|monoamine|oxidase|,|steady-state|datum|inhibition|COMPOUND_ENTITY|oxidation|primary|amine|indicate|possibility|ternary|complex|mechanism|GENE_ENTITY|monoamine|oxidase|.	1033627	0.0	7
sensitivity|GENE_ENTITY|detection|heavy|drinking|,|define|60|g|COMPOUND_ENTITY|daily|,|85.7|%|compare|47.6|%|GGT|.	1033650	0.0	7
spleen|COMPOUND_ENTITY|protein|kinase|,|tpk-i|similar|biochemical|immunological|feature|,|suggestive|close|relatedness|tpk-iia|,|tpk-iib|tpk-iii|relate|GENE_ENTITY|lyn|protein|product|oncogene|src|subfamily|,|lck|,|hck|fyn|.	1033891	0.0	7
Ribavirin|enhance|anti-human|immunodeficiency|virus|activity|2|'|,3|'|-|dideoxyinosine|-lrb-|COMPOUND_ENTITY|-rrb-|GENE_ENTITY|mt-4|,|cem|peripheral|blood|lymphocyte|cell|.	1034117	0.0	7
COMPOUND_ENTITY|generally|think|exert|major|action|:|stimulation|pancreatic|insulin|secretion|enhancement|GENE_ENTITY|insulin|action|hepatic|extrahepatic|tissue|.	1034400	0.0	7
COMPOUND_ENTITY|vindesine|,|dose-dependence|observe|:|drug|concentration|capable|elicit|cytotoxicity|fail|induce|significant|GENE_ENTITY|p-gp|expression|.	1034695	0.0	7
structural|characterization|GENE_ENTITY|reveal|contain|intrachain|disulfide|bond|,|n-glycosylated|,|activate|cell|phosphorylate|COMPOUND_ENTITY|.	1034782	1.0	7
lps|COMPOUND_ENTITY|particle|,|,|efficient|stimulate|GENE_ENTITY|il-1|production|.	1035974	0.0	7
gonadotropin|,|testosterone|,|sex|hormone|binding|globulin|-lrb-|GENE_ENTITY|-rrb-|,|dehydroepiandrosterone|sulphate|,|androstenedione|,|estradiol|,|prolactin|,|COMPOUND_ENTITY|,|thyrotropin|,|free|thyroxine|level|determine|.	1036475	0.0	7
,|presence|crude|GENE_ENTITY|,|calcium|acetate|,|mixture|COMPOUND_ENTITY|chloride/sodium|acetate|,|compound|transesterify|,|suggest|transesterification|crude|recrystallize|compound|occur|different|mechanism|.	1036612	0.0	7
subject|participate|study|,|consist|:|euglycemic|insulin|clamp|,|GENE_ENTITY|plus|epinephrine|,|insulin|plus|COMPOUND_ENTITY|plus|propranolol|,|insulin|plus|propranolol|.	1036901	0.0	7
patient|randomly|select|receive|GENE_ENTITY|treatment|month|;|dose|25|mg|50|mg|COMPOUND_ENTITY|twice|day|drug|suspend|digitalis|use|patient|success|.	1037084	0.0	7
condition|,|12.5|mg|clomipramine|stimulate|secretion|COMPOUND_ENTITY|prolactin|,|unlike|study|conduct|morning|,|clomipramine|suppress|secretion|GENE_ENTITY|growth|hormone|group|.	1037118	0.0	7
clenbuterol|influence|GENE_ENTITY|,|prl|,|COMPOUND_ENTITY|concentration|,|compare|placebo|.	1037776	0.0	7
appear|GENE_ENTITY|true|modulator|intracellular|COMPOUND_ENTITY|level|:|peptide|increase|camp|level|cell|low|baseline|level|.	1038368	0.0	7
subsequent|amplification|cdna|pcr|nucleotide|sequencing|reveal|single-base|mutation|substitute|aspartate|codon|COMPOUND_ENTITY|position|alpha|1-541|GENE_ENTITY|col1a1|gene|.	1038460	0.0	7
want|determine|COMPOUND_ENTITY|produce|adverse|effect|pharmacokinetic|GENE_ENTITY|csa|.	1038646	0.0	7
GENE_ENTITY|,|COMPOUND_ENTITY|,|anaemia|patient|haemodialysis|.	1038846	0.0	7
effect|proline|mutation|unfold|refolding|human|GENE_ENTITY|:|slow|refolding|kinetic|phase|result|COMPOUND_ENTITY|cis-trans|isomerization|.	1039529	0.0	7
growth|hormone|-lrb-|GENE_ENTITY|-rrb-|profile|carry|different|dose|COMPOUND_ENTITY|.	1040450	0.0	7
find|200-fold|molar|excess|COMPOUND_ENTITY|strongly|inhibit|-lrb-|93|%|-rrb-|binding|-lsb-|3h|-rsb-|prg|GENE_ENTITY|Pgp|compare|verapamil|-lrb-|80|%|-rrb-|,|progesterone|-lrb-|78|%|-rrb-|,|testosterone|-lrb-|46|%|-rrb-|,|dexamethasone|-lrb-|25|%|-rrb-|,|aldosterone|-lrb-|56|%|-rrb-|.	1040783	0.0	8
secretin|increase|concentration|,|COMPOUND_ENTITY|output|increase|threefold|secretin|infusion|twofold|GENE_ENTITY|vip|infusion|.	1041011	0.0	8
beta-blockade|COMPOUND_ENTITY|result|enhance|gh|response|GENE_ENTITY|GHRH|,|prevent|attenuation|gh|response|second|ghrh|injection|-lrb-|,|1937|+|/|-|366|micrograms/l|.	1041022	0.0	7
-lsb-|second|drug|nonatopic|asthma|insufficiently|control|GENE_ENTITY|2-adrenergic|stimulant|:|COMPOUND_ENTITY|versus|theophylline|-rsb-|.	1041750	0.0	8
ultracentrifuge|analysis|subsample|cohort|reveal|COMPOUND_ENTITY|raise|level|hdl3-cholesterol|little|effect|GENE_ENTITY|hdl2-cholesterol|.	1042435	0.0	7
COMPOUND_ENTITY|-lrb-|GENE_ENTITY|csa|-rrb-|inhibit|,|vitro|,|proliferation|culture|normal|neoplastic|keratinocyte|exert|vivo|antiproliferative|effect|keratinocyte|normal|human|skin|xenograft|nude|mouse|.	1042810	0.0	7
result|obtain|:|-rrb-|patient|blast|express|p-glycoprotein|resistant|protocol|include|COMPOUND_ENTITY|,|Daunorubicin|,|Etoposide|,|Mithramycin|,|Vincristine|;|b|-rrb-|p-glycoprotein|express|constitutively|case|;|c|-rrb-|GENE_ENTITY|p-glycoprotein|appear|mechanism|responsible|resistance|anthracycline|etoposide|.	1043087	0.0	7
serum|concentration|testicular|adrenal|androgen|androgen|precursor|,|COMPOUND_ENTITY|,|unconjugated|-lrb-|e1|-rrb-|total|estrone|-lrb-|te1|;|greater|equal|85|%|e1|sulfate|-rrb-|,|pituitary|hormone|,|sex|hormone|binding|globulin|-lrb-|GENE_ENTITY|shbg|-rrb-|albumin|measure|14|male|patient|non-diabetic|end|stage|renal|disease|28|age-matched|healthy|control|.	1043825	0.0	7
GENE_ENTITY|-lrb-|10|-lrb-|-11|-rrb-|-10|-lrb-|-9|-rrb-|m|-rrb-|raise|islet|COMPOUND_ENTITY|level|;|individually|,|hghrh|theophylline|exert|positive|effect|insulin|release|,|combined|effect|greater|cause|.	1045019	0.0	7
activation|COMPOUND_ENTITY|phosphorylation|human|t|cell|GENE_ENTITY|cd2|pathway|.	1045395	0.0	7
sequence|analysis|COMPOUND_ENTITY|ak1|*|1|exchange|gln-123|GENE_ENTITY|ak1|*|2|.	1045837	0.0	7
6-month|training|period|significant|positive|correlation|-lrb-|r|=|0.49-0|.58|;|p|0.05-p|0.01|-rrb-|observe|AG|relative|change|testosterone|,|testosterone|:|COMPOUND_ENTITY|ratio|GENE_ENTITY|growth|hormone|relative|performance|change|speed|,|maximal|isometric|force|endurance|,|respectively|.	1180492	0.0	7
cross-reactivity|COMPOUND_ENTITY|GENE_ENTITY|beta-endorphin|eia|0.1|%|,|gly-gly-phe-met|oxidize|Gly-Gly-Phe-Met|2.5|%|10.2|%|,|respectively|.	1180719	1.0	7
addition|natural|cytotoxicity|,|GENE_ENTITY|restore|chemotactic|antibody|dependent|cellular|cytotoxicity|function|COMPOUND_ENTITY|cell|.	1180967	0.0	7
fluorometric|flow-injection|method|determine|carnitine|use|immobilize|enzyme|carnitine|dehydrogenase|-lrb-|ec|1.1.1.108|-rrb-|GENE_ENTITY|-lrb-|ec|1.8.1.4|-rrb-|develop|apply|assay|carnitine|serum|patient|treat|COMPOUND_ENTITY|acid|.	1181315	0.0	7
second|surgery|perform|aggressive|chemotherapy|include|cisplatin|,|GENE_ENTITY|,|cyclophosphamide|,|COMPOUND_ENTITY|doxorubicin|.	1181708	0.0	7
analysis|gd|gene|dideoxy-sequencing|technique|identify|base|difference|code|sequence|predict|ang|gd|gene|code|alanine|-lrb-|gcc|codon|-rrb-|amino|acid|position|84|open|reading|frame|ang|path|GENE_ENTITY|gene|code|COMPOUND_ENTITY|-lrb-|ggc|codon|-rrb-|site|.	1181734	0.0	7
oxidation|methionine|18|GENE_ENTITY|reduce|affinity|50|%|,|oxidation|COMPOUND_ENTITY|8|reduce|affinity|95|%|,|oxidation|methionine|decrease|affinity|membrane|submitochondrial|particle|.	1182964	0.0	7
maximal|concentration|bupivacaine|plain|group|-lrb-|median|515|ng|GENE_ENTITY|,|range|46-875|ng|ml-1|-rrb-|greater|COMPOUND_ENTITY|group|-lrb-|median|33|ng|ml-1|,|range|7-125|ng|ml-1|-rrb-|-lrb-|p|=|0.001|-rrb-|.	1183299	0.0	7
COMPOUND_ENTITY|zipper|GENE_ENTITY|c-myc|require|inhibition|erythroleukemia|differentiation|.	1183801	0.0	7
microsomal|membrane|fraction|isolate|repeat|7|%|ficoll|gradient|centrifugation|free|ouabain-sensitive|-lrb-|na|+|+|k|+|-rrb-|-|atpase|,|GENE_ENTITY|nucleotidase|COMPOUND_ENTITY|dehydrogenase|;|highly|enrich|-lrb-|h|+|+|k|+|-rrb-|-|atpase|k|-lrb-|+|-rrb-|-|stimulate|p-nitrophenylphosphatase|-lrb-|p-nppase|-rrb-|.	1184248	0.0	7
result|suggest|:|-lrb-|1|-rrb-|retinol|metabolism|human|keratinocyte|different|alcohol|,|-lrb-|2|-rrb-|retinal|intermediate|metabolite|conversion|retinol|retinoic|acid|,|-lrb-|3|-rrb-|differentiate|keratinocyte|rich|GENE_ENTITY|probably|target|cell|COMPOUND_ENTITY|acid|action|.	1184711	0.0	7
previous|study|,|establish|camptothecin|-lrb-|COMPOUND_ENTITY|-rrb-|-|resistant|cell|line|,|GENE_ENTITY|a549/cpt|ht-29|/|CPT|,|human|lung|cancer|a549|human|colon|cancer|ht-29|.	1184742	0.0	7
measure|immunologically|active|-lrb-|apo|+|holo|-rrb-|retinol-binding|protein|-lrb-|rbp|-rrb-|,|COMPOUND_ENTITY|a-carrying|-lrb-|holo|-rrb-|free|GENE_ENTITY|rbp|,|transthyretin-bound|-lrb-|ttr|-rrb-|holo-rbp|serum|34|retrospective|case|fluctuate|acute|renal|failure|.	1186152	0.0	8
apolipoprotein|e2-dunedin|-lrb-|228|arg|replace|COMPOUND_ENTITY|-rrb-|:|GENE_ENTITY|apolipoprotein|e2|variant|normal|receptor-binding|activity|.	1187704	0.0	7
attempt|inhibit|expression|GENE_ENTITY|gene|mcf-7|human|breast|cancer|cell|select|resistance|COMPOUND_ENTITY|use|phosphorothioate|analog|oligodeoxynucleotide|.	1187823	0.0	7
drug|alter|GENE_ENTITY|rate|absence|COMPOUND_ENTITY|+|.	1188240	0.0	8
maternal|serum|level|COMPOUND_ENTITY|,|prolactin|,|human|GENE_ENTITY|placental|lactogen|chorionic|gonadotrophin|related|fetal|sex|normal|abnormal|pregnancy|.	1188491	0.0	8
calcium|channel|blocker|verapamil|COMPOUND_ENTITY|inhibit|GENE_ENTITY|sri|62-834-induced|elevation|intracellular|calcium|.	1188539	0.0	7
mutation|lysine|405|COMPOUND_ENTITY|parvovirus|h-1|GENE_ENTITY|ns1|abolish|function|viral|dna|replication|,|late|promoter|trans|activation|,|cytotoxicity|.	1188668	0.0	7
relationship|cortisol|response|dexamethasone|GENE_ENTITY|,|availability|COMPOUND_ENTITY|depressed|female|.	1188771	0.0	8
-lsb-|effect|COMPOUND_ENTITY|GENE_ENTITY|atrial|natriuretic|peptide|regulation|patient|essential|hypertension|-rsb-|.	1188829	0.0	7
study|examine|effect|COMPOUND_ENTITY|metabolism|GENE_ENTITY|hspg|core|protein|culture|glomerular|epithelial|cell|.	1189106	0.0	7
contrast|GENE_ENTITY|,|COMPOUND_ENTITY|plc|activity|inhibit|pertussis|toxin|treatment|cell|.	1189307	0.0	7
suggest|role|glucocorticoid|receptor|mediate|COMPOUND_ENTITY|action|GENE_ENTITY|il2|gene|expression|.	1189321	0.0	7
human|gingival|fibroblast|derive|2|patient|9|month|start|COMPOUND_ENTITY|-lrb-|pht|-rrb-|therapy|study|respect|effect|epidermal|growth|factor|-lrb-|egf|-rrb-|incorporation|3h-thymidine|dna|,|binding|GENE_ENTITY|egf|cell-surface|receptor|,|internalization|egf-receptor-ligand|complex|,|finally|,|respect|egf|receptor|mrna|level|.	1189352	0.0	7
treatment|primary|culture|immature|porcine|granulosa|cell|igf-i|increase|COMPOUND_ENTITY|production|synthesis|immunoprecipitable|p450scc|enzyme|,|examine|possible|molecular|mechanism|subserve|inductive|effect|GENE_ENTITY|igf-i|.	1189969	0.0	7
camp|directly|involve|GENE_ENTITY|action|,|COMPOUND_ENTITY|modulatory|effect|il1-mediated|il6|gene|activation|.	1190526	0.0	7
result|suggest|process|lead|final|expression|GENE_ENTITY|action|mediate|,|point|,|release|COMPOUND_ENTITY|+|intracellular|store|.	1190712	0.0	7
piroxicam|COMPOUND_ENTITY|inhibit|GENE_ENTITY|fmlp-induced|upregulation|cd11b|,|cd11c|,|cd35|,|drug|affect|upregulation|surface|molecule|induce|c5a|ionomycin|.	1191501	0.0	7
conclude|GENE_ENTITY|add|list|growth|factor|bioactivity|attenuate|COMPOUND_ENTITY|clinical|study|suramin|analogue|indicate|igf-i-receptor-positive|malignancy|osteogenic|sarcoma|.	1191688	0.0	7
conclude|igf-i|add|list|growth|factor|bioactivity|attenuate|suramin|clinical|study|COMPOUND_ENTITY|analogue|indicate|GENE_ENTITY|igf-i-receptor-positive|malignancy|osteogenic|sarcoma|.	1191693	0.0	7
contrast|,|high|dose|COMPOUND_ENTITY|add|2|hr|cell|previously|culture|66|hr|produce|80|%|inhibition|-lsb-|3h|-rsb-|tdr|incorporation|fail|inhibit|expression|GENE_ENTITY|il-2|receptor|.	1191885	0.0	7
COMPOUND_ENTITY|pattern|tnt-treated|fiber|different|glycerinate|tni|GENE_ENTITY|tnc|band|,|fainter|tnt-treated|fiber|normal|.	1192324	0.0	7
contrast|,|capacity|induce|camp|accumulation|rest|lgl|,|il-4|negligible|effect|lak|activity|induction|,|COMPOUND_ENTITY|level|increase|lgl|preincubate|GENE_ENTITY|il-2|.	1192353	0.0	7
additionally|,|reduction|glycine|binding|c-5|antagonist|reverse|nmda|receptor|agonist|c-7|competitive|COMPOUND_ENTITY|antagonist|,|provide|evidence|site|action|GENE_ENTITY|c-5|antagonist|nmda|recognition|site|,|result|indirect|modulation|glycine|site|.	1192545	0.0	7
response|GENE_ENTITY|factor|-lrb-|egf|-rrb-|stimulation|,|intrinsic|protein|COMPOUND_ENTITY|kinase|egf|receptor|activate|,|lead|tyrosine|phosphorylation|cellular|substrate|protein|,|include|egf|receptor|molecule|.	1193215	0.0	8
cdna|clone|derive|human|hepatocellular|carcinoma|isolate|basis|homology|alpha|human|COMPOUND_ENTITY|acid|receptor|-lrb-|GENE_ENTITY|rar|alpha|-rrb-|gene|.	1193249	1.0	8
assess|biological|correlate|precipitation|migraine|attack|perimenstrual|period|,|plasma|GENE_ENTITY|-lrb-|beta-ep|-rrb-|cortisol|response|COMPOUND_ENTITY|-lrb-|8|mg|iv|-rrb-|corticotropin|release|hormone|-lrb-|100|microgram|iv|-rrb-|evaluate|follicular|phase|premenstrual|period|7|patient|suffer|menstrual|migraine|7|healthy|,|asymptomatic|control|volunteer|.	1193932	0.0	7
GENE_ENTITY|release|200|microgram|ghrh|completely|block|100|microgram|COMPOUND_ENTITY|.	1194054	0.0	7
ddt-1|hamster|ductus|deferen|tumour|cell|stimulate|pdgf|-lrb-|25|ng/ml|-rrb-|,|GENE_ENTITY|-lrb-|10|ng/ml|-rrb-|COMPOUND_ENTITY|-lrb-|10|nm|-rrb-|.	1194199	0.0	7
COMPOUND_ENTITY|20|100|mm|inhibit|phagocytosis|unopsonized|zymosan|concomitantly|decrease|GENE_ENTITY|paf|concentration|stimulate|macrophage|.	1194201	0.0	7
2|-rrb-|respiratory|burst|GENE_ENTITY|plus|cytochalasin|b|minute|restimulate|COMPOUND_ENTITY|induce|accumulation|phosphatidic|acid|.	1194500	0.0	7
chronic|COMPOUND_ENTITY|treatment|-lrb-|8|d|-rrb-|lead|approximately|12-fold|increase|striatal|content|GENE_ENTITY|preproenkephalin|mrna|relative|control|animal|.	1194590	0.0	7
negative|correlation|exist|GENE_ENTITY|COMPOUND_ENTITY|-lrb-|r|=|-0.49|;|p|0.05|-rrb-|,|main|circulate|metabolite|vitamin|D.|normal|value|immunoradiometric|assay|detect|sequence|human|pth|-|-lrb-|1-84|-rrb-|suggest|fragment|intact|hormone|responsible|pth|elevation|cirrhosis|.	1194616	0.0	7
suggest|altered|spectrum|reduce|severity|GENE_ENTITY|effect|observe|patient|receive|COMPOUND_ENTITY|attributable|suppressive|effect|steroid|il-2-induced|tnf|synthesis|.	1194661	0.0	7
human|pdl|cell|seed|tissue|culture|tube|incubate|interleukin-1|alpha|-lrb-|il-1|alpha|-rrb-|,|il-1|beta|,|tumor|necrosis|factor-alpha|-lrb-|tnf-alpha|-rrb-|,|interferon-gamma|-lrb-|GENE_ENTITY|-rrb-|,|COMPOUND_ENTITY|,|parathyroid|hormone|-lrb-|pth|-rrb-|,|combination|,|1|h|.	1194820	0.0	7
COMPOUND_ENTITY|oppose|diuretic|effect|hydrochlorothiazide|assess|weight|loss|attenuate|rise|plasma|GENE_ENTITY|renin|activity|.	1194956	0.0	7
examine|effect|substrate|availability|COMPOUND_ENTITY|turnover|,|well-regulated|iddm|control|subject|undergo|repeat|GENE_ENTITY|insulin-clamp|study|combine|balanced|amino|acid|infusion|design|increase|circulate|plasma|amino|acid|level|approximately|twofold|.	1195193	0.0	7
methamphetamine-related|change|nt|content|previously|increase|activity|dopamine|d1|receptor|,|result|strongly|suggest|nmda|receptor|play|important|role|mediate|COMPOUND_ENTITY|d1|regulation|GENE_ENTITY|neurotensin|system|.	1195397	0.0	7
COMPOUND_ENTITY|change|nt|content|previously|increase|activity|dopamine|d1|receptor|,|result|strongly|suggest|nmda|receptor|play|important|role|mediate|dopamine|d1|regulation|GENE_ENTITY|neurotensin|system|.	1195403	0.0	7
influence|COMPOUND_ENTITY|treatment|pulsatile|GENE_ENTITY|growth|hormone|release|acromegaly|.	1195678	0.0	7
evidence|support|hypothesis|exist|:|1|-rrb-|GENE_ENTITY|beta|,|nuclear|dna|polymerase|present|adult|neuron|able|repair|damaged|dna|,|incorporate|COMPOUND_ENTITY|dttp|efficiency|.	1195753	1.0	7
hemizygote|classic|disease|manifestation|detectable|GENE_ENTITY|activity|g-to-a|transition|exon|1|-lrb-|codon|44|-rrb-|substitute|termination|codon|-lrb-|tag|-rrb-|COMPOUND_ENTITY|codon|-lrb-|tgg|-rrb-|create|nhei|restriction|site|.	1195756	0.0	7
ability|COMPOUND_ENTITY|enalaprilat|,|2|angiotensin-converting|enzyme|-lrb-|GENE_ENTITY|ace|-rrb-|inhibitor|,|scavenge|superoxide|anion|radical|examine|.	1195774	0.0	7
GENE_ENTITY|protein|alpha|1-antitrypsin|form|92|kda|COMPOUND_ENTITY|heat-stable|complex|human|tissue|kallikrein|.	1195986	0.0	8
failure|benzene|COMPOUND_ENTITY|serve|substrate|peroxidatic|action|GENE_ENTITY|catalase|.	1195991	0.0	7
COMPOUND_ENTITY|effect|induce|metoclopramide|simultaneously|GENE_ENTITY|adrenocorticotropic|hormone|prolactin|patient|pituitary|and/or|hypothalamic|disorder|.	1196011	0.0	7
test|involvement|pge2|ltb4|GENE_ENTITY|production|,|-|seb-activated|pbmc|treat|inhibitor|cyclooxygenase|-lrb-|aspirin|indomethacin|-rrb-|inhibitor|lipoxygenase|-lsb-|nordihydroguaiaretic|acid|-lrb-|COMPOUND_ENTITY|-rrb-|-rsb-|.	1196393	0.0	7
elution|1|mm|COMPOUND_ENTITY|triphosphate|,|additional|GENE_ENTITY|gelsolin|elute|wash|column|high|salt|concentration|.	1196581	0.0	7
pattern|catecholamine|-lrb-|adrenaline|noradrenaline|-rrb-|,|peptide|hormone|-lrb-|adrenocorticotropic|hormone|,|antidiuretic|hormone|,|beta-endorphin|,|GENE_ENTITY|hormone|prolactin|-rrb-|,|hydrocortisone|-lrb-|COMPOUND_ENTITY|-rrb-|immunoglobulin|-lrb-|iga|,|igg|igm|-rrb-|total|differential|leucocyte|count|peripheral|blood|investigate|6|day|thyroid|surgery|20|patient|-lrb-|f/m|:|18/2|-rrb-|perform|acupuncture|anaesthesia|,|supplement|small|dose|pethidine|-lrb-|mean|:|45.0|mg|,|s.d.|8.9|-rrb-|.	1196711	0.0	7
2.0|microm|COMPOUND_ENTITY|-lrb-|3|hr|,|37|degree|c|-rrb-|,|approximate|pharmacologic|serum|peak|level|,|suppress|15|40|%|folate|-|and/or|vitamin|GENE_ENTITY|b12-deficient|cell|32|47|%|control|.	1196913	0.0	7
order|evaluate|prolactin|secretion|female|GENE_ENTITY|dystrophy|-lrb-|md|-rrb-|prolactin|response|trh|,|metoclopramide|COMPOUND_ENTITY|study|13|woman|myotonic|dystrophy|-lrb-|10|normoprolactinaemic|3|hyperprolactinaemic|-rrb-|8|healthy|woman|.	1196951	0.0	7
closely|related|impurity|identify|misfolded|form|igf-i|,|mismatch|disulphide|bond|,|form|single|methionine|residue|GENE_ENTITY|oxidize|methionine|sulphoxide|variant|methionine|residue|substitute|COMPOUND_ENTITY|residue|protein|synthesis|.	1197154	1.0	7
sulfonamide|-lrb-|su|-rrb-|COMPOUND_ENTITY|-lrb-|tp|-rrb-|resistance|know|cause|production|drug|resistant|dihydropteroate|synthase|-lrb-|dhps|-rrb-|GENE_ENTITY|dihydrofolate|reductase|-lrb-|dhfr|-rrb-|,|respectively|.	1198431	0.0	7
gc-globulin|-lrb-|gcg|-rrb-|function|cochemotaxin|GENE_ENTITY|bind|c5a|c5a|des|COMPOUND_ENTITY|enhance|chemotactic|potency|.	1198613	0.0	8
inhibition|GENE_ENTITY|phospholipase|c|activation|a431|cell|erbstatin|,|COMPOUND_ENTITY|kinase|inhibitor|.	1198680	0.0	8
mechanism|decrease|expression|high|affinity|GENE_ENTITY|appear|dual|effect|COMPOUND_ENTITY|,|function|increase|rate|il-2r|internalization|,|decrease|rate|expression|new|receptor|.	1199239	0.0	7
region|hl|gene|,|display|significant|homology|lipolytic|enzyme|contain|putative|catalytic|site|COMPOUND_ENTITY|residue|GENE_ENTITY|hl|,|encode|exon|4|.	1200220	0.0	7
peptide|mapping|subsequent|sequence|analysis|reveal|selective|hpg|modification|occur|arg129|COMPOUND_ENTITY|modification|protect|binding|heparin|GENE_ENTITY|antithrombin|.	1200633	0.0	7
species|GENE_ENTITY|glycosylate|site|;|asn-114|,|asn-114|asn-110|COMPOUND_ENTITY|.	1200811	0.0	8
early|progenitor|cell|growth|factor|,|il-3|,|late-acting|factor|,|GENE_ENTITY|,|stimulate|COMPOUND_ENTITY|serine/threonine|substrate|phosphorylation|.	1201141	0.0	7
contrary|,|microtubule|disrupter|colchicine|,|COMPOUND_ENTITY|,|vincristine|dramatically|potentiate|-lrb-|15|-|35-fold|-rrb-|,|dose-dependent|fashion|,|cell-associated|il1|lesser|extent|-lrb-|2.5|-|7-fold|-rrb-|release|GENE_ENTITY|il1|myelomonocytic|thp1|cell|line|adherent|peripheral|blood|mononuclear|cell|.	1201909	0.0	7
COMPOUND_ENTITY|kinase|activity|associate|GENE_ENTITY|egf-r|evaluate|measure|incorporation|gamma|32p-atp|,|immunoprecipitation|receptor|monoclonal|antibody|egfri|.	1201948	0.0	7
COMPOUND_ENTITY|stimulate|LTA|hydrolase|inhibit|GENE_ENTITY|5-lipoxygenase/lta|synthase|activity|isolate|human|neutrophil|.	1202426	0.0	8
COMPOUND_ENTITY|40|mg|decrease|total|serum|cholesterol|,|ldl|cholesterol|apolipoprotein|b|35|%|,|40|%|35|%|,|respectively|,|hdl|cholesterol|GENE_ENTITY|apolipoprotein|a-i|increase|10|%|-lrb-|p|0.01|-rrb-|7|%|-lrb-|p|0.05|-rrb-|,|respectively|.	1202850	0.0	7
physiological|function|serpin|-lrb-|COMPOUND_ENTITY|proteinase|inhibitor|-rrb-|GENE_ENTITY|heparin|cofactor|ii|-lrb-|hcii|-rrb-|understand|.	1202853	0.0	8
result|suggest|lowering|camp|induce|alf4|-|GENE_ENTITY|ii|mediate|inhibitory|guanine|nucleotide-binding|regulatory|protein|adenylate|cyclase|,|COMPOUND_ENTITY|+|mobilization|.	1364429	0.0	8
agonist|use|COMPOUND_ENTITY|,|GENE_ENTITY|angiotensin|ii|-lrb-|aii|-rrb-|ergometrine|maleate|.	1365166	0.0	7
furthermore|,|infer|translocation|result|generation|COMPOUND_ENTITY|+|independent|form|pk-c|,|pk-m|,|leupeptin|,|inhibit|generation|GENE_ENTITY|pk-m|,|block|o2|-|production|.	1366791	0.0	7
saphenous|vein|maximally|contract|GENE_ENTITY|,|relaxation|COMPOUND_ENTITY|blunt|compare|artery|-lrb-|p|0.005|;|n|=|5|-rrb-|.	1367714	0.0	7
gh|GENE_ENTITY|secretory|pattern|assess|intermittent|sc|administration|,|continuous|sc|infusion|-lrb-|csi|-rrb-|,|continuous|iv|infusion|COMPOUND_ENTITY|.	1368050	0.0	7
COMPOUND_ENTITY|tissue|basal|cell|stain|exclusively|z622|,|predominantly|pke|GENE_ENTITY|rck|102|,|lesser|degree|MCA|144|CAM|5.2|.	1368105	0.0	7
COMPOUND_ENTITY|+|hanp|experiment|,|hanp-induced|change|renal|index|enhance|control|-lrb-|p|0.05|vs|GENE_ENTITY|hanp|experiment|-rrb-|patient|.	1368112	0.0	7
result|support|propose|role|thiol|functionality|facilitate|COMPOUND_ENTITY|-rrb-|reductase|-lrb-|hg|:|nadp|+|GENE_ENTITY|oxidoreductase|,|EC|1.16.1.1|-rrb-|-|catalyze|reduction|hg2|+|tris|-|tetraligation|hg2|+|.	1368401	0.0	7
COMPOUND_ENTITY|phosphorylation|plc-ii|stimulate|low|physiological|concentration|egf|-lrb-|1|nm|-rrb-|,|quantitative|,|maximal|30|sec|incubation|50|nm|egf|37|degree|c.|interestingly|,|antibody|specific|plc-ii|able|coimmunoprecipitate|egf|receptor|antibody|egf|receptor|coimmunoprecipitate|GENE_ENTITY|plc-ii|.	1369136	0.0	7
quantity|-lsb-|32po4|-rsb-|-|label|GENE_ENTITY|receptor|immunoprecipitate|COMPOUND_ENTITY|content|total|-lsb-|32po4|-rsb-|-|label|protein|reduce|addition|egf|stimulation|trifluoperazine|-lrb-|tfp|-rrb-|.	1369759	0.0	7
acute|long-term|hemodynamic|efficacy|positive|inotropic|vasodilatory|drug|pimobendan|-lrb-|5|mg|b.i.d.|-rrb-|compare|GENE_ENTITY|enzyme|-lrb-|ace|-rrb-|inhibitor|COMPOUND_ENTITY|-lrb-|25|mg|t.i.d.|-rrb-|double-blind|,|randomized|study|20|patient|suffer|chronic|congestive|heart|failure|-lrb-|nyha|functional|class|ii-iii|-rrb-|.	1369983	0.0	7
chronotropic|dose|25|isoproterenol|-lrb-|GENE_ENTITY|-rrb-|,|plasma|concentration|catecholamine|,|COMPOUND_ENTITY|thyroxin|,|plasma|renin|activity|aldosterone|,|hemoglobin|,|hematocrit|oxyhemoglobin|dissociation|measure|day|bopindolol|administration|1|,|2|,|3|,|6|,|13|day|abrupt|replacement|placebo|tablet|.	1370224	0.0	7
COMPOUND_ENTITY|relatively|long-lasting|effect|GENE_ENTITY|ace|inhibition|.	1371882	0.0	8
investigate|interaction|alpha|2-macroglobulin|-lrb-|GENE_ENTITY|-rrb-|COMPOUND_ENTITY|proteinase|urokinase|,|activator|plasminogen|.	1371967	1.0	8
binding|levonorgestrel|,|COMPOUND_ENTITY|desogestrel|human|GENE_ENTITY|sex|hormone|binding|globulin|influence|free|testosterone|level|.	1372083	1.0	8
GENE_ENTITY|,|COMPOUND_ENTITY|synthetic|analogue|:|use|bioassay|.	1373137	0.0	8
lack|effect|COMPOUND_ENTITY|implant|platelet|imipramine|GENE_ENTITY|5-ht2|receptor|binding|menopausal|subject|.	1374149	0.0	8
COMPOUND_ENTITY|long|duration|action|,|GENE_ENTITY|ace|inhibition|present|72|h|drug|intake|.	1375297	0.0	8
c5a|GENE_ENTITY|des|COMPOUND_ENTITY|potent|complement-derived|mediator|bind|receptor|peripheral|blood|leukocyte|tissue-specific|cellular|element|elicit|amplify|inflammatory|immunomodulatory|reaction|.	1375684	0.0	8
GENE_ENTITY|b|activity|quantitate|alveolar|macrophage|obtain|hamster|10|,|21|,|105|day|intratracheal|instillation|porcine|pancreatic|elastase|,|COMPOUND_ENTITY|,|normal|saline|.	1375750	0.0	8
physiological|concentration|1,25|-lrb-|oh|-rrb-|2|vitamin|d3|bind|GENE_ENTITY|protein|-lrb-|dbp|-rrb-|COMPOUND_ENTITY|bind|retinol-binding|protein|small|effect|differentiation|proliferation|hl-60|cell|.	1376171	0.0	8
COMPOUND_ENTITY|treatment|lead|increase|heme|content|synthesis|GENE_ENTITY|haptoglobin|,|decrease|synthesis|albumin|afp|.	1376305	0.0	8
clinical|pharmacology|study|COMPOUND_ENTITY|,|bioactivation|cilazaprilat|,|characterize|potent|,|reversible|GENE_ENTITY|angiotensin-converting|enzyme|-lrb-|ace|-rrb-|inhibitor|terminal|half-life|30|50|hour|consistent|saturable|binding|ace|.	1382019	0.0	8
newly|synthesize|COMPOUND_ENTITY|kinase|inhibitor|st|638|inhibit|increase|level|tyrosine|phosphorylation|GENE_ENTITY|p92|,|p78|,|p54|p40|protein|.	1382273	0.0	8
stress|reaction|response|procedure|GENE_ENTITY|test|measure|salivary|serum|COMPOUND_ENTITY|psychological|variable|.	1382857	0.0	8
pmn|separate|flow|cytometry|daf-positive|-|negative|population|use|rabbit|GENE_ENTITY|antiserum|COMPOUND_ENTITY|goat|antirabbit|igg|.	1384605	0.0	8
conduct|competitive|receptor|binding|assay|COMPOUND_ENTITY|,|meclofenamate|ibuprofen|GENE_ENTITY|fmlp|receptor|.	1498767	1.0	8
aim|present|study|examine|possible|interaction|human|growth|hormone|-lrb-|hgh|-rrb-|somatomedin|c|-lrb-|GENE_ENTITY|-rrb-|,|induct|anaesthesia|COMPOUND_ENTITY|healthy|patient|.	1499379	0.0	8
heart|,|marked|increase|GENE_ENTITY|tension|COMPOUND_ENTITY|acid|associate|dramatic|decrease|myocardial|ph|consequent|depression|contractile|function|.	1500121	0.0	8
result|suggest|binding|COMPOUND_ENTITY|binding|site|plasmin|plasminogen|sct-pa|enhance|conversion|tct-pa|GENE_ENTITY|plasmin|,|site|t-pa|molecule|bind|plasminogen|plasmin|.	1503076	0.0	8
GENE_ENTITY|cause|increase|-lsb-|ca2|+|-rsb-|;|,|aii-stimulated|alteration|-lsb-|COMPOUND_ENTITY|-rsb-|display|different|kinetics|compare|cause|pdgf|.	1503369	0.0	8
cell|line|,|albumin|plasma|GENE_ENTITY|protein|permit|COMPOUND_ENTITY|uptake|control|value|.	1504007	0.0	8
rbp|lower|affinity|GENE_ENTITY|COMPOUND_ENTITY|neutral|ph|region|,|base|small|binding|rate|constant|large|dissociation|rate|constant|FMN|.	1509051	0.0	8
establishment|etoposide|-lrb-|COMPOUND_ENTITY|-rrb-|-|resistant|subline|GENE_ENTITY|thp-1|human|monocytic|leukemia|cell|line|.	1509593	0.0	8
furthermore|,|significant|quantity|aa|COMPOUND_ENTITY|metabolite|detect|treatment|neutrophil|a23187|,|GENE_ENTITY|fmlp|.	1511182	0.0	8
monospecific|polyclonal|antibody|COMPOUND_ENTITY|site|reduce|neutrophil|adherence-promoting|activity|GENE_ENTITY|plasmin|.	1515282	0.0	8
GENE_ENTITY|binding|inhibit|epsilon|aminocaproic|acid|indicate|binding|mediate|COMPOUND_ENTITY|region|plasminogen|.	1515841	0.0	8
recent|availability|synthetic|long-acting|somatostatin-analogue|sms|201-995|-lrb-|COMPOUND_ENTITY|-rrb-|greatly|facilitate|therapeutical|application|GENE_ENTITY|somatostatin-polypeptide|.	1632149	0.0	8
result|suggest|binding|GENE_ENTITY|specific|receptor|obligatory|subsequent|delivery|COMPOUND_ENTITY|membrane|.	1636112	0.0	8
Chang|liver|cell|administration|oxytocin|vasopressin|combined|application|hormone|result|positive|binding|imprint|COMPOUND_ENTITY|negative|binding|imprint|GENE_ENTITY|vasopressin|.	1636931	0.0	8
2-3|hr|perfusion|,|COMPOUND_ENTITY|present|medium|increase|GENE_ENTITY|insulin|start|level|.	1637694	0.0	8
contrast|,|gastrectomy|group|significant|rise|plasma|GENE_ENTITY|,|despite|comparable|elevation|plasma|COMPOUND_ENTITY|level|.	1637860	0.0	8
GENE_ENTITY|ii|isolate|porcine|intestinal|epithelium|COMPOUND_ENTITY|+|-|modulate|lipid-binding|protein|.	1643245	0.0	8
GENE_ENTITY|production|induce|pha|strongly|block|COMPOUND_ENTITY|cyclosporin|6-mercaptopurine|,|pharmacological|concentration|use|.	1644801	0.0	8
GENE_ENTITY|alpha|j|ifn-alpha|7|differ|amino|acid|,|position|107|,|lysine|ifn-alpha|j|replace|COMPOUND_ENTITY|acid|ifn-alpha|7|.	1645709	0.0	8
datum|suggest|GENE_ENTITY|receptor|functionally|link|COMPOUND_ENTITY|kinase|,|implicate|biological|function|.	1648265	0.0	8
effect|COMPOUND_ENTITY|relate|enhancement|GENE_ENTITY|mitochondrial|atpase|activity|nicardipine|act|mitochondria|different|mechanism|.	1649640	0.0	8
phosphorylation|reaction|stop|add|excess|COMPOUND_ENTITY|mg|,|component|ep|,|epfast|-lrb-|rate|constant|,|kfast|=|15-20|GENE_ENTITY|min-1|-rrb-|,|epslow|-lrb-|kslow|=|0.3-0|.4|min-1|-rrb-|,|recognize|time|course|ep|decomposition|.	1650001	0.0	8
COMPOUND_ENTITY|-lrb-|GENE_ENTITY|sasp|-rrb-|generally|claim|safer|alternative|second-line|drug|report|incidence|leucopenia|vary|widely|.	1650751	0.0	8
rflp|correspond|charge|aminoacid|variant|position|3611|-lrb-|arginine|COMPOUND_ENTITY|-rrb-|4154|-lrb-|glutamic|acid|lysine|-rrb-|,|lie|near|low-density-lipoprotein|-lrb-|ldl|-rrb-|receptor|binding|region|GENE_ENTITY|apolipoprotein-b|.	1651343	0.0	8
actin|filament|cross-linking|activity|GENE_ENTITY|2|phosphorylate|protein|kinase|ii|,|COMPOUND_ENTITY|protein|kinase|protein|kinase|c|retrieve|phosphorylate|map|2|treat|protein|phosphatase|.	1652539	0.0	8
measure|serum|level|sex-hormone-binding-globulin|-lrb-|GENE_ENTITY|-rrb-|,|testosterone|-lrb-|t|-rrb-|,|free|testosterone|-lrb-|free|t|-rrb-|,|dihydrotestosterone|-lrb-|COMPOUND_ENTITY|-rrb-|,|4|androstenedione|-lrb-|4-ad|-rrb-|,|dehydroepiandrosteronesulphate|-lrb-|dhas|-rrb-|,|gonadotropin|luteinize|hormone|-lrb-|lh|-rrb-|follicular|hormone|stimulating|-lrb-|fsh|-rrb-|.	1654214	0.0	8
COMPOUND_ENTITY|+|-|dependent|myosin|phosphorylation|ca2|+|/|calmodulin-dependent|myosin|light|chain|kinase|-lrb-|GENE_ENTITY|mlc-kinase|-rrb-|protein|kinase|c|study|use|selective|inhibitor|,|isoquinolinesulfonamide|derivative|.	1654464	0.0	8
aspirin|reduce|plasma|txb2|GENE_ENTITY|tg|pf4|,|COMPOUND_ENTITY|reduce|beta|tg|pf4|txb2|.	1654486	0.0	8
active|disease|GENE_ENTITY|polypeptide|response|insulin|hypoglycaemia|higher|subject|ulcer|heal|COMPOUND_ENTITY|therapy|ulcer|.	1787137	0.0	8
contrast|neutrophil|response|mediate|GENE_ENTITY|fmlp|,|COMPOUND_ENTITY|inhibit|enzyme|release|superoxide|anion|generation|neutrophil|stimulate|phorbol|myristate|acetate|.	1788985	0.0	8
tobacco|worker|respiratory|symptom|compatible|pulmonary|disease|cause|organic|dust|trend|increase|GENE_ENTITY|,|nag|,|COMPOUND_ENTITY|level|.	1789395	0.0	8
effect|anti-thyroid|drug|COMPOUND_ENTITY|GENE_ENTITY|interleukin-1|interleukin-2|level|vitro|.	1789452	0.0	8
GENE_ENTITY|protein|-lrb-|55k|+|17k|-rrb-|sea|urchin|egg|COMPOUND_ENTITY|+|-|calmodulin-dependent|phosphoprotein|phosphatase|activity|.	1789454	0.0	8
teleost|insulin|alter|pattern|hepatic|glycogen|depletion|,|increase|glucose|level|COMPOUND_ENTITY|flux|glucose|,|glycogen|,|lipid|,|alanine|flux|GENE_ENTITY|co2|glucose|.	1789819	0.0	8
known|growth|factor|test|,|GENE_ENTITY|factor|-lrb-|bfgf|-rrb-|mitogenic|melanocyte|presence|cyclic-adenosine-monophosphate|-lrb-|COMPOUND_ENTITY|-rrb-|stimulator|.	1790379	0.0	8
,|affinity|-lrb-|kd|-rrb-|GENE_ENTITY|receptor|COMPOUND_ENTITY|type|cell|.	1794015	1.0	8
considerable|difference|extent|binding|COMPOUND_ENTITY|acetate|GENE_ENTITY|lhrh|plasma|contribute|difference|pharmacokinetic|parameter|observe|compound|.	1803139	1.0	8
determine|nature|binding|transcobalamin|ii|-lrb-|GENE_ENTITY|-rrb-|liver|cell|,|covalently|couple|purify|holo-tc-ii|submicron|latex|minibead|use|COMPOUND_ENTITY|.	1803358	0.0	8
cell|seed|medium|contain|igf-i|,|GENE_ENTITY|,|ovalbumin|,|COMPOUND_ENTITY|bfgf|,|growth|minimal|.	1804209	0.0	8
correlation|find|specific|acid|GENE_ENTITY|activity|COMPOUND_ENTITY|fluorescence|different|control|cell|strain|.	1804432	0.0	8
,|effect|adp|COMPOUND_ENTITY|observe|presence|inhibitor|GENE_ENTITY|myokinase|,|p1|,|p5-di|-lrb-|adenosine-5|'|-rrb-|pentaphosphate|-lrb-|ap5a|-rrb-|.	1804943	0.0	8
Ivermectin|,|potent|widely|use|anti-parasitic|drug|,|compete|efficiently|retinol|retinol-binding|site|GENE_ENTITY|,|host-tissue|COMPOUND_ENTITY|site|.	1900707	0.0	8
scatchard|analysis|egf|binding|COMPOUND_ENTITY|ht-29|cell|GENE_ENTITY|crdgf|inhibit|egf|binding|decrease|egf|receptor|affinity|,|previously|observe|non-colonic|cell|type|.	1911323	0.0	8
effect|pronounced|nonchemotactic|dose|c5a|-lrb-|0.01|nm|-rrb-|GENE_ENTITY|des|COMPOUND_ENTITY|-lrb-|1|nm|-rrb-|.	1912873	0.0	8
patient|group|plasma|GENE_ENTITY|concentration|positively|correlate|maximum|post-dexamethasone|plasma|COMPOUND_ENTITY|concentration|.	1913344	0.0	8
GENE_ENTITY|p93|phosphorylate|exclusively|COMPOUND_ENTITY|residue|use|poly|-lrb-|glu|,|tyr|-rrb-|4:1|,|histone|h1|vasoactive|intestinal|peptide|substrate|.	1992245	0.0	8
preincubation|factor|xa|COMPOUND_ENTITY|phospholipid|reduce|rate|inhibition|GENE_ENTITY|htgl|,|indicate|phospholipid-binding|site|involve|.	1992517	0.0	8
binding|affinity|steroid|GENE_ENTITY|receptor|markedly|lower|follow|order|potency|:|estrogen|-lrb-|estradiol|,|ethinyl|estradiol|,|diethylstilbestrol|-rrb-|greater|glucocorticoid|aromatase|inhibitor|COMPOUND_ENTITY|canrenoate|.	2072293	1.0	8
datum|report|hereunder|confirm|existence|binding|species|,|support|hypothesis|COMPOUND_ENTITY|,|phenylalanine|residue|GENE_ENTITY|leu-enkephalin|molecule|involve|peptide-lipid|interaction|.	2077163	0.0	8
effect|piretanide|catecholamine|metabolism|,|plasma|GENE_ENTITY|activity|plasma|aldosterone|:|double-blind|study|versus|COMPOUND_ENTITY|healthy|volunteer|.	2077872	0.0	8
baseline|COMPOUND_ENTITY|GENE_ENTITY|shmt|activity|differentiate|psychotic|nonpsychotic|high|degree|significance|-lrb-|p|0.0001|-rrb-|p|0.01|,|respectively|-rrb-|.	2080647	0.0	8
-lsb-|response|plasma|bradykinin|GENE_ENTITY|axis|COMPOUND_ENTITY|essential|hypertension|-rsb-|.	2081067	0.0	8
sucrose-induced|rise|rest|metabolic|rate|accompany|rise|serum|COMPOUND_ENTITY|value|,|plasma|GENE_ENTITY|insulin|norepinephrine|concentration|.	2081144	0.0	8
second|,|evidence|date|advantage|DAT|programme|contain|COMPOUND_ENTITY|GENE_ENTITY|CTR|III|agent|replace|epipodophyllotoxin|vp16-213|.	2081459	0.0	8
COMPOUND_ENTITY|o-methylate|reaction|catalyze|catechol-o-methyltransferase|-lrb-|GENE_ENTITY|comt|-rrb-|.	2082075	0.0	8
evidence|n-acetylneuraminic|acid|group|principal|acidic|residue|bind|colloidal|COMPOUND_ENTITY|elimination|greater|85|%|colloidal|iron|label|GENE_ENTITY|neuraminidase-treated|cell|membrane|.	2124940	0.0	8
wavelength-resolved|steady|state|spectrum|observe|different|kind|emission|GENE_ENTITY|h1|,|class|protein|single|COMPOUND_ENTITY|residue|.	2124948	0.0	8
sub-unit|chain|electrophoresis|-lrb-|10|%|COMPOUND_ENTITY|two-dimensional|electrophoresis|-rrb-|disclose|sign|abnormality|GENE_ENTITY|fibrinogen|precipitate|hpf|.	2125406	0.0	8
concentration|lidocaine|prilocaine|blood|measure|106|patient|exceed|1100|ng|GENE_ENTITY|lidocaine|200|ng|ml-1|COMPOUND_ENTITY|.	2125410	0.0	8
concentration|shbg|reduce|consequence|increase|level|free|T.|hand|,|COMPOUND_ENTITY|binding|GENE_ENTITY|androgen|receptor|partially|inhibit|action|excess|free|t|,|androgenization|therapy|weak|compare|level|free|T.	2130889	1.0	8
-lsb-|diagnostic|significance|serum|level|COMPOUND_ENTITY|-lrb-|retinol|-rrb-|GENE_ENTITY|retinol-binding-proteine|-lrb-|rbp|-rrb-|author|transl|-rrb-|-rsb-|.	2148706	0.0	8
GENE_ENTITY|hormone|,|theophylline|prostaglandin|e|-lrb-|1|-rrb-|increase|calcium|efflux|,|lanthanum|COMPOUND_ENTITY|effect|.	2149043	0.0	8
effect|weight|reduction|,|triiodothyronine|,|COMPOUND_ENTITY|GENE_ENTITY|growth|hormone|obesity|.	2160527	0.0	8
effect|COMPOUND_ENTITY|hypermetabolism|factor|8|GENE_ENTITY|fibrinogen|man|.	2161212	0.0	8
interaction|pineal|,|hypothalamus|,|pituitary|involve|COMPOUND_ENTITY|,|GENE_ENTITY|MSH|release-inhibiting|factor|msh|.	2161507	0.0	8
reaction|COMPOUND_ENTITY|GENE_ENTITY|catalase|significance|.	2169485	0.0	8
close|arterial|injection|COMPOUND_ENTITY|-lrb-|100|mug|-rrb-|cause|mean|average|fibre|discharge|frequency|5.4|GENE_ENTITY|spikes/sec|.9|.	2169736	0.0	8
hemolytic|effect|standard|single|dosage|primaquine|COMPOUND_ENTITY|GENE_ENTITY|g-6-pd-deficient|caucasian|.	2170407	0.0	8
separation|label|COMPOUND_ENTITY|GENE_ENTITY|vasopressin|animal|,|use|i-131|gel|filtration|method|.	2171181	0.0	8
COMPOUND_ENTITY|201-995|-lrb-|1.12|microgram|kg-1|h-1|-rrb-|appear|longer|duration|action|GENE_ENTITY|sst-14|.	2229572	0.0	8
datum|suggest|COMPOUND_ENTITY|modulate|vivo|release|mediator|immediate|hypersensitivity|reaction|activation|GENE_ENTITY|beta|2-adrenergic|receptor|link|adenylate|cyclase|human|basophil|mast|cell|.	2236029	0.0	8
fc|gamma|receptor|-lrb-|GENE_ENTITY|-rrb-|normal|human|b|lymphocyte|study|use|electron-microscopic|monovalent|ligand|ferritin|-lrb-|COMPOUND_ENTITY|-rrb-|rabbit|igg|anti-fer|.	2237141	0.0	8
binding|pentosan|polysulphate|-lrb-|COMPOUND_ENTITY|-rrb-|human|GENE_ENTITY|polymorphonuclear|leucocyte|elastase|-lrb-|pmne|-rrb-|natural|synthetic|substrate|investigate|.	2239288	0.0	8
GENE_ENTITY|protein|-lrb-|gfap|-rrb-|,|high|affinity|glutamate|gamma-amino|butyric|acid|-lrb-|gaba|-rrb-|uptake|COMPOUND_ENTITY|synthetase|use|indicator|astroglial|differentiation|.	2240637	0.0	8
importance|COMPOUND_ENTITY|binding|site|human|GENE_ENTITY|plasmin|ability|digest|human|fibrinogen|assess|analyze|nature|rate|product|form|presence|epsilon-aminocaproic|acid|.	2242215	1.0	8
response|protein|c|GENE_ENTITY|inhibitor|COMPOUND_ENTITY|therapy|patient|combined|deficiency|factor|v|viii|.	2242489	0.0	8
elucidate|mechanism|action|,|study|effect|COMPOUND_ENTITY|vivo|vitro|cellular|GENE_ENTITY|insulin|receptor|binding|normal|subject|.	2334534	1.0	8
competition|cortisol|binding|thyroid|hormone|cytosol|protein|fraction|b|connection|serum|GENE_ENTITY|change|patient|COMPOUND_ENTITY|administration|discuss|.	2337774	0.0	8
chemotherapeutic|agent|,|exception|COMPOUND_ENTITY|GENE_ENTITY|l-asparaginase|,|induce|aplasia|,|degree|hematotoxicity|vary|accord|drug|.	2338180	0.0	8
double-blind|study|GENE_ENTITY|vs|COMPOUND_ENTITY|therapy|infantile|spasm|.	2338498	0.0	8
compound|,|analogue|dopamine|agonist|COMPOUND_ENTITY|-lrb-|2|-rrb-|GENE_ENTITY|c-7|methylene|remove|,|find|dopamine|antagonist|vitro|receptor|binding|study|.	2527642	0.0	8
patient|thyrotoxicosis|,|remarkable|increase|GENE_ENTITY|level|,|correlate|COMPOUND_ENTITY|content|,|observe|.	2528618	0.0	8
GENE_ENTITY|globulin|-lrb-|shbg|-rrb-|,|testosterone|-lrb-|t|-rrb-|,|5|alpha-dihydrotestosterone|-lrb-|COMPOUND_ENTITY|-rrb-|17|beta-oestradiol|-lrb-|e2|-rrb-|measure|93|man|age|range|36|--|80|yr|.	2531073	0.0	8
GENE_ENTITY|protein|human|seminal|plasma|-lrb-|spabp|-rrb-|high|affinity-low|capacity|dihydrotestosterone|-lrb-|COMPOUND_ENTITY|-rrb-|measure|saturation-charcoal|adsorption|technique|.	2533721	1.0	8
GENE_ENTITY|triamcinolone|act|synergistically|,|combination|triamcinolone|COMPOUND_ENTITY|additive|.	2534095	0.0	8
analyse|mechanism|underlie|induction|apoptosis|agent|find|down-regulation|c-myc|expression|pretreatment|dna|binding|antibiotic|COMPOUND_ENTITY|,|inhibitor|GENE_ENTITY|c-myc|transcription|,|prevent|activation|apoptotic|process|.	2810493	0.0	8
datum|suggest|arrest|cell|g2-phase|cell|cycle|COMPOUND_ENTITY|regulate|dephosphorylation|GENE_ENTITY|cdc2|kinase|.	2810831	0.0	8
selective|biphenylimidazole|tetrahydroimidazopyridine|antagonist|exemplify|losartan|-lrb-|COMPOUND_ENTITY|-rrb-|pd|123319|bind|selectively|angiotensin|at1|GENE_ENTITY|at2|receptor|subtype|,|respectively|.	2812114	0.0	8
lactic|acidosis|induce|exercise|increase|stress|ventilatory|system|GENE_ENTITY|generate|COMPOUND_ENTITY|buffering|hydrogen|ion|stimulation|.	2812796	0.0	8
MAIN|OUTCOME|MEASURES|:|in-hospital|mortality|rate|patient|receive|penicillin-binding|protein|3/tumor|necrosis|factor|-lrb-|pbp3/tnf|-rrb-|-|specific|antibiotic|associate|greatest|degree|endotoxin|release|GENE_ENTITY|production|-lrb-|pbp3/tnf|group|,|n|=|78|:|aztreonam|,|COMPOUND_ENTITY|,|cefotaxime|sodium|-rrb-|compare|patient|receive|agent|-lrb-|non-pbp3|/|tnf|group|,|n|=|256|-rrb-|.	2812827	0.0	8
MAIN|OUTCOME|MEASURES|:|in-hospital|mortality|rate|patient|receive|penicillin-binding|protein|3/tumor|necrosis|factor|-lrb-|pbp3/tnf|-rrb-|-|specific|antibiotic|associate|greatest|degree|endotoxin|release|tnf|production|-lrb-|pbp3/tnf|group|,|n|=|78|:|aztreonam|,|COMPOUND_ENTITY|,|cefotaxime|sodium|-rrb-|compare|patient|receive|agent|-lrb-|non-pbp3|/|GENE_ENTITY|tnf|group|,|n|=|256|-rrb-|.	2812837	0.0	8
study|initiate|determine|phosphorylation|GENE_ENTITY|result|direct|kinase-substrate|interaction|highly|active|COMPOUND_ENTITY|kinase|,|pp60v-src|,|cx43|.	2812914	0.0	8
gz-mediated|inhibition|adenylyl|cyclase|,|trigger|activation|COMPOUND_ENTITY|receptor|,|,|respectively|,|abolish|-lrb-|g2ac3a|-rrb-|,|impaired|-lrb-|g2a|-rrb-|,|enhance|-lrb-|GENE_ENTITY|c3a|-rrb-|.	2815157	0.0	8
incorporation|fragmented|dna|COMPOUND_ENTITY|nucleotide|GENE_ENTITY|terminal|deoxynucleotidyl|transferase|-lrb-|tdt|-rrb-|recently|standard|flow|cytometric|assay|identification|quantitation|apoptosis|.	2815497	0.0	8
regulatory|factor|include|prostaglandin|e2|-lrb-|COMPOUND_ENTITY|-rrb-|,|GENE_ENTITY|interferon-gamma|-lrb-|ifn-gamma|-rrb-|interleukin-4|-lrb-|il-4|-rrb-|measure|cell|supernatant|.	2815757	0.0	8
GENE_ENTITY|-lrb-|ec|3.5.1.12|-rrb-|catalyze|hydrolysis|biocytin|,|product|biotin-dependent|carboxylase|degradation|,|biotin|COMPOUND_ENTITY|.	2815850	0.0	8
association|propranolol|-lrb-|n|=|8|-rrb-|COMPOUND_ENTITY|-lrb-|n|=|7|-rrb-|prazosin|increase|reduction|hvpg|attenuate|increase|plasma|GENE_ENTITY|renin|activity|.	2816456	0.0	8
examine|COMPOUND_ENTITY|calmodulin|control|ligand|binding|electron|acceptor|property|GENE_ENTITY|nos|heme|iron|.	2816691	1.0	8
inhibitory|effect|retinoid|counteract|selective|antagonist|nuclear|COMPOUND_ENTITY|acid|receptor|rar|alpha|,|suggest|GENE_ENTITY|rar|alpha|mediate|mechanism|angiogenesis|inhibition|.	2820694	0.0	8
possible|means|improve|therapeutic|index|COMPOUND_ENTITY|and/or|GENE_ENTITY|ifn-alpha|aids|patient|addition|hematopoietic|growth|factor|.	2821665	0.0	8
inhibitor|COMPOUND_ENTITY|protein|phosphatase|GENE_ENTITY|pp1|pp2a|,|okadaic|acid|calyculin|induce|lt|alpha|mrna|expression|.	2821865	0.0	8
dose-dependent|manner|,|COMPOUND_ENTITY|inhibit|binding|neutrophil|t|lymphocyte|lps|il-1|beta|GENE_ENTITY|tnf-alpha-activated|huvec|.	2832748	0.0	8
group|differ|significantly|respect|age|,|weight|,|GENE_ENTITY|time|methotrexate|administration|,|COMPOUND_ENTITY|administer|.	2832839	0.0	8
system|activity-dependent|GENE_ENTITY|release|initiate|high|potassium|-lrb-|COMPOUND_ENTITY|-rrb-|,|veratridine|,|glutamate|carbachol|.	2832910	0.0	8
finally|,|gh|GENE_ENTITY|induce|rapid|COMPOUND_ENTITY|phosphorylation|associated|kinase|,|janus|kinase|2|,|receptor|.	2832970	0.0	8
significant|difference|growth|hormone|secretion|,|serum|GENE_ENTITY|I|,|igf-binding|protein-3|level|,|methylprednisolone|COMPOUND_ENTITY|dose|.	2833788	0.0	8
conclude|GENE_ENTITY|mediator|bile-induced|volume|COMPOUND_ENTITY|secretion|.	2842326	0.0	8
finding|implicate|COMPOUND_ENTITY|GENE_ENTITY|peripheral-type|benzodiazepine|receptor|pathogenesis|edema|associate|fulminant|hepatic|failure|.	2842767	0.0	8
exogenous|histamine|add|airway|increase|mucous|glycoprotein|release|,|effect|prevent|COMPOUND_ENTITY|,|GENE_ENTITY|h-2|antagonist|.	2843062	0.0	8
6|h|,|COMPOUND_ENTITY|produce|increase|activity|iron-regulatory|protein|,|cytoplasmic|mrna-binding|protein|responsible|regulate|translation|GENE_ENTITY|transferrin|receptor|ferritin|mrna|.	3133792	0.0	8
fos-family|protein|bind|dna|dimerize|GENE_ENTITY|protein|investigate|expression|jun|b|protein|2|week|1|month|striatal|COMPOUND_ENTITY|,|produce|medial|forebrain|bundle|transection|.	3145515	0.0	8
double-blind|placebo-controlled|crossover|study|,|plasma|level|GENE_ENTITY|measure|immediately|-lrb-|5-30|s|-rrb-|80|min|infusion|NTG|-lrb-|COMPOUND_ENTITY|-rrb-|saline|12|healthy|subject|.	3145818	0.0	8
unexpectedly|,|COMPOUND_ENTITY|actually|synergize|GENE_ENTITY|il-4|upregulation|cd23|expression|down-regulation|type|ii|-lrb-|p75|-rrb-|tnf|receptor|,|b|cell|line|,|rapamycin|simultaneously|inhibit|il-4-dependent|production|tnf|alpha|beta|.	3146888	1.0	8
potential|n-linked|glycosylation|site|-lrb-|asn20|,|COMPOUND_ENTITY|,|asn272|,|asn384|-rrb-|GENE_ENTITY|lcat|determine|contain|sialylate|triantennary|and/or|biantennary|complex|structure|.	3147300	0.0	8
gc|globulin|-lrb-|vitamin|d|binding|protein|-rrb-|augment|significantly|leukocyte|chemotactic|activity|activate|complement|peptide|GENE_ENTITY|c5a|des|COMPOUND_ENTITY|.	3149737	0.0	8
gc|globulin|-lrb-|vitamin|d|binding|protein|-rrb-|augment|significantly|leukocyte|chemotactic|activity|activate|complement|peptide|c5a|GENE_ENTITY|des|COMPOUND_ENTITY|.	3149743	0.0	8
result|suggest|change|plasma|hdl-cholesterol|concentration|treatment|COMPOUND_ENTITY|relate|decrease|ltp|GENE_ENTITY|lcat|activity|drug|.	3149981	0.0	8
kinetics|p56lck|GENE_ENTITY|src|homology|2|domain|binding|COMPOUND_ENTITY|peptide|determine|competition|assay|surface|plasmon|resonance|.	3150260	0.0	8
GENE_ENTITY|normally|repress|transcription|c-fos|,|repression|depend|presence|cyclic|amp|-lrb-|COMPOUND_ENTITY|-rrb-|response|element|located|immediately|upstream|-54|yy1|dna-binding|site|.	3152618	0.0	8
measurement|:|follow|hormone|measure|:|gh|,|GENE_ENTITY|,|tsh|,|t4|,|free|t4|,|free|t3|,|prl|,|acth|,|beta-endorphin|COMPOUND_ENTITY|.	3153439	0.0	8
second|post-operative|day|,|reduce|urinary|GENE_ENTITY|ratio|observe|COMPOUND_ENTITY|group|compare|placebo|.	3153887	0.0	8
acute|promyelocytic|leukaemia|cell|resistant|COMPOUND_ENTITY|acid|perturbation|GENE_ENTITY|rar|alpha|signal|transduction|system|.	3154205	0.0	8
approach|time|course|COMPOUND_ENTITY|,|creatinine|,|k|+|,|na|+|,|cl|-|,|hco3|-|,|h|+|GENE_ENTITY|co2|predict|.	3155043	0.0	8
methyl-thf|neutralize|COMPOUND_ENTITY|pernicious|anemia|,|effect|certainly|enhance|addition|GENE_ENTITY|cn-cbl|.	3156335	0.0	8
expression|GENE_ENTITY|kinase|phosphorylation|COMPOUND_ENTITY|human|normal|tumour|cell|tissue|.	3157369	0.0	8
computer|program|estimate|influence|body|COMPOUND_ENTITY|pool|GENE_ENTITY|co2|breath|test|.	3158210	0.0	8
e5|oncoprotein|encode|bovine|papillomavirus|type|1|homodimeric|,|hydrophobic|polypeptide|localized|predominantly|golgi|membrane|transform|cell|type|apparently|induce|COMPOUND_ENTITY|phosphorylation|platelet-derived|growth|factor|receptor|-lrb-|GENE_ENTITY|pdgf-r|-rrb-|.	3162226	0.0	8
study|indicate|COMPOUND_ENTITY|residue|human|GENE_ENTITY|mao|b|essential|catalysis|.	3400124	0.0	8
COMPOUND_ENTITY|binding|human|GENE_ENTITY|transthyretin|variant|:|mutation|position|119|,|position|54|,|increase|thyroxine|binding|affinity|.	3400717	1.0	8
inhibition|cell|proliferation|associate|differentiation|cell|express|astrocytic|phenotype|evidence|morphology|,|increase|glial|fibrillary|acidic|protein|-lrb-|GENE_ENTITY|-rrb-|immunoreactivity|elevated|COMPOUND_ENTITY|synthetase|expression|.	3401240	0.0	8
GENE_ENTITY|increase|jak1|jak3|,|jak2|tyk2|,|COMPOUND_ENTITY|phosphorylation|observe|.	3407813	0.0	8
study|,|examine|role|amino|acid|-lrb-|COMPOUND_ENTITY|-rrb-|human|GENE_ENTITY|mao|b|think|play|crucial|role|bind|2|'|-|hydroxy|group|ribose|amp|moiety|fad|.	3408344	0.0	8
,|datum|suggest|AM|inhibit|lung|nk|activity|interfere|post-binding|lytic|event|-lrb-|s|-rrb-|production|COMPOUND_ENTITY|GENE_ENTITY|tgf-beta|1|.	3409265	0.0	8
datum|indicate|GENE_ENTITY|detect|COMPOUND_ENTITY|tissue|classic|immunohistochemical|analysis|flow|cytometry|.	3409285	0.0	8
cell|negative|glial|fibrillary|acidic|protein|,|COMPOUND_ENTITY|synthetase|,|galactocerebroside|,|GENE_ENTITY|carbonic|anhydrase|ii|.	3409832	0.0	8
treatment|erythrodermic|GENE_ENTITY|include|low-dose|COMPOUND_ENTITY|,|ifn|,|extracorporeal|photopheresis|,|single|agent|combination|chemotherapy|.	3410733	0.0	8
heavy|chain|human|GENE_ENTITY|-lrb-|n4|-|-lrb-|beta-n-acetylglucosaminyl|-rrb-|-|l-asparaginase|-lrb-|ec|3.5.1.26|-rrb-|-rrb-|cysteinyl|residue|-lrb-|cys-61|,|cys-64|,|cys-69|,|cys-163|,|COMPOUND_ENTITY|-rrb-|.	3412174	0.0	8
GENE_ENTITY|product|act|dominant|negative|regulator|transcription|mediate|COMPOUND_ENTITY|acid|receptor|.	3412555	0.0	8
hand|,|presence|dqb1|allele|COMPOUND_ENTITY|position|57|sufficient|confer|resistance|disease|irrespective|GENE_ENTITY|dqa1|genotype|.	3412579	0.0	8
molecular|cloning|characterization|receptor|-lsb-|arg8|-rsb-|GENE_ENTITY|COMPOUND_ENTITY|recently|accomplish|.	3413026	0.0	8
effect|GENE_ENTITY|factor|basolateral|iodide|uptake|apical|COMPOUND_ENTITY|permeability|filter-cultured|thyroid|epithelium|.	3413086	0.0	8
importance|rbp|transport|COMPOUND_ENTITY|tissue|suggest|observation|visceral|yolk|sac|liver|fetus|transcribe|translate|GENE_ENTITY|rbp|.	3413273	0.0	8
possible|role|mapkap|kinase-1|,|GENE_ENTITY|kinase-2|map|kinase|regulation|COMPOUND_ENTITY|hydroxylase|vivo|discuss|.	3413685	0.0	8
extract|ordinary|house|dust|contain|COMPOUND_ENTITY|protease|cleave|HA|GENE_ENTITY|ha1|ha2|.	3413716	0.0	8
exposure|COMPOUND_ENTITY|result|dose-dependent|accumulation|rhodamine|123|GENE_ENTITY|mdr-1|overexpressing|cell|.	3414091	0.0	8
GENE_ENTITY|prevent|killing|neuronal|cell|COMPOUND_ENTITY|amyloid|beta|protein|.	3416193	0.0	8
growth|factor|stimulation|,|COMPOUND_ENTITY|phosphorylated|egf|receptor|bind|GENE_ENTITY|grb2/sos|complex|,|translocate|plasma|membrane|.	3416765	0.0	8
GENE_ENTITY|alpha|induce|dna|synthesis|human|amnion|cell|,|COMPOUND_ENTITY|inhibit|tgf|alpha-induced|dna|synthesis|.	3416812	0.0	8
significant|linear|relationship|observe|p|and/or|po|sap|,|COMPOUND_ENTITY|,|map|,|tpr|,|BAD|,|BAF|,|GENE_ENTITY|BVR|,|CAD|CVR|.	3426632	0.0	8
mutational|analysis|GENE_ENTITY|gene|demonstrate|catalytic|site|regulatory|site|,|likely|COMPOUND_ENTITY|binding|site|,|located|highly|conserve|carboxy|terminus|.	3426757	0.0	8
Maximum|tolerate|dose|three-drug|combination|GENE_ENTITY|,|2|x|10|-lrb-|6|-rrb-|u/m2|,|COMPOUND_ENTITY|600|mg/m2|,|ifn-alpha|,|4|x|10|-lrb-|6|-rrb-|u/m2|.	3427203	0.0	8
mobilization|-lrb-|peak|response|-rrb-|GENE_ENTITY|,|tsh|,|COMPOUND_ENTITY|-lrb-|t3|-rrb-|,|thyroxin|-lrb-|t4|-rrb-|,|il-1|beta|,|il-2|,|il-6|trh|test|,|prl|,|il-1|beta|,|il-2|,|il-6|MCP|test|evaluate|.	3427527	0.0	8
binding|-lsb-|125i|-rsb-|igf-ii|receptor|presence|absence|excess|unlabeled|GENE_ENTITY|,|igf-i|,|insulin|determine|incubation|homobifunctional|cross-linking|agent|follow|COMPOUND_ENTITY|gel|electrophoresis|.	3661866	0.0	8
mutation|ap-1|GENE_ENTITY|binding|site|abolish|il-8|gene|repression|dexamethasone|,|suggest|site|target|COMPOUND_ENTITY|.	3663664	0.0	8
northern|blot|analysis|reveal|COMPOUND_ENTITY|5|alpha-dihydrotestosterone|strongly|induce|accumulation|GENE_ENTITY|zn-alpha|2-gp|mrna|t-47d|human|breast|cancer|cell|.	3664708	0.0	8
production|bone|influence|GENE_ENTITY|COMPOUND_ENTITY|suggest|possible|mechanism|disease|.	3666158	0.0	8
GENE_ENTITY|,|zinc|finger|dna-binding|protein|,|identify|transcription|factor|regulate|steroidogenic|p-450|gene|COMPOUND_ENTITY|manner|.	3666764	1.0	8
antioxidant|drug|COMPOUND_ENTITY|-lrb-|nac|-rrb-|inhibit|antigen-mediated|GENE_ENTITY|syk|activation|lyn|activation|phosphorylation|beta|gamma|maintain|.	3667251	0.0	8
previously|identify|GENE_ENTITY|immediate-early|mitogen-inducible|COMPOUND_ENTITY|phosphatase|nucleus|t|cell|.	3670536	0.0	8
De|novo|synthesis|GENE_ENTITY|polypeptide|enhance|il-1|beta|pma|,|dramatically|suppress|COMPOUND_ENTITY|-lrb-|dex|-rrb-|.	3672154	0.0	8
presence|diaryl|ditelluride|COMPOUND_ENTITY|,|ferric|GENE_ENTITY|cytochrome|c|rapidly|reduce|.	3673563	0.0	8
tumor-derived|molecule|responsible|inhibition|il-10|,|GENE_ENTITY|1|,|COMPOUND_ENTITY|e2|.	3680009	0.0	8
examination|COMPOUND_ENTITY|binding|bovine|serum|amine|oxidase|porcine|kidney|GENE_ENTITY|diamine|oxidase|reveal|dissociation|constant|196|9.1|microm|,|respectively|.	3680578	1.0	8
report|,|intact|cell|,|activation|interleukin|6|promoter|combination|factor|nf-il6|p65|subunit|nf-kappa|b|inhibit|COMPOUND_ENTITY|-lrb-|ligand|-rrb-|-|activate|GENE_ENTITY|glucocorticoid|receptor|.	3893231	1.0	8
c-fos|expression|GENE_ENTITY|COMPOUND_ENTITY|neuron|reveal|functional|heterogeneity|magnocellular|neuron|.	3909196	0.0	8
visible|solar|radiation|benefit|release|COMPOUND_ENTITY|visual|pigment|GENE_ENTITY|rhodopsin|.	3909935	0.0	8
complementary|m|ssbauer|epr|study|iron|-lrb-|iii|-rrb-|diferric|human|serum|GENE_ENTITY|oxalate|COMPOUND_ENTITY|synergistic|anion|.	3910371	0.0	8
Electron|microscopic|analysis|resected|liver|patient|receive|il-2-mitomycin-c|/|COMPOUND_ENTITY|-lrb-|GENE_ENTITY|il-2|.	3910820	0.0	8
8-anilinonaphthalene-1-sulfonate|-lrb-|ans|-rrb-|,|strongly|fluoresce|dye|,|bind|COMPOUND_ENTITY|binding|site|GENE_ENTITY|ttr|.	3912073	0.0	8
distribution|glycinergic|synaps|mammalian|retina|study|monoclonal|antibody|COMPOUND_ENTITY|receptor|glycine|receptor-related|protein|-lrb-|GENE_ENTITY|gephyrin|-rrb-|.	3913115	0.0	8
aliquot|incubate|1|mg|ml-1|COMPOUND_ENTITY|37|degree|c|,|5|%|GENE_ENTITY|co2|30|min|.	3913157	0.0	8
examination|p85|amino|acid|sequence|reveal|COMPOUND_ENTITY|sequence|n-terminal|region|similar|present|3bp1|,|3bp2|,|GENE_ENTITY|SOS|.	3914559	0.0	8
absence|GENE_ENTITY|increase|transcutaneous|COMPOUND_ENTITY|application|underscore|safety|tnds|smoking|withdrawal|therapy|.	4166393	0.0	8
effect|GENE_ENTITY|kinase|peptide|COMPOUND_ENTITY|+|exchange|n|-|c-terminal|ca2|+|binding|site|calmodulin|.	4166577	0.0	8
GENE_ENTITY|inhibitor|,|COMPOUND_ENTITY|-lrb-|dic|-rrb-|flavin|adenine|dinucleotide|-lrb-|fad|-rrb-|,|inhibit|mmc-induced|dna|damage|cytotoxicity|non-toxic|concentration|.	4168385	0.0	8
MAIN|OUTCOME|MEASURES|:|GENE_ENTITY|-|COMPOUND_ENTITY|increase|area|vivo|recording|curve|10|minute|ec50|concentration|dose-response|vitro|.	4168552	0.0	8
neuronal|synthase|-lrb-|nnos|-rrb-|consist|reductase|domain|bind|fad|,|GENE_ENTITY|,|nadph|,|calmodulin|,|oxygenase|domain|bind|heme|,|COMPOUND_ENTITY|,|substrate|l-arginine|.	4170171	0.0	8
hormonal|treatment|pancreatic|carcinoma|:|phase|ii|study|GENE_ENTITY|agonist|goserelin|plus|COMPOUND_ENTITY|.	4170790	0.0	8
active|site|GENE_ENTITY|specifically|modify|COMPOUND_ENTITY|analog|5|'|-|p-fluorosulfonylbenzoyladenosine|-lrb-|fsba|-rrb-|.	4180457	0.0	8
previously|undescribed|62-kda|protein|-lrb-|GENE_ENTITY|-rrb-|contain|COMPOUND_ENTITY|,|,|bind|specifically|isolate|src|homology|2|-lrb-|sh2|-rrb-|domain|p56lck|identify|.	4193599	0.0	8
COMPOUND_ENTITY|chelation|decrease|GENE_ENTITY|nf-kappa|b|hiv|type|1|activation|oxidative|stress|.	4194892	0.0	8
surprisingly|high|level|anaphylatoxin|GENE_ENTITY|des|COMPOUND_ENTITY|extractable|psoriatic|scale|.	4196225	0.0	8
GENE_ENTITY|,|group|b|,|n|=|17|-rrb-|,|``|low-dose|COMPOUND_ENTITY|''|-lrb-|7|micrograms.kg-1|.	4196347	0.0	8
end|period|,|plasma|level|GENE_ENTITY|-lrb-|igf-i|-rrb-|igf-binding|protein-3|-lrb-|igfbp-3|-rrb-|measure|0745|h|,|24-h|profile|plasma|gh|COMPOUND_ENTITY|obtain|15-min|interval|24-h|urinary|excretion|free|cortisol|.	4509560	0.0	8
synthesize|COMPOUND_ENTITY|GENE_ENTITY|synthase|-lrb-|nos|-rrb-|,|exist|calcium-dependent|calcium-independent|isoform|enzyme|.	4521179	0.0	8
increase|COMPOUND_ENTITY|-lrb-|t4|-rrb-|binding|thyroid|binding|prealbumin|-lrb-|GENE_ENTITY|tbpa|-rrb-|albumin|cause|biochemical|picture|suggestive|thyrotoxicosis|increase|total|t4|-lrb-|tt4|-rrb-|.	4521446	1.0	8
use|steroid-responsive|reporter|construct|,|find|ga|inhibit|COMPOUND_ENTITY|transactivating|activity|GENE_ENTITY|gr|transfect|cell|.	4522067	0.0	8
gdnf|bind|,|induce|tyrosine|phosphorylation|,|product|c-ret|proto-oncogene|,|orphan|receptor|COMPOUND_ENTITY|kinase|,|GENE_ENTITY|gdnf-responsive|motor-neuron|cell|line|.	4525723	0.0	8
homocysteine|response|COMPOUND_ENTITY|challenge|obligate|heterozygote|homocystinuria|relationship|GENE_ENTITY|cystathionine|beta-synthase|mutation|.	4527288	0.0	8
COMPOUND_ENTITY|59|located|mads|GENE_ENTITY|mef2|domain|mef2c|phosphorylate|vivo|phosphorylate|vitro|casein|kinase-ii|-lrb-|ckii|-rrb-|.	4531094	0.0	8
kinetic|analysis|GENE_ENTITY|normal|fibroblast|km|COMPOUND_ENTITY|260|+|/|-|94|nmol/l|-lrb-|mean|+|/|-|s.d.|;|n|=|5|-rrb-|.	4533753	0.0	8
,|broad|spectrum|,|irreversible|COMPOUND_ENTITY|protease|inhibitor|,|aebsf|,|inhibit|constitutive|production|GENE_ENTITY|beta|different|human|cell|line|,|neural|nonneural|.	4534683	0.0	8
conclusion|,|combination|COMPOUND_ENTITY|GENE_ENTITY|ifn|exhibit|high|response|rate|atl|patient|prolong|survival|.	4535122	0.0	8
COMPOUND_ENTITY|effect|weal|flare|response|GENE_ENTITY|paf|bk|.	4536718	0.0	8
malignant|t|lymphoma|cell|,|dephosphorylation|nuclear|translocation|GENE_ENTITY|occur|spontaneously|constitutive|activation|COMPOUND_ENTITY|phosphatase|.	4537471	0.0	8
primary|defect|case|study|date|appear|decrease|affinity|GENE_ENTITY|substrate|,|COMPOUND_ENTITY|-lrb-|Gompertz|et|al.|1971|-rrb-|.	5121074	0.0	8
compare|vehicle|,|ra|isomer|COMPOUND_ENTITY|induce|GENE_ENTITY|24-ohase|mrna|.	5124109	0.0	8
single|replacement|icl|,|lys-368|--|>|COMPOUND_ENTITY|gln|,|ICL|III|,|arg-526|--|>|glu|tyr-528|--|>|ser|,|result|mutant|lhr|characteristic|wild-type|GENE_ENTITY|lhr|trafficking|,|hcg|binding|hcg-mediated|camp|production|.	5134857	0.0	8
COMPOUND_ENTITY|versus|lisinopril|treatment|essential|hypertension|elderly|patient|low|blood|GENE_ENTITY|renin|.	5134981	0.0	8
COMPOUND_ENTITY|,|dopamine|forskolin|,|raise|level|phosphorylate|GENE_ENTITY|c-jun|activity|jun|kinase|-lrb-|sapk/jnk|-rrb-|striatal|culture|.	5157341	0.0	8
COMPOUND_ENTITY|content|GENE_ENTITY|gamma|glutamyl|cysteine|synthetase|mrna|expression|predict|cisplatin|resistance|head|neck|cancer|cell|line|.	5157360	0.0	8
report|brother|familial|Creutzfeldt|Jakob|disease|-lrb-|cjd|-rrb-|heterozygous|point|mutation|codon|200|GENE_ENTITY|protein|gene|-lrb-|COMPOUND_ENTITY|--|>|ly|-rrb-|:|cjd200|.	5157775	0.0	8
plasma|COMPOUND_ENTITY|measure|colorimetric|method|Neeld|_|Pearson|GENE_ENTITY|rbp|radial|immunodiffusion|technique|.	5473815	0.0	8
GENE_ENTITY|platelet|aggregation|inhibit|COMPOUND_ENTITY|protease|inhibitor|,|aprotinin|bdellin|,|lysine|binding|site|inhibitor|,|epsilon-aminocaproic|acid|-lrb-|eaca|-rrb-|.	5475227	0.0	8
GENE_ENTITY|lack|COMPOUND_ENTITY|carboxyl-terminal|domain|dynamin|bind|sh3|domain|activate|.	5481714	0.0	8
basal|GENE_ENTITY|level|similar|normal|control|COMPOUND_ENTITY|user|remain|unmodified|control|test|.	5488953	0.0	8
examine|effect|COMPOUND_ENTITY|myeloblastic|cell|line|m1|respond|GENE_ENTITY|interleukin-6|-lrb-|il-6|-rrb-|growth|arrest|monocytoid|differentiation|.	5489743	0.0	8
GENE_ENTITY|COMPOUND_ENTITY|oxide|dose|10|100|ppm|facemask|.	5489986	0.0	8
COMPOUND_ENTITY|acid|nuclear|receptor|GENE_ENTITY|alpha|-lrb-|rar|alpha|-rrb-|play|major|role|retinoid-mediated|inhibition|growth|human|breast|carcinoma|cell|.	5492204	1.0	8
pretreatment|inhibitor|COMPOUND_ENTITY|kinase|affect|desensitization|GENE_ENTITY|orl1|.	5492453	0.0	8
Run|experiment|demonstrate|COMPOUND_ENTITY|increase|stability|GENE_ENTITY|pai-1|mrna|endometrial|stromal|cell|.	5495427	0.0	8
widespread|expression|chondroitin|COMPOUND_ENTITY|serglycin|GENE_ENTITY|cd44|binding|ability|hematopoietic|cell|.	5496353	0.0	8
Mitosis|specific|COMPOUND_ENTITY|phosphorylation|downregulation|focal|adhesion|protein|,|GENE_ENTITY|paxillin|.	5504652	0.0	8
result|COMPOUND_ENTITY|inhibit|icam-1|GENE_ENTITY|cd29|basal|expression|cell|study|-lrb-|p|<|0.05|-rrb-|:|budesonide|effective|dose-dependent|manner|.	5504885	0.0	8
GENE_ENTITY|rd2|abundant|COMPOUND_ENTITY|glycine|residue|,|proline|serine|residue|,|respectively|.	5505163	0.0	8
differential|regulation|plasminogen|activator|inhibitor-1|-lrb-|GENE_ENTITY|-rrb-|gene|expression|growth|factor|COMPOUND_ENTITY|human|endometrial|stromal|cell|.	5505886	0.0	8
examine|inter-action|GENE_ENTITY|COMPOUND_ENTITY|ovarian|cell|.	5506652	0.0	8
dna|analysis|suggest|significantly|increase|endometrial|cancer|risk|COMPOUND_ENTITY|valine|substitution|nucleotide|677|GENE_ENTITY|mthfr|gene|odds|ratio|2.8|-lrb-|95|%|confidence|interval|:|1.36-6|.14|,|p|=|0.002|-rrb-|.	5506823	0.0	8
regulatory|role|COMPOUND_ENTITY|e2|induction|GENE_ENTITY|cyclo-oxygenase-2|thromboxane|a2|analogue|-lrb-|u46619|-rrb-|basic|fibroblast|growth|factor|porcine|aortic|smooth-muscle|cell|.	5506990	0.0	8
cdna-expressed|GENE_ENTITY|-lrb-|arg|144|COMPOUND_ENTITY|144|-rrb-|favor|s-2|-|s-3-hydroxyibuprofen|formation|,|CYP2C8|favor|r-2-hydroxyibuprofen|formation|.	5507753	0.0	8
background|:|GENE_ENTITY|act|adaptor|protein|transduction|signal|receptor|COMPOUND_ENTITY|kinase|ras|.	5508683	1.0	8
purpose|study|evaluate|expression|COMPOUND_ENTITY|-rrb-|-|bind|s100|protein|s100a1|,|s100a2|,|s100a3|,|GENE_ENTITY|s100a4|,|s100a6|s100b|normal|skin|.	5509263	0.0	8
COMPOUND_ENTITY|receptor|-lrb-|glyr|-rrb-|cytoplasmic|domain-associated|protein|,|GENE_ENTITY|gephyrin|,|cluster|postsynaptic|membrane|constitute|good|model|address|question|.	5509270	0.0	8
binding|protein|sh2|domain|GENE_ENTITY|report|occur|mainly|COMPOUND_ENTITY|follow|receptor|activation|.	5509383	0.0	8
GENE_ENTITY|inhibitor|-lrb-|slpi|-rrb-|COMPOUND_ENTITY|protease|inhibitor|,|produce|locally|respiratory|genital|gland|,|liver|.	5509980	0.0	8
GENE_ENTITY|beta-1|-lrb-|tgf|beta-1|-rrb-|secretion|downregulate|COMPOUND_ENTITY|treatment|increase|follow|treatment|epristeride|-lrb-|3|x|10|-lrb-|-9|-rrb-|m|,|p|<|0.05|-rrb-|.	5510050	0.0	8
voltage-clamp|condition|,|COMPOUND_ENTITY|block|GENE_ENTITY|herg|dose|dependent|half-maximal|inhibitory|concentration|6.5|nm|22|degree|c|-lrb-|n|=|25|cell|-rrb-|.	5510366	0.0	8
underlie|mechanism|hcs-deficiency|,|discover|1981|,|decrease|affinity|GENE_ENTITY|COMPOUND_ENTITY|impair|formation|holocarboxylase|physiological|biotin|level|.	5512076	0.0	8
COMPOUND_ENTITY|+|-|independent|cytosolic|GENE_ENTITY|phospholipase|hl-60|cell|differentiate|granulocyte|.	5512097	0.0	8
GENE_ENTITY|-lrb-|7-36|-rrb-|amide|induce|membrane|depolarization|associate|inhibition|whole-cell|k|-lrb-|COMPOUND_ENTITY|-rrb-|current|.	5512903	0.0	8
,|unclear|intrinsic|COMPOUND_ENTITY|kinase|activity|GENE_ENTITY|egf|receptor|involve|.	5852690	0.0	8
activate|transcription|factor|1|-lrb-|GENE_ENTITY|-rrb-|COMPOUND_ENTITY|element|-lrb-|cre|-rrb-|-|binding|protein|-lrb-|creb|-rrb-|activate|transcription|cre|locate|promoter|cellular|viral|gene|.	5853690	0.0	8
ici|164384|reverse|COMPOUND_ENTITY|induction|GENE_ENTITY|p21|.	5854149	0.0	8
COMPOUND_ENTITY|protein|-lrb-|GENE_ENTITY|rbp|-rrb-|function|transporter|retinol|-lrb-|vitamin|-rrb-|plasma|higher|eukaryote|.	5861048	0.0	8
COMPOUND_ENTITY|reduce|tc|-lrb-|-29|%|-rrb-|,|ldl-c|-lrb-|-37|%|-rrb-|tg|-lrb-|-25|%|-rrb-|-lrb-|p|<|0.001|-rrb-|,|affect|GENE_ENTITY|lp|-lrb-|-rrb-|.	5862135	0.0	8
stimulation|GENE_ENTITY|/|sil-6r|,|gp130|,|cytoplasmic|janus|kinase|jak1|jak2|COMPOUND_ENTITY|phosphorylated|.	5862214	0.0	8
plasma|level|GENE_ENTITY|baseline|condition|cold|pressor|test|-lrb-|COMPOUND_ENTITY|-rrb-|measure|.	5868252	0.0	8
anti-neoplastic|property|human|GENE_ENTITY|factor|:|involvement|COMPOUND_ENTITY|oxide|pathway|.	5869408	0.0	8
sin-1|snap|reduce|-lsb-|COMPOUND_ENTITY|-rsb-|,|GENE_ENTITY|sin-1|reduce|-lsb-|NAD|+|-rsb-|.	5869729	0.0	8
activation|npr-a|guanylyl|cyclase|require|GENE_ENTITY|binding|extracellular|domain|COMPOUND_ENTITY|binding|putative|site|cytoplasmic|region|.	5869839	0.0	8
,|quinestrol|,|ethinyl|estradiol|derivative|,|weakly|degrade|GENE_ENTITY|,|estradiol|COMPOUND_ENTITY|effect|.	5869951	0.0	8
presence|COMPOUND_ENTITY|-lrb-|2.79|microm|-rrb-|find|significant|effect|response|bk|GENE_ENTITY|des-arg9-bk|.	5871699	0.0	8
hypoxia|,|transition|metal|,|COMPOUND_ENTITY|chelator|,|antioxidant|stabilize|GENE_ENTITY|hif-1alpha|protein|,|allow|formation|transcriptionally|active|hif-1|complex|.	5871727	0.0	8
chimeric|receptor|,|raralpha/vdr|,|contain|dna-binding|domain|COMPOUND_ENTITY|acid|receptor|-lrb-|GENE_ENTITY|raralpha|-rrb-|ligand-binding|domain|vitamin|d|receptor|-lrb-|vdr|-rrb-|.	5873801	1.0	8
COMPOUND_ENTITY|d3|receptor|-lrb-|GENE_ENTITY|drd3|-rrb-|ser9gly|polymorphism|schizophrenia|:|haplotype|relative|risk|study|association|clozapine|response|.	5874063	1.0	8
COMPOUND_ENTITY|administer|significantly|decrease|circulate|GENE_ENTITY|icam-1|plasma|level|diabetic|patient|,|effect|observe|normal|subject|.	5874105	0.0	8
genomic|clone|contain|GENE_ENTITY|gene|isolate|cosmid|library|t.|virens|base|complementation|COMPOUND_ENTITY|auxotrophic|mutant|fungus|.	5875340	0.0	8
finding|indicate|COMPOUND_ENTITY|agent|opposite|effect|-lsb-|ca2|+|-rsb-|i-mediated|GENE_ENTITY|vwf|secretion|pgi2|release|.	5881984	0.0	8
express|hca-rp|GENE_ENTITY|COMPOUND_ENTITY|fusion|protein|-lrb-|gst-hca-rp|viii|-rrb-|.	5882197	0.0	8
gene|involve|COMPOUND_ENTITY|-lrb-|protein|kinase|c-alpha|-rrb-|ampa|receptor|recycling|-lrb-|GENE_ENTITY|neep-21|-rrb-|downregulate|.	20660403	0.0	8
,|presence|COMPOUND_ENTITY|d|,|dna-damaging|agent|,|addition|GENE_ENTITY|ifn-beta|enhance|susceptibility|pbmc|apoptosis|.	20660596	0.0	8
addition|COMPOUND_ENTITY|derivative|,|small|molecule|inhibitor|GENE_ENTITY|p67/metap2|recently|identify|drug|phase|iii|trial|cancer|therapy|.	20661763	0.0	8
find|GENE_ENTITY|engagement|induce|spleen|COMPOUND_ENTITY|kinase|-lrb-|syk|-rrb-|syk|involve|tyrosine|phosphorylation|ezrin|.	20661794	0.0	8
GENE_ENTITY|member|COMPOUND_ENTITY|kinase|family|properly|regulate|cell|division|process|,|recently|implicate|tumorigenesis|.	20662944	0.0	8
COMPOUND_ENTITY|significantly|suppress|expression|level|lpl|mrna|GENE_ENTITY|lpl|protein|dose-dependent|time-dependent|manner|,|respectively|.	20665768	0.0	8
COMPOUND_ENTITY|dehydrogenase|5|expression|melanoma|increase|disease|progression|associate|expression|bcl-xl|GENE_ENTITY|mcl-1|,|bcl-2|protein|.	20665997	0.0	8
zymosan|induce|rapid|expression|GENE_ENTITY|production|COMPOUND_ENTITY|-rrb-|il-10|.	20666524	0.0	8
contrast|,|elf-emf|decrease|GENE_ENTITY|expression|,|COMPOUND_ENTITY|-rrb-|production|,|catalase|activity|o|-lrb-|2|-rrb-|-lrb-|-|-rrb-|production|.	20667228	0.0	8
comparison|gene|reveal|novel|GENE_ENTITY|product|structure|conserve|ras|14-3-3|binding|domain|,|lack|COMPOUND_ENTITY|phosphorylation|site|.	20668721	0.0	8
-lrb-|GENE_ENTITY|-rrb-|5-pcr|reference|framework|COMPOUND_ENTITY|acid|bacterium|.	20669615	0.0	8
Imatinib|COMPOUND_ENTITY|reverse|multidrug|resistance|cancer|cell|inhibit|efflux|activity|mrp7|-lrb-|GENE_ENTITY|abcc10|-rrb-|.	20670436	0.0	8
concomitantly|,|COMPOUND_ENTITY|g2/m|arrest|associate|reduction|cyclin|b1|expression|GENE_ENTITY|phosphorylated-cdc2|-lrb-|thr-161|-rrb-|.	20670480	0.0	8
binding|mode|support|observation|reduce|nag|affinity|mutation|COMPOUND_ENTITY|residue|GENE_ENTITY|CPSI|-lrb-|recombinantly|express|use|baculovirus/insect|cell|-rrb-|;|fine-mapping|n-chloroacetyl-l-glutamate|photoaffinity|label|site|CPSI|;|previously|establish|structure-activity|relationship|nag|analogue|.	20671226	0.0	8
accordingly|,|GENE_ENTITY|insensitive|intracellular|atp|,|,|previously|observe|trpv1|,|sensitize|effect|COMPOUND_ENTITY|trpv4|require|intact|binding|site|.	20679189	0.0	8
GENE_ENTITY|gene|encode|pore|form|alpha-1a|subunit|neuronal|voltage-dependent|p/q-type|COMPOUND_ENTITY|-rrb-|channel|.	21108506	0.0	8
erythrocyte|sedimentation|rate|,|c-reactive|protein|,|adrenocorticotropic|hormone|-lrb-|acth|-rrb-|,|cortisol|,|prolactin|,|GENE_ENTITY|factor-1|-lrb-|igf-1|-rrb-|,|insulin-like|growth|factor-binding|protein|3|,|free|t3|,|free|t4|,|thyroid-stimulating|hormone|,|interleukin-6|-lrb-|il-6|-rrb-|level|,|24-h|urinary|COMPOUND_ENTITY|evaluate|active|period|remission|.	21113218	0.0	8
single|nucleotide|polymorphism|position|388|GENE_ENTITY|amino-acid|sequence|result|substitution|glycine|-lrb-|gly|-rrb-|arginine|-lrb-|COMPOUND_ENTITY|-rrb-|higher|frequency|ArgArg|genotype|previously|find|prostate|cancer|patient|.	21113367	0.0	8
GENE_ENTITY|promoter|mutation|nc.-153c|>|t|non|p.c282y|homozygous|patient|COMPOUND_ENTITY|overload|.	21113618	0.0	8
comparison|croaker|human|GENE_ENTITY|similar|estrogen|binding|characteristic|,|typical|estrogen|membrane|receptor|,|activate|estrogen|signaling|pathway|stimulatory|g|protein|-lrb-|gs|-rrb-|result|increase|COMPOUND_ENTITY|production|.	21122702	0.0	8
animal|study|implicate|COMPOUND_ENTITY|GENE_ENTITY|vasopressin|social|bonding|,|physiological|stress|response|,|wound|healing|.	21137879	0.0	8
remove|extracellular|-lrb-|2|+|-rrb-|chelate|cytosolic|COMPOUND_ENTITY|-rrb-|equally|inhibitory|GENE_ENTITY|apoa-i|lipidation|.	21138613	0.0	8
GENE_ENTITY|-lrb-|buche|-rrb-|enzyme|capable|hydrolyse|wide|variety|ester|include|COMPOUND_ENTITY|,|molecule|involve|neurotransmission|modulation|immune|cell|activity|.	21140181	1.0	8
GENE_ENTITY|catalyze|COMPOUND_ENTITY|rearrangement|displace|sf3a|sf3b|complex|branchpoint|spliceosome|.	21141285	0.0	8
background|:|trimethylation|COMPOUND_ENTITY|27|histone|h3|-lrb-|h3k27me3|-rrb-|enhancer|zeste|homolog|2|-lrb-|GENE_ENTITY|ezh2|-rrb-|epigenetic|mark|mediate|gene|silencing|.	21144738	0.0	8
objective|:|retinol|binding|protein|4|-lrb-|GENE_ENTITY|-rrb-|,|specific|carrier|COMPOUND_ENTITY|blood|,|novel|adipokine|implicate|pathophysiology|insulin|resistance|,|gene|expression|associate|adipose|tissue|inflammation|.	21145317	1.0	8
conclusion|:|large|series|,|GENE_ENTITY|mutation|common|cause|COMPOUND_ENTITY|responsive|hh|.	21565877	0.0	8
strikingly|,|find|pak1|phosphorylation|cortactin|COMPOUND_ENTITY|residue|405|418|increase|association|GENE_ENTITY|n-wasp|.	21567272	0.0	8
COMPOUND_ENTITY|,|excitatory|amino|acid|transporter|,|xc|-|antiporter|,|glutamine|synthetase|,|GENE_ENTITY|gamma-glutamyltranspeptidase|human|corneal|epithelium|.	21567329	0.0	8
plasma|GENE_ENTITY|activity|24|h|aliskiren|intake|61|%|higher|COMPOUND_ENTITY|phase|placebo|phase|-lrb-|p|=|0.008|-rrb-|.	21571124	0.0	8
,|COMPOUND_ENTITY|long-acting|release|-lrb-|lar|-rrb-|add|reach|normalization|gh|GENE_ENTITY|igf-i|level|.	21572911	0.0	8
hab18g/cd147|downregulate|,|e-cadherin|expression|hek293ar|cell|significantly|suppress|;|,|knockdown|e-cadherin|GENE_ENTITY|sirna|blocking|e-cadherin|binding|activity|specific|antibody|COMPOUND_ENTITY|significant|effect|hab18g/cd147|expression|.	21572986	0.0	8
result|:|mean|neocortical|GENE_ENTITY|receptor|binding|positively|correlate|COMPOUND_ENTITY|-lrb-|p|=|0.0001|-rrb-|,|independent|effect|testosterone|demonstrate|.	21582857	0.0	8
result|indicate|,|time|,|dose-dependent|GENE_ENTITY|mrna|protein|downregulation|Valsartan|COMPOUND_ENTITY|treatment|.	21582880	0.0	8
finding|identify|novel|GENE_ENTITY|modification|,|include|rsk-mediated|phosphorylation|bifunctional|residue|COMPOUND_ENTITY|zipper|regulate|dna|binding|homodimerization|promote|cell|cycle|arrest|.	21584254	0.0	8
COMPOUND_ENTITY|enhance|GENE_ENTITY|toll-like|receptor|2|expression|activate|bronchial|epithelial|cell|.	21585234	0.0	8
,|result|provide|evidence|unique|metabolic|role|GENE_ENTITY|,|link|COMPOUND_ENTITY|metabolism|,|energy|,|ros|homeostasis|,|contribute|p53|tumor|suppressor|function|.	21589507	0.0	8
conclusion|:|COMPOUND_ENTITY|effectively|inhibit|secretion|proinflammatory|cytokine|include|GENE_ENTITY|il-6|,|ifn-gamma|tnf-alpha|secretion|il-2|,|il-12|,|il-17|,|gm-csf|g-csf|.	21589838	0.0	8
GENE_ENTITY|overexpression|pc3|pncap|increase|transcriptional|activity|ar|low|level|COMPOUND_ENTITY|.	21590533	0.0	8
thaa|aa|inhibit|production|nitric|oxide|-lrb-|-rrb-|COMPOUND_ENTITY|-rrb-|suppress|expression|inducible|synthase|GENE_ENTITY|cyclooxygenase-2|,|respectively|,|lps-activated|raw264|.7|macrophage|.	21591142	0.0	8
furthermore|,|GENE_ENTITY|phosphorylation|require|hdac2|interaction|transcription|factor|,|co-repressor|complex|formation|,|cbp|recruitment|,|acetylation|COMPOUND_ENTITY|residue|modulate|transrepression|activity|.	21591265	0.0	8
conclusion|:|patient|stable|COPD|,|level|serum|COMPOUND_ENTITY|GENE_ENTITY|rbp|-lrb-|4|-rrb-|significantly|decrease|,|associate|nutritional|status|.	21591594	0.0	8
doc2|protein|cytosolic|,|function|analogously|GENE_ENTITY|higher|COMPOUND_ENTITY|+|sensitivity|.	21592038	0.0	8
Clotrimazole|potentiate|inhibitory|effect|COMPOUND_ENTITY|key|glycolytic|enzyme|GENE_ENTITY|6-phosphofructo-1-kinase|.	21592779	0.0	8
mutagenesis|establish|COMPOUND_ENTITY|important|,|contribute|approximately|5-10-fold|rate|acceleration|GENE_ENTITY|fxa|fxia|inhibition|.	21594039	0.0	8
COMPOUND_ENTITY|stimulation|smct1|-lrb-|GENE_ENTITY|slc5a8|-rrb-|heterologous|expression|system|:|rpe|specific|phenomenon|.	21594930	0.0	8
primary|human|hepatocyte|use|study|LCA|COMPOUND_ENTITY|-rrb-|activation|GENE_ENTITY|vdr|signaling|.	21595519	0.0	8
COMPOUND_ENTITY|induce|up-regulation|pten|GENE_ENTITY|ppargamma|leiomyoma|cell|,|normal|cell|.	21595544	0.0	8
,|prostaglandin|e|-lrb-|2|-rrb-|-lrb-|COMPOUND_ENTITY|-rrb-|,|GENE_ENTITY|cox-2-derived|eicosanoid|,|find|affect|numerous|tumorigenic|process|.	21595809	0.0	8
background|:|COMPOUND_ENTITY|hydrochloride|-lrb-|cas|120014-06-4|-rrb-|piperidine-based|,|reversible|inhibitor|enzyme|GENE_ENTITY|acetylcholinesterase|-lrb-|ache|-rrb-|.	21596590	0.0	8
finding|support|use|liraglutide|effective|GENE_ENTITY|agent|add|COMPOUND_ENTITY|.	21597976	0.0	8
COMPOUND_ENTITY|acid|-lrb-|ra|-rrb-|-|stimulate|human|promyelocytic|leukemia|-lrb-|hl-60|-rrb-|cell|,|transcription|GENE_ENTITY|blt1|gene|find|significantly|activate|.	21598124	0.0	8
vitro|,|GENE_ENTITY|stimulate|dose-dependently|placental|COMPOUND_ENTITY|secretion|,|stimulation|inhibit|antisauvagine-30|,|crf-receptor|2|antagonist|.	21598342	0.0	8
investigate|signalling|event|downstream|GENE_ENTITY|determine|sensitivity|aml|cell|COMPOUND_ENTITY|.	21599947	0.0	8
antibiotic|substrate|GENE_ENTITY|include|kanamycin|,|kanamycin|b|,|tobramycin|,|sisomicin|,|neomycin|b|,|COMPOUND_ENTITY|,|lividomycin|,|ribostamycin|.	21600122	0.0	8
mutate|residue|COMPOUND_ENTITY|individually|combination|markedly|suppress|integrin|binding|GENE_ENTITY|erbb3|phosphorylation|.	22022337	0.0	8
recently|novel|activator|GENE_ENTITY|receptor|available|:|COMPOUND_ENTITY|eltrombopag|.	22022347	1.0	8
western|blot|decrease|GENE_ENTITY|2|,|p-akt1|/|2/3|,|p-stat3|,|p-ampkalpha|expression|level|COMPOUND_ENTITY|treatment|group|.	22022718	0.0	8
depletion|GENE_ENTITY|endometrial|carcinoma|cell|abrogate|artn-stimulated|resistance|doxorubicin|COMPOUND_ENTITY|.	22022900	0.0	8
similarly|COMPOUND_ENTITY|,|interaction|la-12|molecular|chaperone|GENE_ENTITY|hsp90|propose|.	22034193	0.0	8
mesencephalic|COMPOUND_ENTITY|neuron|culture|,|majority|isolate|dopamine|neuron|express|vglut2|,|GENE_ENTITY|vglut1|3|,|demonstrate|.	22034619	0.0	8
her1|,|GENE_ENTITY|,|her4|comprise|major|functional|domain|:|extracellular|ligand-binding|domain|,|hydrophobic|transmembrane|domain|,|cytoplasmic|COMPOUND_ENTITY|kinase|domain|.	22035192	0.0	8
Discovery|bishomo|-lrb-|hetero|-rrb-|arylpiperazine|novel|multifunctional|ligand|target|COMPOUND_ENTITY|d|-lrb-|3|-rrb-|serotonin|5-ht|-lrb-|1a|-rrb-|GENE_ENTITY|5-ht|-lrb-|2a|-rrb-|receptor|.	22035390	0.0	8
status|GENE_ENTITY|inhibitor|,|include|dasatinib|,|saracatinib|,|COMPOUND_ENTITY|,|phase|1|,|2|,|3|trial|,|highlight|.	22036064	0.0	8
COMPOUND_ENTITY|inhibit|lps-induced|inflammatory|signaling|GENE_ENTITY|ppargamma-dependent|mechanism|human|thp-1|macrophage|.	22036925	0.0	8
oral|antidiabetic|drug|work|stimulate|GENE_ENTITY|secretion|,|repaglinide|COMPOUND_ENTITY|,|available|U.S.|.	22037167	0.0	8
receptor|COMPOUND_ENTITY|kinase|RET|,|receptor|GENE_ENTITY|gdnf|-lrb-|glial|cell|line-derived|neurotrophic|factor|-rrb-|,|function|majority|tyrosine|residue|phosphorylate|unknown|.	22037611	0.0	8
find|difference|basal|plasma|adiponectin|,|resistin|GENE_ENTITY|-lrb-|tnfa|-rrb-|,|increase|find|basal|leptin|,|COMPOUND_ENTITY|treatment|.	22039500	0.0	8
enantioselective|synthesis|GENE_ENTITY|-1,3|-|amino|alcohol|COMPOUND_ENTITY|sequential|alpha-aminoxylation/alpha-amination|horner-wadsworth-emmons|olefination|aldehyde|.	22039916	0.0	8
tubulin|hyperacetylation|COMPOUND_ENTITY|40|enhance|kinesin-1|GENE_ENTITY|jip-1|recruitment|microtubule|allow|jnk|phosphorylation|activation|.	22040336	0.0	8
vitamin|metabolite|,|COMPOUND_ENTITY|acid|,|mediate|alternative|splicing|protein|kinase|c|deltaviii|-lrb-|pkcdeltaviii|-rrb-|isoform|GENE_ENTITY|splicing|factor|sc35|.	22041688	1.0	8
inhibition|COMPOUND_ENTITY|phosphatase|-lrb-|ptp|-rrb-|,|enrich|focal|adhesion|,|block|GENE_ENTITY|il-1-induced|mmp3|release|.	22041780	0.0	8
zn|-lrb-|ii|-rrb-|inhibit|fibrillation|monomeric|insulin|physiological|ph|value|form|soluble|COMPOUND_ENTITY|-rrb-|-|GENE_ENTITY|insulin|complex|.	22042582	0.0	8
conclusion|implication|:|drug-drug|interaction|cyp2d6|cyp3a|affect|COMPOUND_ENTITY|pharmacokinetic|magnitude|depend|GENE_ENTITY|cyp2d6|genotype|.	22043468	0.0	8
conclusion|:|ez/simva|effective|therapeutic|option|patient|achieve|recommend|GENE_ENTITY|treatment|target|COMPOUND_ENTITY|20|mg|monotherapy|.	22044329	0.0	8
immunohistochemical|study|tumour|cell|positive|inhibin|,|CD|99|,|Melan|A|GENE_ENTITY|negative|CK|AE1|,|CK|AE3|,|COMPOUND_ENTITY|estrogen|receptor|.	22044494	0.0	8
GENE_ENTITY|--|placebo|control|trial|COMPOUND_ENTITY|acute|low|pain|:|design|randomised|controlled|trial|.	22046345	0.0	8
position|COMPOUND_ENTITY|residue|influence|substrate|affinity|k|+|coupling|human|glutamate|transporter|,|GENE_ENTITY|eaat1|.	22049406	0.0	8
her1|,|GENE_ENTITY|,|her4|comprise|major|functional|domain|:|extracellular|ligand-binding|domain|,|hydrophobic|transmembrane|domain|,|cytoplasmic|COMPOUND_ENTITY|kinase|domain|.	22049637	0.0	8
